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ABSTRACT 
The folding of interphase chromatin into large-scale chromatin structure and its 
spatial organization within nucleus has been suggested to have important roles in gene 
regulation.  In this study, we created engineered chromatin regions consisting of 
tandem repeats of BAC transgenes, which contain 150-200 kb of defined genomic 
regions, and used them as a model system to study the mechanisms and functional 
significance of large-scale chromatin organization.   
The BAC transgene arrays recapitulated several important features of endogenous 
chromatin, including transcription level and intranuclear positioning.  Using this 
system, we showed that tandem arrays of housekeeping gene loci form open 
large-scale chromatin structure independent of their genomic integration sites, 
including insertions within centromeric heterochromatin.  This BAC-specific 
large-scale chromatin conformation provided a permissive environment for 
transcription, as evidenced by the copy-number dependent and position independent 
expression of embedded reporter mini-genes.  This leads to the development of a 
novel method for reliable transgene expression in mammalian cells, which should 
prove useful in a number of therapeutic and scientific applications.    
We also demonstrated that BAC transgene arrays can be employed as an effective 
system for dissecting sequence determinants for intranuclear positioning of gene loci.   
We showed that in mouse ES and fibroblast cells a BAC carrying a 200 kb human 
genomic fragment containing the beta-globin locus autonomously targets to the 
nuclear periphery.  Using BAC recombineering, we dissected this 200kb region and 
identified two genomic regions sufficient to target the BAC transgenes to nuclear 
periphery.  This study represents a first step towards elucidation of the molecular 
mechanism for the nuclear peripheral localization of genes in mammalian cells.
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CHAPTER 1 
INTRODUCTION 
For cells to function and propagate, the information stored in DNA molecules 
needs to be precisely retrieved and duplicated.  Understanding the mechanisms for 
regulation of transcription and replication is therefore one of the main themes of 
current biological research.  Advances in sequencing technology in last twenty years 
have led to the rapid expansion of genomic databases and improved the understanding 
of the function of genome.  However, to fully elucidate the mechanisms for genome 
regulation, one must realize that in eukaryotic cells the genome exists in the form of 
chromatin, a highly compacted and organized structural entity, rather than in the form 
of one dimensional DNA molecules. The organization and dynamics of chromatin 
structure plays a critical role in gene regulation. 
The compaction of over 1 meter of DNA into chromatin fibers which fit within the 
limited space of nucleus is achieved via a hierarchy of folding events (Woodcock, 
2006).  The basic building block of chromatin is the nucleosome, consisting of 146 
bp of DNA wrapping around a core histone octamer (Luger et al., 1997).  In vitro 
studies have shown that purified or reconstituted nucleosomes arrays can fold into 
30nm chromatin fiber and higher order chromatin fiber upon the addition of cation 
(Hansen, 2002; Simpson et al., 1985).  While the 30nm fiber has been well accepted 
as an intermediate level of chromatin structure, the chromatin folding above 30nm 
fiber in interphase nuclei, defined as large-scale chromatin structure, has been poorly 
characterized and understood (Maeshima et al., 2010; Woodcock and Ghosh, 2010).  
The relationship between large-scale chromatin structure and the regulation of nuclear 
processes involving DNA, although implied by many studies, is still not well 
established (Belmont et al., 1999). 
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On the other hand, the highly folded chromatin is arranged in the three 
dimensional space of the nucleus in a non-random fashion.  The nuclear radial 
positioning of chromatin domains and genes and their location relative to specific 
nuclear subcompartments or other genomic loci have been shown to have 
comprehensive implications on gene regulation (Ferrai et al., 2010; Misteli, 2007).  
Research in the Belmont laboratory focuses on understanding the organization and 
functional significances of higher-order chromatin structure.  Since the mid 1990s, 
the laboratory has been working on the development of new strategies for visualizing 
chromatin structure in vivo and studying the ultrastructure and dynamics of chromatin.  
The studies in this thesis are based on a new generation of experimental system which 
recapitulates the chromatin structure of endogenous loci at a higher degree by using 
tandem repeats of bacterial artificial chromosome (BAC) transgene arrays (Bian and 
Belmont, 2010; Hu et al., 2009a; Sinclair et al., 2010).  Using this method, I 
investigated the functional implication of “open” large-scale chromatin structure at 
the microscopic level and developed a new strategy for expressing transgenes at high 
level.  I also performed a study to identify the sequence determinants for the 
localization of a genomic region at nuclear periphery.  This study is a first step 
towards better understanding the molecular mechanism for the nuclear peripheral 
localization of genes in mammalian cells. 
 
Hierarchical folding of chromatin 
A nucleosome core particle is formed by wrapping 146 base pairs of DNA double 
helix around an octameric histone core (two copies of histone H2A, H2B, H3 and H4) 
in 1.65 left handed superhelical turn (Luger et al., 1997).  The tails of the core 
histone protrude from the histone octamer and are subject to covalent modifications. 
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Such posttranslational histone modification can alter the interactions between histones 
and DNA and other chromatin-bound proteins and therefore may play critical roles in 
regulating chromatin structure (Horn and Peterson, 2002).  In addition to the core 
histones, another species of histone, linker histone, is present in most metazoan cells.  
Linker histone binds to the linker DNA between nucleosomes and protects about 20bp 
of linker DNA from nuclease digestion (Parseghian et al., 2001).  Multiple lines of 
evidence has suggested linker histone plays important roles in mediating interactions 
between nucleosomes and chromatin fibers and promoting the formation of 
higher-order chromatin structure (Bednar et al., 1998; Fan et al., 2005; Woodcock et 
al., 2006). 
The studies on purified or reconstituted oligo nucleosome arrays have suggested a 
hierarchical folding model for chromatin structure.  In low ionic environment, the 
oligo nucleosome arrays exhibit an extended "beads on a string" conformation with a 
diameter of about 10nm.  Upon the addition of 1-2 mM of bivalent cation, 
nucleosomes on the arrays interact with each other and lead to the formation of a 
compact, fiber-like structure with a diameter of 30nm (Hansen, 2002).  Although 
there is a general agreement that such "30 nm" fiber is a bona fide chromatin structure 
and an intermediate state of in vitro chromatin folding, how the nucleosomes and 
linker histones are arranged with in the 30nm fiber structure still remains 
controversial (Maeshima et al., 2010; Woodcock and Ghosh, 2010).  Separate lines 
of evidence support either of two models for the folding path of 30nm fiber- the one 
start solenoid model and the two start zigzag model, with some recent evidence 
suggesting the two modes of folding may coexist in the same 30nm fiber under certain 
conditions (Grigoryev et al., 2009; Maeshima et al., 2010).  Further increases of 
cation concentration increase the interactions between 30nm fibers and leads to the 
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formation of high molecular weight aggregates of 10 and 30nm fibers.  Importantly, 
the linker histone H1 and some other chromatin architectural proteins such as MeCP2, 
MENT and polycomb have been shown to regulate the compaction of the oligo 
nucleosome arrays and the formation of the thicker chromatin fibers in vitro, which 
may mimic the in vivo regulation of chromatin folding (Francis et al., 2004; Georgel 
et al., 2003; Springhetti et al., 2003; Woodcock, 2006). 
In contrast to this reproducible generation of the 30nm chromatin fiber in vitro, 
there is lack of solid evidence for the existence of 30nm fiber in vivo.  Uniform 
30nm fibers could only be observed in a few cell types, and in some cases only after a 
carefully controlled swelling procedure (Horowitz et al., 1994; Woodcock and 
Horowitz, 1995).  On the other hand, a recent study using cryo-electron microscopy 
of thin section of vitrified mitotic chromosomes did not reveal any ordered fiber 
structure. In fact, the results suggested the chromatin form a homogenous "grainy" 
mass (Eltsov et al., 2008).  Such a "melted" chromatin state may be due to the 
extremely high compaction in mitotic chromosomes and therefore may not resemble 
the chromatin state in less compacted euchromatic regions in interphase nuclei.  Still, 
the gap between the in vitro observation and limited in vivo evidence complicates the 
interpretation of folding mechanisms of chromatin. 
 
Models of large-scale chromatin folding 
In the interphase nucleus where transcription and DNA replication occur, DNA 
primarily exists in structures well above the 30nm fiber. Such chromatin structures are 
usually referred as “large-scale chromatin structure” (Belmont et al., 1999).  Under 
light microscopy, the fluorescent in situ hybridization (FISH) signals of 100-200kb 
genomic regions usually appear as spots below the diffraction limit (Lawrence et al., 
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1990; Yokota et al., 1995).  Even at transcriptionally active, less condensed 
chromosomal regions, the compaction level of chromatin is several fold higher than 
the 1:40 linear compaction ratio expected from 30nm fiber (Mahy et al., 2002; Muller 
et al., 2004).  How the lower-level chromatin units fold into the higher-order 
chromatin structure remains mysterious due to technical limitations of current 
methods available for structural analysis of nuclei and chromosomes. 
Several models have been used to explain large-scale chromatin folding.  A 
radial-loop, helical folding model for interphase chromatin has been extended from 
the radial-loop model of mitotic chromatin folding (Manuelidis, 1990).  On the other 
hand, the numerical modeling of the distances between the FISH signals of regions 
with different genomic separations suggested a giant loop, random walk model 
(Munkel et al., 1999; Yokota et al., 1995).  In this model, chromatin is organized in 
giant loops several megabase pairs in size. Such giant loops are then attached to a 
flexible backbone.  Finally, an alternative “chromonema” model is supported by the 
ultrastructure analysis on interphase chromatin using in vitro light microscopy and 
transmission electron microscopy (Belmont and Bruce, 1994; Li et al., 1998; Robinett 
et al., 1996).  In this model, 30nm fibers first organize into chromonema fibers with 
the diameter of 60-80 nm.  These fibers can be further coiled into thicker fibers with 
the diameter of 100-130 nm. 
Most previous studies on chromatin structure using light microscopy, limited by 
the resolution, could not provide sufficient evidence to confirm any of the proposed 
models for large-scale chromatin folding.  For instance, a FISH study on two 
genomic loci with the sizes of 300-400 kb revealed that the chromatin regions 
decondensed into elongated structures consisting of a series of adjacent puncta, or 
bead-like domains after transcription activation (Muller et al., 2004).  However, such 
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features of chromatin organization can be explained with any of the random-walk, 
radial-loop and chromonema models.  Therefore, technical improvements on light 
microscopy and electron microscopy which allow the structural analysis of specific 
chromatin regions at higher resolution will be essential for elucidating the folding 
paths of large-scale chromatin structure.  
 
Large-scale chromatin structure and gene regulation 
Nucleosome positioning, DNA methylation and histone modifications play critical 
roles in gene regulation by affecting local chromatin structure (Zhou et al., 2011).  
However, it has been increasingly recognized that the large-scale chromatin structure 
also has important functional implications on gene regulation. 
The correlation between chromatin compaction level and transcriptional activity 
has been observed at multiple levels of chromatin organization.  It has long been 
noticed that the active genes are often found in less condensed euchromatin while 
more condensed heterochromatin is enriched in transcriptionally inactive sequences.  
It has been shown that in mammalian cells the gene-rich, transcriptionally active 
chromosomes occupy larger nuclear space than the gene-poor chromosomes (Croft et 
al., 1999).  On the other hand, chromatin decondensation was found accompanying 
transcription activation in different organisms.  In insect polytene chromosomes, 
dramatic chromatin decondensation occurs at highly transcribed chromosome regions, 
known as the phenomenon “puffing” (Callan, 1982; McKenzie et al., 1975).  In 
mammalian cells, chromatin decondensation was observed at certain genomic regions 
with sizes from several hundred Kbp to several Mbp after gene activation (Mahy et al., 
2002; Ragoczy et al., 2003; Volpi et al., 2000).  Such decondensation has also been 
recapitulated in multiple artificial transgene arrays (Hu et al., 2009a; Muller et al., 
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2001; Tumbar et al., 1999). 
Large-scale chromatin structure may affect transcription by acting as an 
accessibility barrier for regulatory factors (Dillon and Festenstein, 2002).  Such a 
model, although attractive, is challenged by observations in yeast and mammalian 
cells that chromatin-associated proteins such as swi6 and HP1 can rapidly exchange at 
sites within highly compact heterochromatin (Cheutin et al., 2004; Cheutin et al., 
2003; Festenstein et al., 2003).  Another study showed inert probes with a radius of 
gyration of 6 nm, which corresponds to spherical proteins with a molecular weight of 
more than 1400 KD, could diffuse freely into condensed heterochromatin domains 
(Verschure et al., 2003).  These results suggest that higher-order chromatin 
compaction itself does not provide an insurmountable barrier for the diffusion of large 
protein complexes, although it may still slow down the rate of this diffusion.  
Whether the lower level chromatin structures within different chromatin domains 
restrain the accessibility of nuclear proteins remains to be tested. 
Another mechanism for gene regulation via chromatin organization is chromatin 
looping (Fraser, 2006).  Chromatin loops have been considered as one of the most 
important structural and functional units in chromatin organization.  In a chromatin 
loop, genes can be placed in proximity with distant regulatory elements, thereby 
positively or negatively affecting gene expression.  The most studied examples for 
such a regulatory role of chromatin loops are the mouse and human beta-globin loci.  
The expression of beta-globin genes are regulated by a distant regulatory element 
called the locus control region (LCR), which is located ~50 kb upstream of 
beta-globin cluster (Grosveld et al., 1987).  The LCR contains several DNase I 
hypersensitive sites, which may function as enhancers and/or chromatin insulators.  
Chromatin loops mediate the direct interaction between different beta-globin genes 
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with LCR during development and give rise to a precise temporal expression pattern 
of beta-globin genes.  The existence of direct regulatory interactions in vivo between 
the DNase hypersensitive sites within LCR and the beta-globin genes has been 
confirmed by several assays such as RNA tagging and recovery of associated proteins 
(RNA TRAP) (Carter et al., 2002) and chromatin conformation capture (3C) (Tolhuis 
et al., 2002). 
Furthermore, organizing chromatin into large-scale loops may contribute to gene 
regulation.  The large-scale chromatin loops may physically segregate large genomic 
regions with distinct transcription patterns away from their genomic neighborhoods 
and place them to the proximity of specific nuclear compartments.  For instance, 
giant chromatin loops containing several megabases of DNA protruding from 
chromosome territory were observed at highly transcribed major histocompatibility 
complex (MHC) gene clusters in several human cell types (Volpi et al., 2000).  The 
upregulation of MHC genes resulted in higher frequency of the formation of such 
large-scale chromatin loops, suggesting a functional link between organization of 
large-scale chromatin loops and transcription.  At the mouse Hox locus, the 
formation of large-scale chromatin loops was observed upon the induction of Hox 
genes (Chambeyron and Bickmore, 2004).  The remarkably synchrony between the 
protrusion of chromatin from chromosome territory and the temporal expression 
pattern of Hox genes implies a direct regulatory role of the large-scale chromatin 
loops. 
 
Spatial organization of chromatin within nucleus 
The highly ordered chromatin is arranged in the 3D nuclear space in a 
non-random way.  This  spatial organization pattern of chromatin may have 
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important implications on gene expression.  Early electron microscopic studies 
suggested condensed, transcriptionally inactive heterochromatin is usually found near 
nuclear periphery and surrounding nucleolus, while euchromatin is located in the 
interior of nucleus.  The correlation between nuclear radial positioning of whole 
chromosomes, chromosome regions and individual genes and their gene density, 
transcriptional activity and replication timing has been observed in a number of 
studies.  In human lymphocytes, the gene-poor chromosome 18 is usually located 
toward nuclear periphery while the gene-rich chromosome 19 is usually positioned in 
nuclear interior (Croft et al., 1999).  The genomic regions in early-replicating R band 
are usually located toward the interior of nucleus compared with the regions in 
late-replicating G bands (Ferreira et al., 1997; Gilbert et al., 2004).  At the single 
gene level, genes like beta-globin and immune-globin heavy chain are located at the 
nuclear periphery when they are inactive (Kosak et al., 2002; Ragoczy et al., 2006).  
Upon gene activation during development these genes relocate to a more interior 
nuclear position.  These investigations point to a link between the spatial 
organization of chromatin and genome function. 
Is nuclear radial positioning a determining factor for gene expression?  The 
answer is likely no.  In mammalian cells, the two alleles of the same gene may 
exhibit different radial positions but usually show similar transcriptional activity 
(Takizawa et al., 2008a; Takizawa et al., 2008b).  This observation is consistent with 
the fact that there is no radial gradient of concentration for most transcription 
regulators.  The exact functional significance of nuclear radial positioning remains to 
be revealed. 
One extreme case for nuclear radial positioning is the attachment of genomic 
regions to the nuclear lamina.  The nuclear lamina is formed by a layer of specialized 
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intermediate filaments and underlays the inner nuclear membrane in higher 
eukaryotes (Dechat et al., 2008).  In addition to providing mechanical support to 
nucleus, the nuclear lamina may play an important role in genome organization and 
transcription regulation.  The mutation of lamin genes leads to aberrant gene 
expression patterns and a number of laminopathies such as Hutchison- Gilford 
progeria syndrome and Emery- Dreifuss muscular dystrophy (Gruenbaum et al., 2005).  
Chromatin associated with the nuclear lamina is depleted of RNA polymerase II and 
active chromatin markers such as histone acetylation and histone H3 lysine 4 
dimethylation (Luco et al., 2008; Sadoni et al., 1999).  A recent effort to map the 
genomic regions preferentially associated with the nuclear lamina identified more 
than 1000 domains which comprise about 30% of mammalian genome (Guelen et al., 
2008).  These lamin-associated domains (LADs) are enriched of transcriptionally 
inactive genomic regions and repressive chromatin markers such as histone H3 lysine 
27 trimethylation.  Therefore, the nuclear lamina may function in gene repression. 
Three recent studies tested whether the association with nuclear lamina had a 
direct silencing effect on gene expression.  All these studies employed an artificial 
tethering system to relocate transgene arrays or whole chromosomes containing 
tandem repeats of lac operator (LacO) sequence to the nuclear periphery by 
expressing fusion proteins consisting of lac repressor (LacI) and lamin protein or 
lamin associated peptides.  Interestingly, different effects of nuclear periphery 
attachment on transcription were observed in these three independent studies.   
In one study, a doxycycline-inducible transgene array was tethered to the nuclear 
lamina using a Lamin B1-LacI fusion protein (Kumaran and Spector, 2008).  This 
peripheral tethering did not result in changes in the kinetics of doxycycline stimulated 
transcription or decrease of transcript levels after induction. Rather, the percentage of 
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cells responding to the induction dropped from 90% to 70%.   
In another study, an entire chromosome containing a single LacO array was 
repositioned to nuclear periphery by expressing a Lap2β-LacI fusion protein (Finlan 
et al., 2008).  Reduction of transcription was observed at several genes close to the 
anchoring site.  However, most genes in the chromosome did not show detectable 
changes of transcription level.  Finally, a study used an Emerin-LacI fusion to tether 
a plasmid transgene array to the nuclear lamina (Reddy et al., 2008).  This tethering 
leads to a 75% reduction of the selectable marker gene next to the LacO repeat, the 
most dramatic change reported so far.   
The different results observed in these studies may be due to the different fusion 
proteins used to tether genes to nuclear periphery but may also reflect gene-specific 
repressive effects upon attachment to nuclear lamina. 
Although gene silencing was observed in all these artificial tethering studies, it is 
important to note the direct tethering may not recapitulate the peripheral association 
of genes in vivo.  It is still unclear whether the peripheral localization of genes is the 
result of direct interaction with the nuclear lamina or lamin-associated peptides.  
FISH studies suggested genes within LADs typically show peripheral localization in 
30-50% of the cells, implying that the interactions between chromatin with the 
nuclear lamina may be transient and/or stochastic (Guelen et al., 2008).  In contrast, 
the artificial tethering system resulted in peripheral localization in nearly 100% of 
cells.  To what extent the effects observed with these systems reflect the real 
influence of nuclear peripheral localization is therefore questionable.  
Besides the radial organization of chromatin inside the nucleus, another important 
theme of the spatial organization of the genome is the association of specific genomic 
regions with different nucleoplasmic compartments.  The proteins involved in 
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different nuclear activities may accumulate in the nucleus, giving rise to a variety of 
nuclear subcompartments or nuclear bodies.  For instance, transcription is 
compartmentalized in the nucleus with RNA polymerase II complexes accumulating 
at many transcription hot spots to form “ transcription factories” (Wansink et al., 
1993).  The proteins involved in splicing of transcripts accumulate into distinct 
nuclear speckles (Hall et al., 2006).  Other nuclear bodies, such as the Cajal body, 
the PML body, and the polycomb body, all have specialized functions in certain 
nuclear processes (Bernardi and Pandolfi, 2007; Gall, 2003; Schuettengruber et al., 
2007).  In mouse B lymphocytes, the Myc gene, upon transcriptional activation 
preferentially moved to transcription factories preoccupied by the Igh gene which is 
located on a different chromosome (Osborne et al., 2007).  A more recent study 
revealed that genes regulated by a specific transcription factor Klf1 co-associated at a 
limited number of transcription factories containing Klf1, again suggesting genome 
organization could facilitate transcription regulation (Schoenfelder et al., 2010).  
Similarly, genes regulated in the same pathway in skeleton muscles or erythroid cells 
tend to co-associate at nuclear speckles (Smith et al., 1999; Xing et al., 1995).  
Therefore, the spatial organization of genome relative to these functional 
compartments may have important implications in coordinating nuclear activities and 
optimizing genome function.  
 
Technologies for studying chromatin and nuclear structure 
To understand the organization of large-scale chromatin structure and its 
functional relationship with transcription and replication, methods for visualizing 
specific chromatin regions at high resolution are needed.  The traditional and most 
widely used method for visualizing chromatin structure is DNA fluorescent in situ 
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hybridization (FISH), in which DNA probes are used to bind to their complementary 
sequences in the genome (Lawrence et al., 1990; Yokota et al., 1995).  This method 
is relatively convenient and can be used to detect any genomic regions with nearly 
any size.  However, the DNA hybridization in this procedure requires heat 
denaturation of nuclear DNA.  Such a harsh treatment, while not necessarily 
producing obvious structural changes of chromatin under the light microscope, results 
in poor ultrastructure preservation of chromatin and the nucleus at the electron 
microscopic structural level (Solovei et al., 2002).  
One of the goals of the research in Belmont lab has been to develop methods to 
study the structure and dynamics of chromatin organization.  In the 1990s, the 
Belmont lab first created an in vivo tagging system to visualize specific chromatin 
regions (Belmont and Straight, 1998; Robinett et al., 1996).  This method employs 
the specific interaction between the well studied lac repressor protein (LacI) and the 
lac operator DNA (LacO).  DNA constructs containing direct repeats of LacO 
sequence were used to generate transgene arrays in mammalian cells.  By expressing 
LacI-GFP fusion protein in living cells or staining with LacI in fixed cells, the 
chromosome regions tagged with LacO repeats could be visualized. 
One obvious advantage of the in vivo tagging system is the improvement of 
chromatin structure preservation.  Without the need of heat denaturation, the 
chromatin structure visualized by LacI binding more likely reflects the native state of 
chromatin.  More importantly, the in vivo tagging system possesses several unique 
advantages which can not be achieved by using other systems.  First, this system 
makes it possible to study the dynamics of specific chromatin regions in living cells.  
In a previous study, a transgene array tagged with LacO repeats was observed to move 
from the nuclear periphery to the nuclear interior after tethering a transcriptional 
14 
 
activator VP16 to the array (Tumbar and Belmont, 2001).  Using live cell imaging, 
we demonstrated that this long range movement is unidirectional along a curvilinear 
path and provided important insights in understanding chromatin reorganization upon 
transcription activation (Chuang et al., 2006).   
Second, the functions of chromosomal proteins such as transcriptional activators, 
repressors and chromosome architectural proteins can be studied by tethering these 
proteins to LacO tagged chromatin regions (Carpenter and Belmont, 2004).  For 
instance, a study showed that acidic transcriptional activator VP16 induced dramatic 
chromatin decondensation at a gene-amplified heterochromatic chromatin region, 
producing extended large-scale chromonema fibers (Tumbar et al., 1999).  Other 
acidic activators, such as Gal4, Hap4 and p65 were shown to have similar chromatin 
decondensation activity (Carpenter et al., 2005).   
Third, this in vivo labeling system is valuable for ultrastructural studies of specific 
chromatin regions by the electron microscopy.  Chromatin regions tagged with LacO 
repeats can be detected using Nanogold-conjugated antibodies.  In a recent study, 
Nanogold-conjugated IgG was microinjected into the cells before embedding without 
the need of detergent treatment (Kireev et al., 2008).  Such a method not only 
improved the ultrastructure preservation of chromatin but also significantly improved 
the labeling efficiency of the Nanogold-coupled antibodies. 
Since the establishment of the in vivo chromosome tagging system, it has been 
adapted by a number of groups to study chromatin structure and dynamics in 
mammalian cells, prokaryotic cells, yeast, Drosophila and C. elegans.  Meanwhile, 
the Belmont lab has been working to improve this system by making it better 
resemble the native chromatin.  The earliest version of the in vivo tagging system 
was used to visualize gene-amplified chromatin regions consisting of hundreds to 
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thousands copies of plasmid DNA and co-amplified genomic DNA (Li et al., 1998; 
Robinett et al., 1996; Tumbar et al., 1999).  These engineered chromosome regions 
exhibited high heterogeneity of chromatin compaction levels and might not represent 
the conformation of endogenous chromatin.   
A more physiological relevant system instead used tandem repeats of plasmid 
transgenes that contained endogenous promoters and/or cis-regulatory elements of 
genes (Dietzel et al., 2004; Muller et al., 2001).  However, variation of chromatin 
conformation and transcription activation kinetics was still observed among different 
cell clones carrying the plasmid transgene arrays, suggesting the behavior of these 
plasmid arrays was under the influence of chromatin position effect.  In addition, 
multi-copy plasmid transgenes were often subject to transgene silencing and 
heterochromatinization (Dorer and Henikoff, 1997; Garrick et al., 1998).  Electron 
microscopic studies on several cell lines carrying plasmid arrays showed that they 
form chromatin structures more condensed than surrounding chromatin (Kireev et al., 
2008).  These drawbacks of the plasmid transgene arrays systems lead to the 
development of the bacterial artificial chromosome (BAC) transgene array system for 
studying chromatin structure and dynamics. 
 BACs are large DNA constructs which can carry 100-300kb of mammalian 
genomic DNA (Shizuya et al., 1992).  They usually contain not only the genes and 
promoters but also other cis-regulatory sequences important for gene regulation and 
chromatin organization.  BACs have been widely exploited as vectors for gene 
expression.  It has been shown that BAC transgenes in mammalian cells and 
transgenic animals reproduce expression patterns and levels of endogenous genes. We 
reasoned that the BACs might also recapitulate the large-scale chromatin structure of 
endogenous genomic regions.   
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Recently published studies from the Belmont lab showed that tandem repeats of 
DHFR, MT or Hsp70 BAC transgenes which consist of several to tens of copies of 
BACs tagged with LacO repeats appeared as extended arrays of LacI-GFP spots in 
CHO cells (Hu et al., 2009a).  All different stable cell clones containing these BAC 
transgene arrays showed similar conformation, with the LacI spots separated by 
0.2-0.3 μm and each LacI spot containing similar copy number of BAC for each type 
of BAC transgene.  Electron microscopic studies revealed that these BAC transgenes 
form large-scale chromatin fibers indistinguishable to the surrounding euchromatin 
regions (Kireev et al., 2008).  The BAC transgenes were expressed at levels within 
several fold of their endogenous counterparts.  In the case of Hsp70 BAC transgenes, 
the BAC transgenes showed very similar rate of gene activation to endogenous Hsp70 
genes upon heat shock.  Such a synchronous and homogenous pattern of gene 
activation was not observed in the plasmid transgene system.  Together these results 
suggest that BAC transgene arrays recapitulate the behavior of endogenous chromatin 
better than previously used gene amplification and plasmid based systems. 
The BAC transgene array system provides us some unique opportunities to study 
chromatin structure.  Multi-copy 100-300kb BAC transgenes will allow us to 
analyze changes in chromatin structure upon transcription activation that may be too 
subtle to be visualized at endogenous genomic loci.  By combining the in vitro 
modification of the BAC DNA and the in vivo analysis we will have the capability to 
identify cis-determinants for a number of chromatin properties and behaviors.  By 
studying the conformation and dynamics of the tandem repeats of BAC transgenes we 
will be able to move one step closer to understanding the mechanisms for large-scale 
organization of endogenous chromatin and their functions in regulating nuclear 
processes. 
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CHAPTER 2 
BAC TG-EMBED: ONE STEP METHOD FOR HIGH-LEVEL, COPY 
NUMBER DEPENDENT, POSITION INDEPENDENT TRANSGENE 
EXPRESSION  
 
ABSTRACT 
Chromosome position effects combined with transgene silencing of multi-copy 
plasmid insertions lead to highly variable and usually quite low expression levels of 
mini-genes integrated into mammalian chromosomes.  Together, these effects greatly 
complicate obtaining high-level expression of therapeutic proteins in mammalian cells 
or reproducible expression of individual or multiple transgenes.  Here we report a 
simple, one-step procedure for obtaining high level, reproducible mini-gene 
expression in mammalian cells.  By inserting mini-genes at different locations within 
a BAC containing the DHFR housekeeping gene locus, we obtain copy number 
dependent, position independent expression with chromosomal insertions of one to 
several hundred BAC copies.  These multi-copy DHFR BAC insertions adopt similar 
large-scale chromatin conformations independent of their chromosome integration site, 
including insertions within centromeric heterochromatin.  Prevention of 
chromosome position effects, therefore, may be the result of embedding the mini-gene 
within the BAC-specific large-scale chromatin structure.  The expression of reporter 
mini-genes can be stably maintained during continuous, long-term culture in the 
presence of drug selection.  This method is extendable to reproducible, high level 
expression of multiple mini-genes, providing improved expression of both single and 
multiple transgenes.  Finally, we show that the removal of a divergent promoter 
region from the DHFR BAC results in ~10 folds increase of reporter mini-gene 
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expression level.  We suggest the BAC TG-EMBED should be useful in a wide 
range of applications involving transgene expression.  
 
INTRODUCTION 
 Plasmid based expression cassettes using cDNA mini-genes driven by viral or 
cloned eukaryotic promoters represent the most common method for expression of 
transgenes.   Stable expression is usually achieved by integration of these cassettes 
into the host eukaryotic genome.  However, expression levels of these mini-genes 
are typically greatly influenced by the chromatin structure surrounding the integration 
site, producing chromosome position effects, sometimes accompanied by variegation 
of expression(Karpen, 1994).  Transgenes integrated into repressive chromatin 
regions are expressed at low levels and tend to be silenced over time.  This effect is 
particularly pronounced in mammalian cells.  A second phenomenon contributing to 
low levels of transgene expression is multi-copy transgene silencing, observed for 
most plasmid mini-genes(Dorer and Henikoff, 1997; Garrick et al., 1998).  In 
transgene silencing, expression per gene copy tends to decrease with increasing 
transgene copy number such that transgene expression levels do not increase 
proportionally with copy number and very high copy number insertions may express 
at levels comparable or even lower than single copy insertions. 
 The combined impact of chromosome position effects and transgene silencing 
makes typical transgene expression in mammalian cells both unpredictable and 
unstable, and has hindered both industrial and clinical applications as well as 
biomedical research applications. These problems are compounded when cell lines 
expressing multiple transgenes are required.  
 As just one example, a number of recombinant proteins are important therapeutic 
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reagents with enormous market value.  Mammalian cell culture has been the 
dominant expression system for therapeutic protein production as it facilitates both 
proper protein folding and posttranslational modifications(Andersen and Krummen, 
2002; Wurm, 2004).  In the absence, however, of a robust, single-step method for 
reliable, high-level, multi-copy transgene expression, gene amplification remains the 
method of choice for obtaining high expressing cell clones(Gandor et al., 1995).  
This process of gene amplification, in which cell mutants carrying hundred of copies 
of an inserted mini-gene are gradually selected, requires repeated rounds of cell 
selection, subcloning, and clone characterization over a period of many months.  
Even then, selection of amplified cell clones with high level, stable expression can be 
difficult and unpredictable, in many cases requiring a year or more for clone 
development and stabilization. 
To improve the efficiency and minimize the unpredictability of transgene 
expression, various cis-regulatory elements have been used to flank transgenes to 
maintain accessible chromatin structure and counteract chromosome position effects.  
Locus control regions (LCRs)(Grosveld et al., 1987), insulators(Chung et al., 1993; 
Pikaart et al., 1998), ubiquitous chromatin opening elements (UCOEs)(Antoniou et al., 
2003; Williams et al., 2005), Scaffold/Matrix associated regions (SAR/MARs)(Kim et 
al., 2004; Zahn-Zabal et al., 2001), and antirepressor elements (STAR) (Kwaks et al., 
2003)have all been shown to improve transgene expression to some degree(Kwaks 
and Otte, 2006).   
Locus control regions were identified as DNA sequences conferring copy number 
dependent, position independent expression close to endogenous gene expressions in 
transgenic mice(Li et al., 2002).  Specifically, this property of copy number 
dependent expression is used as an operational definition distinguishing LCR 
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elements from enhancers.  Known LCRs generally function in a tissue-specific 
manner, restricting their use to certain cell types.  Also, as demonstrated for the 
beta-globin LCR, they are thought to act by interacting with only one promoter at any 
one moment in time, limiting their use to promote the expression of multiple 
transgenes simultaneously(Wijgerde et al., 1995).  A “mini-locus” cosmid construct 
piecing together the LCR, 3’ beta-globin DNase I hypersensitivity site, and other 
beta-globin regulatory sequences showed highly linear, copy number dependent 
beta-globin expression over a 1-94 range in cosmid copy number(Grosveld et al., 
1987).  Copy number dependent expression has also been reproduced after random 
insertion of 244 kb or 155 kb yeast artificial chromosomes containing the intact 
beta-globin locus(Peterson et al., 1998).  Instead, a 100 kb DNA genomic DNA 
region containing the entire beta-globin locus and LCR on a bacterial artificial 
chromosome (BAC) produced variable position effects in transgenic mice, with BAC 
transgenes expressing anywhere from 0-105% the level of the endogenous genes, with 
most lines expressing at ~1/3 the level of the endogenous genes(Kaufman et al., 1999).  
To reduce the original cosmid mini-LCR to a size allowing the use of more traditional 
cloning vectors, including viruses, “micro-LCRs” have been constructed using 
various combinations of the small DNA regions corresponding to the DNase I 
hypersensitivity sites of the LCR.  These micro-LCRs are necessary but not 
sufficient for conferring chromosome position independent expression, with 
additional and different regulatory regions present in the introns and intergenic 
regions of specific globin genes, possibly arranged in a specific spatial pattern, 
required to confer copy number dependent expression(Bharadwaj et al., 2003; Guy et 
al., 1996; Kang et al., 2004; Rubin et al., 2000; Stamatoyannopoulos et al., 1997).  
For all of these reasons, use of LCRs in cloning vectors as a general tool for 
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conferring high-level protein expression or multi-gene transgenesis may be limited.  
Insulators are another important class of cis-regulatory elements used to shield 
transgenes from chromosome position effects created by spreading of activating or 
repressive chromatin marks from regions flanking the transgene insertion site(Chung 
et al., 1997).  Most published studies using insulator sequences have not included 
careful analysis of the degree to which these sequences confer copy number 
dependent expression(Chung et al., 1997; Sekkali et al., 2008).  In at least one case 
where such analysis was done, the chicken HS4 insulator was not sufficient to confer 
copy number dependent transgene expression in B cells(Truffinet et al., 2005).  Copy 
number dependent expression in this system required additional, LCR-like cis 
regulatory sequences in the transgene together with the insulator sequence.  Most of 
the other cis-regulatory elements described above also are not sufficient to confer both 
position independent and copy number dependent transgene expression.  
Here we describe a new transgene expression system based on embedding 
mini-gene constructs within large, cloned mammalian genomic DNA regions.   
When these DNA constructs are integrated into the mammalian genome they appear 
to create a reproducible, favorable chromatin environment for transcription 
independent of their chromosome integration site.  We have implemented this system 
using bacterial artificial chromosomes (BACs) as the cloning vector.  Using GFP and 
mRFP reporter mini-gene constructs, we show that by inserting these reporter genes 
into a BAC containing the mouse DHFR locus we obtain position independent, copy 
number dependent expression of reporters in cells clones carrying one to several 
hundred copies of the BAC.  This contrasts with the typical position dependent, copy 
number independent, and lower expression values observed after directly transfecting 
cells with the very same mini-genes, with or without flanking chicken HS4 core 
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insulator sequences.  
Therefore in a single stable transformation we can isolate cell clones expressing 
mini-genes amplified up to several hundred folds.  These cell clones show stable 
chromosome karyotype, transgene copy number, and expression over many passages 
in the presence of selection.  Moreover, we also demonstrate position independent, 
copy number dependent, simultaneous expression of both RFP and GFP reporter 
genes inserted within a single BAC construct, showing the ability to use this method 
for multi-gene transgenesis.  This BAC TG-EMBED (BAC TransGene EMBEDded) 
method provides a new methodology for single and multi-transgene expression 
capable of facilitating a wide range of applications.   
 
RESULTS 
 
Establishing the BAC TG EXPRESS system in mammalian cells  
BACs can carry 100-300kb of eukaryotic genomic DNA insertions (Shizuya et al., 
1992) and are therefore large enough to contain not only the coding regions of genes 
but also many of their distal regulatory elements.  In transgenic animals, genes 
contained within large genomic BAC inserts usually express within several fold of the 
endogenous gene expression level and show similar tissue expression patterns  
(Antoch et al., 1997; Heintz, 2000; Kaufman et al., 1999; Yang et al., 1997).  We 
hypothesized that a BAC containing a housekeeping gene locus would assemble into a 
large-scale chromatin structure permissive for transcription when integrated into the 
chromosome of any mammalian cell line. Furthermore, we predicted that insertion of 
typical mini-gene constructs anywhere within this open large-scale chromatin 
environment would allow high level, reproducible mini-gene expression, independent 
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of the BAC chromosomal insertion site. 
To test this idea we used Tn5 mediated transposition to insert a reporter gene 
cassette into a BAC with a 175 kb mouse genomic DNA insert containing the full 
length DHFR gene and most of the Msh3 gene.  The DHFR gene is expressed in 
proliferating cells with a significant upregulation seen at the late G1/ early S phase 
boundary(Slansky and Farnham, 1996).  Expression decreases in quiescent 
fibroblasts and after differentiation of myoblasts into myotubes(Schmidt and Merrill, 
1989a; Schmidt and Merrill, 1989b).  The DHFR and Msh3 genes are transcribed 
from a divergent promoter.  In NIH 3T3 cells both the DHFR and Msh3 genes were 
shown to show similar, growth regulated expression patterns(Schilling and Farnham, 
1995), whereas in rat embryonic fibroblasts and human fibroblasts the expression of 
Msh3 was reported to be constitutive(Iwanaga et al., 2004).   
To help visualize the large-scale chromatin structure of the BAC transgene, we 
inserted a Tn5 transposon containing a 256mer lac operator direct repeat plus a 
kanamycin selectable marker(Levi et al., 2005).  We then used Tn5 transposition 
again to insert a reporter gene cassette containing an mRFP mini-gene driven by a 
CMV promoter plus a prokaryotic / eukaryotic zeocin selectable marker (Fig. 2.1a).    
A BAC with the lac operator transposon inserted within the Msh3 gene was 
chosen as the template for transposition with the second reporter gene transposon.  
Two BAC clones with insertions of the reporter gene transposon within different 
Msh3 gene introns were selected for further analysis (Fig. 2.1b).  In clone C27 the 
reporter gene is transcribed in the same direction as the Msh3 gene, while in clone C4 
the reporter gene is transcribed in the opposite direction.  Reporter gene insertion 
sites of both clones were more than 50kb away from the lac operator repeat to 
minimize possible silencing effects from repetitive DNA.  Linearized BAC DNA 
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was transfected into mouse NIH 3T3 cells and stable transformants were selected 
using zeocin.  As controls, we transfected just the reporter gene cassette alone, with 
and without flanking insulator sequences (2 copies of the chicken β-globin core HS4 
insulator(Chung et al., 1997) (Fig. 2.1a).  Flanking mini-genes with this core 
insulator sequence previously was shown to reduce chromosome position 
effects(Emery et al., 2000; Recillas-Targa et al., 2002).  
After 3 weeks of selection, reporter gene expression in mixed clonal populations 
of stable transformants was measured for each DNA construct using flow cytometry 
(Fig. 2.1c).  Flow cytometry of nontransfected cells established the fluorescence 
background levels.  A large fraction of cells transfected with the reporter cassette 
fragment alone showed no detectable fluorescence above background levels.  A 
broad fluorescent intensity distribution biased towards low expression levels with a 
long tail extending to higher fluorescence values was observed.  Cells transfected 
with the reporter gene cassette flanked by insulator sequences showed a somewhat 
decreased fraction of non-fluorescent cells.  The distribution was more symmetric 
with an increased fraction of fluorescent cells. 
Strikingly, the reporter gene cassette embedded in either location within the 
DHFR BAC resulted in essentially 100% of cells with fluorescence values above 
background levels.  Moreover the intensity modes for the fluorescence distributions 
corresponding to the reporter cassette embedded within the BACs were 1-2 orders of 
magnitude higher than that observed for the reporter cassette alone or with flanking 
insulators.  
We next examined variability of reporter gene expression within individual cell 
clones isolated from these mixed clonal populations (Fig. 2.1d-f).  Flow cytometry 
was performed on two clones with comparable mean reporter gene expression levels 
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from each cell population.  Both cell clones with the reporter gene embedded within 
the BAC transgene showed noticeably more homogeneous expression (Fig. 2.1f), as 
compared to cell clones containing just the reporter gene cassettes with (Fig. 2.1e) or 
without (Fig. 2.1d) flanking insulators.  In particular, the plasmid based reporter 
genes produced clones with very broad intensity distributions, with long tails skewed 
towards lower fluorescence values. Notably, this tail of low expressing cells, 
indicative of variegated expression within individual cell clones, was absent in cell 
clones carrying the BAC transgenes. 
 
BAC embedded mini-genes show copy number dependent and position 
independent expression 
A key test of transgene protection from chromosome position effects is to verify 
copy number dependent, position independent expression.  We used qPCR to 
determine transgene copy number in 7-12 individual cell clones for each transfected 
DNA construct.  We then plotted mean expression levels, measured by flow 
cytometry, versus mini-gene copy number for each clone (Fig. 2.2a-c).  As expected, 
the reporter gene cassette alone shows poor linearity of reporter gene expression with 
copy number, indicative of copy number independent expression (Fig. 2.2a, 
correlation coefficient R2= 0.153, fixing the y-intercept to the fluorescence 
background level of non-transfected cells).  Somewhat improved linearity is 
observed for the reporter gene cassette construct flanked by insulators (Fig. 2.2b, 
R2=0.657).   
However, there is a striking increased linearity for the reporter gene cassette 
embedded at either location within the BAC.  In fact, cell clones derived from BACs 
containing the reporter gene inserted at either of two locations within the BAC 
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showed nearly identical expression levels per BAC copy (Fig. 2.2c).  The net 
correlation coefficient calculated using data from all 15 clones (Fig. 2.2c, R2=0.930), 
demonstrates a markedly increased copy number dependence produced by embedding 
the reporter gene within the BAC. 
Position independent expression of the transgenes embedded in the BAC is 
implied by the observed copy number dependence, assuming each clone has an 
independent chromosome insertion site.  We verified different chromosome 
integration sites for a handful of clones using mitotic chromosome spreads and 
fluorescence in situ hybridization (FISH), revealing single insertion sites for 
multi-copy BAC integrations, including clones with hundreds of BAC copies (Fig. 
2.2d).  In contrast to the high degree of chromosome instability observed with gene 
amplification, all clones showed a single chromosome integration site and uniform 
size of the multi-copy BAC insertions.  Insertions were mapped cytologically both to 
the middle and ends of chromosomes, including insertions cytologically close to the 
telomere (Fig. 2.2d, top left) and even one which inserted within the centromeric 
heterochromatin as confirmed by two-color FISH using a DHFR BAC probe together 
with a pan-centromeric probe (Fig. 2.2d, top right, and Fig. 2.2e), yet all showed 
position independent expression proportional to BAC copy number.   
 
BAC transgenes show similar large-scale chromatin structures independent of 
chromosome integration sites 
The design of the new transgene expression system was motivated by our 
hypothesis that large mammalian genomic inserts cloned within BACs would create a 
BAC specific, large-scale chromatin conformation independent of chromosome 
insertion site.  Previous work from our laboratory characterizing two different CHO 
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(Chinese Hamster Ovary) cell lines containing multiple integrated copies of the same 
DHFR BAC used in this study revealed a large-scale chromatin fiber-like 
conformation similar to surrounding euchromatic chromosome regions(Hu et al., 
2009a).  
To examine the large-scale chromatin structure of the multi-copy insertions of the 
DHFR BAC containing the mRFP reporter gene in a number of independently derived 
NIH 3T3 cell clones, we performed two-color 3D FISH with both lac operator and 
DHFR BAC probes (Fig. 2.3).  Lac operator FISH signals appeared as arrays of 
dot-like structures while the BAC FISH signals produced more continuous staining 
patterns.  Particularly for cell clones with smaller copy number BAC insertions, 
these lac operator FISH signals frequently showed linear configurations, with the 
BAC FISH signal forming a more continuous, fiber-like conformation.  All NIH 3T3 
cell clones examined showed similar FISH patterns.   
To avoid possible changes in structure induced by DNA denaturation during the 
FISH procedure, in the cell clones characterized in Fig. 2c-d we transiently expressed 
an EGFP- lac repressor (dimer)- NLS fusion protein to visualize the lac operator 
repeats in these cells(Robinett et al., 1996).  Interphase nuclei showed string-like 
chains of GFP stained dots similar in conformation for each clone (Fig. 2.4), including 
in cells from a clone with the BAC copies inserted within centromeric 
heterochromatin (Fig. 2.2).  Further characterization of these cell clones has revealed 
a similar spacing between GFP spots (0.33-0.4μm) and a similar ratio of number of 
BAC copies to GFP spots(Sinclair et al., 2010), suggesting similar large-scale 
chromatin compaction levels in all cell lines independent of the chromosome 
integration site. 
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Stability of BAC transgene array structure and embedded mini-gene expression 
 To test the long-term stability of transgene arrays formed by chromosomal 
integration of multiple BAC copies, we continuously passaged three NIH 3T3 cell 
clones (C4-2, C27-6, C27-13) over a 63-day period, replating cells every three days in 
the presence of drug selection (75μg/ml Zeocin).  Expression levels of mRFP were 
monitored by flow cytometry after 18, 43, and 63 days of passaging.  Expression 
levels remained at ~80-100% of the starting values for all three clones over this time 
period, demonstrating stable reporter gene expression with continuous, long-term 
culture (Fig. 2.5a).  After 63 days we also examined mitotic chromosome spreads by 
FISH to assay the stability of the chromosomal BAC transgene arrays.  For all three 
clones examined, the BAC transgene arrays showed no detectable chromosomal 
rearrangements, with the chromosomal location and size of the BAC array unchanged, 
as assayed by the distinctive appearance of the chromosome carrying the BAC 
insertion and the ratio of the chromosomal length of the BAC transgene array to the 
total chromosome arm length (Fig. 2.5b).   
 In parallel, the same cell clones were passaged for 60 days in the absence of drug 
selection.  In this case, mRFP expression levels dropped by 30% to 80% from the 
starting levels for the three clones examined (Fig. 2.6a).  Silencing was not due to 
loss of BAC transgene copies as mitotic spreads demonstrated that the chromosome 
location and size of the BAC transgene array remained constant over this same time 
period (Fig. 2.6b).  Silencing also was not accompanied by global changes in 
large-scale chromatin compaction of the BAC transgene array.  Staining of the BAC 
transgene array by transient expression of EGFP-lac repressor revealed similar 
numbers of GFP spots and separation between GFP spots in nuclei from silenced 
clones to that observed in nuclei from parental cells, prior to long-term passaging 
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without drug selection (data not shown).  The observed time course for silencing of 
the reporter gene in the absence of selection is similar to previously observed reporter 
gene silencing in plasmids without insulator sequences(Hino et al., 2004; 
Recillas-Targa et al., 2002), which has been attributed, at least in part, to promoter 
DNA methylation(Mutskov et al., 2002; Pikaart et al., 1998).  
  
Copy number dependent, position independent co-expression of multiple 
mini-genes  
As described previously, we obtained strikingly similar values of reporter gene 
expression per transgene copy for NIH 3T3 clones carrying BACs with the reporter 
cassette inserted at two different locations within the BAC.  qRT-PCR data revealed 
copy number dependent expression both for the kan/neo selectable marker linked to 
the reporter gene as well as the DHFR gene itself (data not shown).  This is 
consistent with our hypothesis that the BAC DNA creates a global large-scale 
chromatin conformation permissive for reporter gene expression, while also 
suggesting that the same BAC embedding approach could be extended to reliable, 
copy number dependent expression of multiple transgenes.   
To test this idea explicitly, we used BAC recombineering(Warming et al., 2005) to 
insert two different reporter gene cassettes into the parent DHFR BAC.  We inserted 
a CMV promoter-driven EGFP reporter gene cassette containing the 
kanamycin/neomycin selectable marker, into Msh3 intron 8, the same intron into 
which the original reporter gene transposon inserted in BAC clone C27.  We then 
inserted the original CMV promoter-driven mRFP reporter gene / zeocin selectable 
marker cassette into Msh3 intron 19, the same intron into which the original reporter 
gene transposon inserted in BAC clone C4.  We transfected NIH 3T3 cells with the 
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linearized two-reporter BAC and selected for stable transformants with zeocin.  As a 
control, we also transfected cells with a plasmid construct containing both the mRFP 
and EGFP expression cassettes. 
As observed for the single reporter gene constructs, transfection with the dual 
reporter gene fragments alone resulted in most stable transformants showing only 
background fluorescence levels (Fig. 2.7a).  Examining this mixed population of cell 
clones, cells with higher than background fluorescence levels showed poor correlation 
of mRFP and EGFP reporter gene expression, with most cells showing higher EGFP 
versus mRFP expression.  Only a small fraction of cells showed a linear relationship 
between EGFP and mRFP expression. 
In contrast, in the mixed population of stable colonies derived from transfection of 
the two-reporter BAC nearly all cells expressed both mRFP and EGFP at higher than 
background levels (Fig. 2.7b).  The average BAC expression levels were roughly 2 
orders of magnitude higher than the average plasmid expression levels.  Moreover, 
flow cytometry revealed a striking linear correlation (R2=0.8262) of mRFP versus 
EGFP fluorescence intensities.  5/5 individual clones containing the BAC transgene 
showed a similar ratio of mRFP/ EGFP expression to the mixed clonal population (Fig. 
4c, 4 clones shown).  These results demonstrate the potential of this BAC transgene 
embedding method for simultaneous expression of multiple transgenes at reproducible 
relative expression levels independent of the chromosome integation site, with 
expression levels proportional to BAC copy number. 
 
Multiple locations with DHFR BAC support similar levels of reporter mini-gene 
expression 
Previously, we showed very similar expression levels for two different locations 
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of the mRFP reporter gene within the DHFR BAC (Fig. 2.7c).  The two-reporter 
approach described in the previous section provided a rapid way to evaluate the 
potential of multiple locations within the DHFR BAC to support reporter gene 
expression and to explore the variability of reporter gene expression when placed at 
different locations within the BAC.   
We randomly inserted the CMV-mRFP-Zeocin transposon into the DHFR BAC 
already containing the CMV-EGFP reporter, thereby generating a number of BAC 
clones containing EGFP at the same fixed position but mRFP at different locations 
(Fig. 2.7d).  Six randomly chosen BAC clones (057-GN-RZ-1, 2, 3, 4, 6 and 9) 
showed CMV-mRFP-Zeocin transposon insertions within different introns of the 
Msh3 gene, mapping from ~3-80 kb away from the EGFP reporter gene (Fig. 2.7e).  
Each of these BACs was then transfected into independent cultures of NIH 3T3 cells 
and mixed populations of stable colonies (dozens to hundreds per flask) from each 
transfection were selected and propagated together.   
 After selection, the expression levels of both reporters in these mixed clonal cell 
populations of cells were measured by flow cytometry (Fig. 2.7e) and compared to 
stably transfected cells carrying the original two color reporter BAC construct 
(057-GN-RZ) (Fig. 2.7b).  Nearly 100% cells of all mixed clonal populations 
showed high expression levels of both EGFP and mRFP reporters and excellent linear 
correlation of EGFP and mRFP expression (Fig. 2.7e).  The ratio of mRFP to EGFP 
fluorescence from each mixed population showed no more than a 2.4 fold variation 
with no correlation observed between the mRFP/EGFP ratio and the DNA distance 
between reporters. This small variation in reporter fluorescence ratio not only 
confirms the previously described chromosome position independent expression of 
the BAC-TG-EMBED system, but also suggests that mini-gene expression is 
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relatively independent of location within the BAC, at least throughout the Msh3 gene 
region. 
 
Deletion of the divergent DHFR promoter increases the expression level of 
reporter mini-genes 
Next, we aim to understand the molecular basis for the transcriptionally 
permissive environment established on the DHFR BAC transgene arrays.  As the 
first step towards this goal, we want to examine whether there are any sequence 
elements required for the protection of reporter mini-genes from chromosome position 
effect and whether they play a role in the establishment of the “open” large-scale 
chromatin structure.  
The expression of DHFR and Msh3 genes are controlled by a divergent promoter 
region.  This region contains a major and a minor promoter 500bp apart from each 
other, which produce ~90% and 10% of total DHFR transcripts, respectively (Linton 
et al., 1989).  It has been shown that some divergent promoters function as 
chromatin open elements and can prevent the spreading of surrounding 
heterochromatin (Antoniou et al., 2003; Williams et al., 2005).  Therefore, we would 
like to investigate whether the divergent DHFR promoter plays a direct role in 
establishing the permissive environment for the transcription at the BAC transgene 
arrays.  
Using BAC recombineering, we deleted a ~2.8 kb region, which includes both the 
major and minor divergent DHFR promoters and the first exon of DHFR and Msh3 
genes from the DHFR BAC clone C27 (Fig. 2.8a).  This modified BAC was 
introduced into NIH/3T3 cells and stable cell clones containing the tandem repeats of 
the promoter-less BAC arrays were isolated as described before. 
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We next examined whether the deletion of the divergent promoter region 
eliminated the transcription of DHFR and Msh3 genes in the BAC transgene arrays 
using RNA FISH.  The DNA of unmodified DHFR BAC was used to prepare the 
FISH probes.  To our surprise, RNA FISH signals were still detected at the BAC 
transgene arrays for all clones examined, although at a lower level (data not shown).  
One possible explanation to this is there are other previously uncharacterized 
promoters in DHFR BAC and therefore the divergent promoter region is not 
responsible for 100% of total transcription at the BAC transgene.  In fact, previous 
genome-wide analysis indicated there are other species of Msh3 transcript species 
originating from sites more than 80kb away from the major divergent promoter region.  
In addition, it has been suggested that it is common for genes to utilize alternative 
promoters located at 5’ distal regions (Denoeud et al., 2007).  And the removal of the 
major promoters from the BAC could increase the possibility of using alternative 
promoters.  More carefully analysis on the transcripts from the BAC transgene will 
be needed to understand the transcription events occurring at the promoter-less BAC. 
To test whether the divergent promoter deletion affects the expression of the 
embedded mRFP reporter, flow cytometry analysis was performed on 8 independent 
subclones carrying the promoter-less BAC.  All 8 clones showed high level and 
homogenous expression of mRFP, similar to the clones carrying the intact BAC 
transgenes.  We then measured the transgene copy number in these clones and fit the 
mRFP expression levels to the transgene copy number (Fig. 2.8b).  The result 
showed a good linear correlation (R2= 0.810) which is comparable to the intact DHFR 
BAC (R2=0.930), therefore suggesting the mRFP reporter was expressed in a copy 
number dependent, position independent fashion. 
Strikingly, we observed much higher mRFP expression level per copy for the 
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clones containing the promoter-less DHFR BAC.  The slope for the linear fitting 
between the mRFP fluorescent level and transgene copy number suggested the mRFP, 
when embedded in the promoter-less BAC, was expressed about ten times higher than 
embedded in the intact BAC (12.65 versus 1.34) (Fig. 2.8b).  Therefore, BAC 
TG-EMBED method as an approach for transgene expression can be significantly 
improved by removing the divergent promoter from the DHFR BAC.  
The mechanisms underlying this dramatic increase of reporter expression remain 
under investigation.  One hypothesis is there are sequence elements in the divergent 
promoter region of DHFR which function as transcription repressors on mRFP 
reporter.  Alternatively, the transcription originating from the divergent promoter 
may inhibit the otherwise very strong transcription of mRFP reporter via some 
competition mechanisms.  Whether this is a general mechanism for the divergent 
promoters or specific to the DHFR locus is unknown. 
We next wanted to analyze whether the removal of the divergent promoter region 
has any effects on large-scale chromatin structure of the BAC transgene arrays.  
After transfecting cells with the EGFP- lac repressor fusion protein, the BAC 
transgenes in all clones appeared as extended arrays of GFP spots which are 
indistinguishable to the previously characterized intact DHFR BAC transgene arrays 
(Fig. 2.8c).  The separations between neighboring GFP spots were also similar to 
observed with the intact BAC transgenes.  However, more detailed analysis on three 
clones suggested that each GFP spot represent 12-15 copies of promoter-less DHFR 
BAC, about two times higher than the 6-7 copies per spot in the clones containing the 
intact DHFR BAC(Sinclair et al., 2010).  Therefore, although the deletion of the 
divergent promoter region does not seem to alter the general large-scale chromatin 
fiber-like conformation, it indeed increases the chromatin condensation level within 
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the BAC transgene arrays.  We reason this increased linear DNA compaction ratio 
may be related to the seemingly decreased transcription level at the promoter-less 
BAC transgene arrays indicated by RNA FISH.  In a previous study, we reported that 
the DHFR BAC transgene arrays in CHO cells showed a similar two-fold 
condensation upon the G0 arrest(Hu et al., 2009a).  However, this change was not 
observed on intact DHFR BAC arrays in 3T3 cells.  Whether there is a causal 
relationship between the transcription repression and the chromatin condensation will 
be further investigated.  
 
DISCUSSION 
Here we have described a novel transgene expression scheme that essentially 
eliminates chromosome position effects in mouse NIH 3T3 cells by embedding 
mini-transgene constructs within large genomic fragments cloned within BACs.  
Both the BAC array and expression of the mini-transgene constructs embedded within 
the BAC remain stable during continuous growth in the presence of drug selection.  
We suggest this effect is related to the ability of BACs containing housekeeping gene 
loci to maintain a euchromatin-like large-scale chromatin conformation conducive to 
transgene expression.  Similar levels of expression were observed for multiple 
locations of the mini-transgene within the BAC.  Moreover we showed that by 
embedding two mini-reporter genes at different locations within the same BAC that 
our method conferred reproducible, chromosome position independent expression for 
both reporter genes simultaneously, suggesting the usefulness of this method for 
multi-gene transgenesis.  Although so far only the DHFR BAC was tested, we 
speculate that BACs with genomic inserts containing other active gene loci may 
behave similarly.  Experiments are now in progress to better define the cis elements 
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within these genomic loci that confer this behavior.  
Our BAC TG-EMBED method is both simple and fast, with a transposon reaction 
typically requiring just 2 days to insert an expression cassette into a BAC and a single 
transfection and selection yielding mammalian cell clones stably expressing 
transgenes at levels up to hundreds of fold higher than a single transgene copy. 
Therefore by selecting individual cell clones with different BAC copy numbers, a 
wide range of expression levels should be obtainable from a single stable transfection 
experiment. 
Using our method, we have demonstrated chromosome position independent, 
copy number dependent expression, with linearly proportional increases in expression 
over more than a 100 fold variation in transgene copy number.  While insulator 
sequences have generally been used successfully to protect transgenes against 
chromosome position effects, in a direct comparison the BAC TG-EMBED method 
produced nearly a 10 fold improved linear correlation coefficient of reporter gene 
expression versus copy number than that observed by flanking the same reporter gene 
with two copies of the chicken HS4 core insulator sequence (0.80 versus 0.09).   
We anticipate that the BAC TG-EMBED method will be able to be combined with 
the use of additional cis elements adjacent to the mini-transgene, chosen to maximize 
or stabilize transgene expression(Kwaks and Otte, 2006), to provide the benefits of 
both approaches.  Indeed, whereas the chicken HS4 insulator sequence is capable of 
protecting against reporter gene silencing during long-term cell growth in the absence 
of selection(Pikaart et al., 1998), we observed significant reduction in reporter gene 
expression using the BAC TG-EMBED method in some clones after 60 days of 
continuous cell passaging without drug selection.  This suggests that the mechanism 
by which the BAC TG-EMBED method shields reporter genes from chromosome 
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position effects is different from the mechanism underlying insulator action.  
Experiments are now in progress to determine the mechanism underlying reporter 
gene silencing over time in the absence of selection and to test whether flanking the 
mini-reporter genes with insulator sequences can overcome the observed silencing 
during long-term cell growth in the absence of selection.  An obvious alternative 
approach would be to test whether the use of eukaryotic rather than viral promoters to 
drive transgene expression could overcome this effect.  
We showed that the expression level of reporter genes could be further improved 
by about ten folds by a simple deletion of the DHFR divergent promoter region, while 
the reporter genes were still expressed in a copy number dependent, position 
independent manner.  Although the exact molecular mechanism for this dramatic 
improvement is still unclear, this promoter deletion method will undoubtedly facilitate 
a wide range of applications of the BAC TG-EMBED method.  We note that in the 
case of DHFR BAC, the deletion of the divergent promoter did not completely block 
the transcription at the DHFR BAC transgenes and an “open” large-scale chromatin 
structure was still observed.  These features may be specific to the DHFR locus.  
Therefore, whether the removal of the divergent promoter can be used as a general 
method to improve reporter genes embedded at other housekeeping gene loci remains 
to be seen.  
On a broader scope, experiments are also in progress to better understand the basic 
molecular mechanism by which the BAC TG-EMBED method protects mini-gene 
constructs from chromosome position effects.  Our data indicated the open 
large-scale chromatin structure formed over the DHFR BAC transgene arrays is 
correlated with the favorable environment for transcription. Whether the open 
large-scale chromatin structure is sufficient or necessary for establishing such an 
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environment is still unknown.  The results from the promoter-less BAC transgene 
arrays suggested that shielding of transgenes from position effect can still occur at 
large-scale chromatin structure two times more condensed than the intact BAC 
transgene arrays.  Future experiments will be aimed at testing our hypothesis that 
this protection is related to the ability of the BAC transgene arrays to adapt an open 
large-scale chromatin conformation and/or to position near specific nuclear 
compartments.  These studies should also improve our understanding on the 
functional significance of the open large-scale chromatin structure.  We note that the 
methodology described here to compare the expression levels of multiple reporter 
genes contained within BAC transgene arrays can be adapted to dissect the molecular 
origin of chromosome position effects produced by specific cis sequences contained 
within the BAC. 
Although we used the CMV promoter for our reporter gene constructs, the DHFR 
gene contained within the BAC, driven by its natural promoter, also appeared to show 
copy number dependent expression. We speculate that the BAC TG-EMBED method 
may work with many other promoters, therefore allowing considerable flexibility for 
transgene expression.  By choosing a BAC containing a cloned genomic region that 
will assume an open chromatin conformation in the desired target cells, this method 
may be extendable to expression of transgenes in a wide range of cell types. 
With regard to production of therapeutic proteins in mammalian cells, the BAC 
TG-EMBED method offers several additional key advantages over the current 
prevailing method, gene amplification.  Using a single transfection step, the 
equivalent of several hundred-fold gene amplification can be obtained.  Whereas 
gene amplification requires the use of transformed cell lines capable of gene 
amplification, the BAC TG-EMBED method should be applicable to a wide range of 
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cell types.  Finally our results indicate that in contrast to the genome instability 
inherent in gene amplification, even large BAC transgene arrays show genome 
stability, as assayed by the stability of the BAC transgene array chromosome 
integration site and by the size of the transgene array after long-term cell passaging. 
Similar stability of multi-copy BAC transgene arrays has also been observed in CHO 
and murine embryonic stem cells (data not shown). 
We note that an alternative BAC based expression system for increased expression 
of a gene present in the genome of the host cell, would be simply to increase the copy 
number of this gene by transfecting an unmodified BAC containing the actual 
genomic locus coding for the protein to be expressed.  We expect that at least for low 
copy number insertions this approach would also yield copy number dependent, 
position independent expression when transfected into a cell type normally expressing 
this protein.  However, the transcription factors regulating the genomic locus might 
be present at low concentrations, preventing copy number dependent expression at 
high BAC copy numbers.  The endogenous promoter might be weak, preventing 
high-level expression even at high copy number.  Finally, the cell type normally 
expressing the target transgene might not be amendable to large-scale protein 
production methods or even in vitro culture.  The BAC TG-EMBED method has the 
advantage of allowing choice of the promoter and cell type to use for expression. 
In principle, BAC recombineering could be used to replace the coding region of a 
housekeeping gene, in a BAC containing the housekeeping genomic locus, with the 
cDNA for the target transgene.  Again though one would still be restricted in the 
choice of promoters to optimize expression level and control over gene induction and 
the required BAC recombineering would be more complicated as compared to 
transposon mediated insertion of a mini-gene using the BAC TG-EMBED approach.  
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Moreover, this BAC recombineering approach would not work as well as the BAC 
TG-EMBED method for expression of multiple transgenes. 
In conclusion, the BAC TG-EMBED expression method provides a novel, 
complimentary approach to current transgene expression methodologies with several 
key advantages for specific applications.  Future extensions of this methodology 
should prove useful for industrial production of therapeutic proteins, production of 
recombinant proteins for biochemical studies, improved transgene expression for gene 
therapy, and multi-transgene expression for cell and tissue engineering. 
 
MATERIALS AND METHODS 
 
Plasmid Constructions   
Plasmid p[CMV-mRFP-Zeo] (pCRZ) was created from the EZ-Tn5™ 
pMOD-2<MCS> transposon construction vector (Epicentre Technologies).  The 
SV40-zeocin fragment was cut from pSV40/Zeo2 (Invitrogen) and cloned into the 
SacI and HindIII sites of pMOD-2 vector to generate an intermediate construct p[Zeo]. 
The CMV-mRFP DNA fragment was obtained by PCR amplification (forward primer, 
5’-CGA GCT CTG AGC TAT GAG AAG CGC CA-3’; reverse primer, 5’-CCC TCG 
AGT GCC GAT TTC GGC CTA TTG GTT-3’) from vector pmRFP(Hu et al., 2009a), 
digested with SacI and XhoI, and cloned into p[Zeo] to generate pCRZ. 
Plasmid pBSKS-cHS4(Wuebbles et al., 2009), a gift from Dr. Peter Jones 
(University of Illinois, Urbana-Champaign), contains two copies of a 2 copy cHS4 
core element (Chung et al., 1997) cloned into the BamH1-Not1 digested pBluescript 
KS (+) (Stratagene).  The CMV-mRFP-Zeo expression cassette was cut from pCRZ 
by PshAI digestion and cloned into the AflII site of pBSKS-cHS4 to generate 
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pcHS4-CRZ or into the AflIII site of vector pEGFP-N1 (Clontech) to generate 
plasmid pGNRZ. 
 
BAC constructions   
A 256mer lac operator direct repeat and kanamycin selectable marker was inserted 
into mouse DHFR BAC 057L22 (CITB mouse library) using a Tn5 transposon as 
described previously(Levi et al., 2005).  BAC Clone 057-k8.32-C29 containing this 
lac operator transposon inserted 75kb downstream of the Msh3 transcription initiation 
site was selected for subsequent engineering.  The [CMV-mRFP-Zeo] transposon 
generated by PshAI digestion of pCRZ was inserted into 057-k8.32-C29 using Tn5 
transposase (Epicentre Technologies) following the manufacturer’s directions and 
bacterial clones were selected using 25μg/ml zeocin.  Primer pMOD-Seq-For 
(5’-GCC AAC GAC TAC GCA CTA GCC AAC-3’) was used to sequence the 
[CMV-mRFP-Zeo] transposon insertion site; BAC clones C4 and C27 with the 
[CMV-mRFP-Zeo] transposon inserted into nucleotides 117695 and 23426 of Msh3 
gene, respectively, were selected for use in these experiments (Sup. Fig. 1). 
DHFR BAC 057-GN-RZ carrying both EGFP and mRFP reporters was 
constructed by λ Red-mediated homologous recombination(Warming et al., 2005).  
A EGFP-Kan/Neo DNA fragment flanked by homology arms was created by PCR 
from vector pEGFP-C1 (Clontech Labratories, Inc.) using 60-bp primers (forward, 5 – 
ATG AAT GCA CAT CTG TAC ATG CAT TAT TCA TTG TTC TAT GTT TTT GTG 
ATG CTC GTC AGG - 3'; reverse, 5' – ATT ATA CCA AGA GCA ACT TCA GAA 
TAA GTT TCC TAG AAT TGG TGG GGA AAA GGA AGA AAC - 3').  Each 
primer contained a 17bp template homology sequence and a 43bp BAC target site 
homology sequence.  Recombination protocols followed standard protocols 
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(Warming et al., 2005) and recombinants were selected with 20μg/ml kanamycin.  
BAC clone 057-GN carrying the EGFP-Kan/Neo DNA fragment was chosen for 
further recombineering.  To insert RFP, a 1.3kb homology region flanking the BAC 
target site was PCR amplified (forward primer, 5' - GGA ATT CGT TTA AAC CAT 
GGG TAC TTG GGA GCA CT - 3'; reverse primer, 5' - GGA ATT CGT TTA AAC 
AAA ACA CAT CTG CCC AGG TC - 3' ) and cloned into EcoRI digested 
pMOD-2<MCS>.  The mRFP expression cassette was cut from pCRZ using PshAI 
and inserted into the homology region, within pMOD-2<MCS>, at the EcoRV site.  
The mRFP-Zeo plus homology region fragment generated by PmeI digestion was 
used for a 2nd recombination reaction followed by 20μg/ml kanamycin and 25 μg/ml 
zeocin selection.   
To construct BACs containing reporter genes EGFP at a fixed position and mRFP 
at different locations, the [CMV-mRFP-Zeo] transposon was used to randomly 
transpose mRFP into BAC 057-GN as described above, generating BAC 057-GN-RZ 
clones 1-9.  Transposon insertion sites and directions for clones were mapped by 
DNA sequencing.  BAC clones 057-GN-RZ-1, 2, 3, 4, 6 and 9 with the transposon 
insertions into nucleotides 42769, 30688, 27130, 73522, 104954, and 28045 of the 
Msh3 gene, respectively, were selected for transfection into NIH/ 3T3 cells.   
To delete the divergent promoter region from the BAC, the GalK selectable 
marker was PCR amplified from vector pGalK, a gift from Dr. Neal G. Copeland 
(National Cancer Institute), using primers 5’- CTG CCT CAC TGA AGA CCA CAG 
CCT TCA TCC CAC CGT GTC TTC CCG ACG GCC AGT GAA TTG- 3’ and 5’- 
TTC CTG CTG TCA CCT TCT GTC ACC TGT ATC GGG AAG GTT GGA ATG 
CTT CCG GCT CGT ATG- 3’. Each of the primers contains a 17bp sequence 
homologous to pGalK template and a 43bp sequence homologous to the region 
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flanking the target region. Homologous recombination was performed per standard 
protocols and the recombinants in which the target region is substituted by GalK were 
selected on minimal media with 0.2% galactose as the only carbon source. 
After each BAC modification, the integrity of the BAC constructs and the length 
of the lac operator repeat were checked by a HindIII and XhoI digest.  Observed gel 
band sizes were compared with the predicted digestion patterns generated by the Gene 
Construction Kit software (Textco BioSoftware).  Only BAC clones showing the 
correct digestion pattern and a full length lac operator repeat were chosen for future 
modifications.   BAC DNA for transfection into mammalian cells was prepared with 
the Qiagen Large Construct Kit.  
 
Cell culture and transfection   
NIH 3T3 cells (CRL-1658, ATCC) were grown in Dulbecco modified Eagle’s 
medium (Invitrogen) plus 10% Bovine Growth Serum (HyClone).  pCRZ was 
digested with PshAI and pcHS4-CRZ digested with EcoRV and NotI.   DNA 
fragments containing the CMV-RFP-Zeo expression cassette were gel purified prior to 
transfection.  EcoRV linearized pGNRZ was used for transfection.  BAC clones C4 
and C27 were linearized with SrfI and BAC 057-GN-RZ was linearized with BsiWI 
prior to transfection.  The linear integrity of all BACs after restriction digestion was 
confirmed by PFGE.  All DNA fragments were ethanol precipitated and transfected 
into NIH 3T3 cells using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s directions.  Mixed clonal populations of stable transformants were 
obtained after 3 weeks of zeocin (75μg/ml) selection; individual subclones were 
obtained by serial dilution.  A lentivirus expression construct (Paul Sinclair, Andrew 
Belmont) was used to transiently express EGFP-LacI.  EGFP-LacI binding to the lac 
operator repeats localized on each BAC copy provided an outline of the large-scale 
chromatin conformation of the BAC transgene array in well-preserved nuclei.  Three 
days after lentivirus transduction, cells were plated on coverslips, fixed with 1.6% 
paraformaldehyde (Polysciences) in calcium, magnesium free PBS buffer and stained 
with 0.2 ug/ml DAPI (Sigma-Aldrich).  BAC transgene array large-scale chromatin 
conformation was also visualized by 2 color DNA FISH (described below).  
Deconvolution wide field light microscopy was carried out as described 
previously(Hu et al., 2009a).  
 
Flow cytometry  
 Reporter gene expression levels were measured on a MoFlo flow cytometer 
(Cytomation) using 584 nm and 488 nm laser excitation for mRFP and EGFP 
respectively.  Emission filters centered at 607 nm and 507 nm were used for mRFP 
and EGFP respectively.  Rainbow fluorescent beads RFP-30-5A (Spherotech, Inc.) 
were used for calibration of both mRFP and EGFP fluorescence.  Untransfected NIH 
3T3 cells were used to establish background fluorescence levels. The linear fitting of 
mean RFP expression level versus transgene copy number for each group of clones 
was performed using Microsoft Excel fixing the y-intercept, a, to the fluorescence 
background level of non-transfected cells. The correlation coefficient R2 when the 
y-intercept is fixed is defined as: R2 = bb ′, where  
and . 
 
Transgene copy number measurement   
Genomic DNA from individual clones was isolated using the Purelink Genomic 
DNA mini-kit (Invitrogen) and DNA concentration measured with the Fluorescent 
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DNA Quantitation kit (Bio-Rad).  The BAC or plasmid transgene copy number was 
determined by real-time quantitative PCR using a SYBR-Green PCR master mix 
(Applied BioSystem) and the iCycler machine (Bio-Rad).  Primers used to measure 
BAC copy number (5’- GAA CTG CCT CCG ACT ATC CA-3’ and 5’-CGA GGA 
GCT CAT TTT CTT GC-3’) amplify a 106 bp region within DHFR exon 4.  Primers 
used to measure plasmid copy number (5’-ATG AGG CTG AAG CTG AAG GA-3’ 
and 5’-GTC CAG CTT GAT GTC GGT CT-3’) amplify a 114 bp region within the 
mRFP coding region.  Standard curves were measured using serial dilutions of a 
plasmid containing both mRFP and DHFR (pSV2-DHFR-CRZ). 
  
Mitotic spreads and FISH   
Metaphase spreads were prepared and FISH was performed according to standard 
protocols(Hu et al., 2009a).  For mapping BAC transgenes, a biotin labeled probe 
was prepared from BAC 057L22 DNA using the BioNick Labeling Kit (Invitrogen).  
For simultaneous detection of the BAC transgene and centromeric sequences in NIH 
3T3 clone C4-10, the digoxigenin BAC probe was hybridized to metaphase 
chromosomes together with a biotin labeled pan-centromeric chromosome paint 
(Cambio).  For two color 3D FISH, a plasmid pSV2-DHFR-8.32 containing the 
256mer lac operator repeat(Robinett et al., 1996) was used to generate a biotin labeled 
lacO probe and the 057L22 DNA was used to generate a digoxigenin labeled BAC 
probe using the BioNick Labeling Kit and digoxigenin conjugated dUTP (Roche 
Applied Science).  Biotin and digoxigenin labeled probes were detected with 
Alexa-594 tagged streptavidin (Invitrogen) and fluorescein conjugated 
anti-digoxigenin antibody (Roche Applied Science), respectively. 
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FIGURES 
 
 
Fig. 2.1 Outline of experimental system.  (a) The CRZ (top) and cHS4-CRZ 
(bottom) expression cassettes showing the 19 bp Tn5 mosaic ends, mRFP and zeocin 
mini-genes, and the cHS4 insulator sequences.  (b) DHFR BAC map showing BAC 
vector backbone (black), mouse genomic sequence (gray), 256mer lac operator 
transposon (green), and mRFP expression cassette transposon insertion sites 
(arrowheads) for C4 (orange) and C27 (red) clones.  (c) mRFP expression levels 
(x-axis) measured by flow cytometry show higher and more uniform expression levels 
for NIH 3T3 mixed clonal populations of stable transformants after transfection with 
BAC transgenes (green and red) versus plasmid constructs with (blue) or without 
(yellow) cHS4 insulator sequences. Nontransfected cells (black) establish the 
background fluorescence level.  (d-f) BAC transgenes produce more homogeneous 
expression within individual cell clones.  Expression distribution for 2 stable cell 
clones with similar average expression levels selected from each transfection 
experiment: CRZ plasmid (d), cHS4-CRZ (e), BAC clone C4 (f).  Controls (black) 
correspond to nontransfected cells.  (c-f) Fluorescence measured in the same 
arbitrary units. 
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Fig 2.2 Mini-genes embedded in BAC transgenes are protected from position 
effects.  (a-c) Mini-genes embedded in BAC transgenes, but not mini-genes alone, 
show copy number dependent, position independent expression.  Average mRFP 
expression levels (y-axis) of individual cell clones are plotted versus mini-gene copy 
number (x-axis) for CRZ mini-gene (a), cHS4-CRZ mini-gene (b), and BAC C4 
(blue) or C27 constructs (orange).  Linear regression fits (black line) with 
y-intercepts set at background fluorescence levels are shown with corresponding 
correlation coefficients.  (d) BAC insertion sites and size of inserts are shown by 
FISH on metaphase chromosomes for cell clones C4-2, C4-6, and C4-10 (top, left to 
right) and C27-5, C27-12, and C27-13 (bottom, left to right) using a BAC 
hybridization probe (red) and DAPI (green) counterstain.  Interruption of DAPI 
bright staining (d, top right) and splitting (e) of pan-centromeric FISH signal (red) by 
BAC FISH signal (green) shows BAC insertion into centromeric heterochromatin in 
C4-10 clone.  Copy number dependent expression in clone C4-10 is maintained (c, 
arrowhead).  
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Fig. 2.3 Two color DNA FISH reveals similar, extended large-scale chromatin 
conformations formed by BAC transgenes in independently derived NIH/3T3 
clones.  Two examples from each of four NIH/3T3 clones are shown.  Lac operator 
FISH (red), BAC FISH (green), and DNA DAPI staining (blue) show large BAC 
transgene arrays typically located within the nuclear interior.  Extended, linear 
configurations are frequently observed.  Spacing between lac operator FISH foci is 
similar in different clones.  Scale bar = 2 μm. 
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Fig. 2.4 Mini-genes are located within similar large-scale chromatin structures 
formed over BACs independent of chromosomal insertion site.  Similar 
interphase large-scale chromatin conformation is observed for BAC transgenes in 
three cell clones as judged by spacing between GFP-LacI (Green) spots.  DNA is 
stained by DAPI (blue).  Scale bar = 2 μm. 
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Fig. 2.5 BAC transgenes and expression of embedded reporter genes are stably 
maintained with selection.  (a) Expression levels of mRFP reporter gene in three 
NIH/3T3 clones over 60 days of continuous passaging are plotted relative to values 
measured on day 1.  Values represent the average cellular fluorescence as measured 
by flow cytometry.  (b) Sizes and chromosomal locations of BAC transgene arrays 
within metaphase chromosomes remain stable before and after 60 days of culture as 
visualized by FISH using DHFR BAC probe (red) and DAPI staining (green).  Scale 
bar = 1 μm.  Right- BAC transgenes in clone C4-2 and C27-13 map close to the 
telomere, while the BAC transgenes in clone C27-6 are located on a 
mini-chromosome.  Left- For clones C4-2 and C27-13, the ratios between the 
chromosomal arm length of the BAC transgene array relative to the total chromosome 
arm length were measured from more than 10 examples for each time point.  Mean 
values and standard deviations of the ratios are plotted.  No obvious changes in BAC 
trangene sizes are observed.   
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Fig. 2.6 Decrease of reporter gene expression over time in the absence of drug 
selection despite chromosomal stability of the BAC transgene array.  (a) Three 
NIH/3T3 clones were propagated in the absence of Zeocin for 60 days.  mRFP mean 
expression levels, as measured by flow cytometry, are plotted relative to initial values 
at day 1.  A several fold drop in expression is observed between days 40 and 60 for 2 
of the three cell clones.  (b) Left- Metaphase chromosome location and size of BAC 
transgene arrays are analyzed by DNA FISH (green- DAPI DNA staining, red- BAC 
FISH).  Right- The sizes of the BAC transgene arrays, measured by the ratio of the 
length of the chromosome region containing the BAC transgene array relative to the 
total chromosome arm length, show no obvious changes after 60 days of cell 
passaging without drug selection. 
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Fig. 2.7 Two reporter mini-genes embedded within single BAC show near 
constant expression ratios and higher and more uniform expression levels than 
plasmid constructs containing both mini-genes.  (a & b) Scatter-plots showing 
EGFP (x-axis) and mRFP (y-axis) expression levels measured by flow cytometry of 
mixed clonal populations of NIH/3T3 cells stably transfected with pGNRZ plasmid 
construct (a) or DHFR BAC 057-GN-RZ containing both mini-gene reporters (b).  
Each spot represents a single cell measurement.  Black rectangles (lower left) 
demarcate ranges of background green and red fluorescence values measured for 
control, nontransfected cells.  Majority of cells carrying plasmid construct show only 
background mRFP or GFP fluorescence levels; of the cells showing above average 
background fluorescence the majority show higher than background GFP expression 
but background levels of mRFP expression. Only a small fraction of cells with  
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Fig. 2.7 (con’t) 
plasmids show linearly correlated GFP and mRFP expression. This contrasts with 
high level, linear coexpression of both reporter genes in cells carrying the BAC 
construct.  (c) High level, linearly correlated, more uniform co-expression levels for 
reporter genes are observed in four different cell clones carrying DHFR BAC 
057-GN-RZ.  (d) The two-reporter gene BAC can be used to measure the relative 
expression levels of reporters inserted at different locations within the BAC.  A BAC 
carrying the GFP reporter at a fixed site was used as the template for random 
transposition to insert the mRFP reporter at different BAC locations.  After separate 
transfection of BACs carrying the mRFP at different locations, stable, mixed clonal 
populations derived from each of these BACs were analyzed by flow cytometry.  (e) 
Ratios between the mean values of mRFP and EGFP reporter expression of mixed 
clonal cell populations derived from a total of 7 two-reporter BACs are summerized. 
The green arrowhead indicates the insertion site of the EGFP reporter in all BAC 
constructs. The red arrowheads indicate the insertion sites of mRFP reporters in 
different BAC constructs. Arrows indicate the directions of reporter gene transcription. 
All mixed populations show high level and linearly correlated expression for both 
reporters, with expression ratios varying less than 2.4 fold across the BAC. 
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Fig. 2.8 The deletion of divergent DHFR promoter increases the expression of 
reporter mini-genes.  (a) The 2.8kb divergent promoter region was removed from 
the DHFR BAC containing mRFP reporter.  (b) The mRFP mini-genes embedded in 
the promoter-less BAC show copy-number dependent, position independent 
expression.  Average mRFP expression levels (y-axis) of individual cell clones are 
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Fig. 2.8 (con’t) 
plotted versus mini-gene copy number (x-axis) for promoter-less BAC (red) and the 
full-length DHFR BAC (blue).  Linear regression fits (black line) with y-intercepts 
set at background fluorescence levels are shown.  The slopes for the regression lines 
indicate mRFP embedded in the promoter-less BAC express at higher level than 
embedded in the intact DHFR.  (c) The promoter-less BAC transgenes in three stable 
cell clones appear as extended arrays of LacI-GFP spots (Green) similar to the intact 
DHFR BAC transgenes.  Average BAC copy number represented by each LacI-GFP 
spot is listed. DNA is stained by DAPI (blue).  Scale bar = 2 μm. 
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CHAPTER 3 
IDENTIFYING DNA SEQUENCES REQUIRED FOR LOCALIZATION OF 
THE HUMAN BETA-GLOBIN LOCUS TO THE NUCLEAR PERIPHERY 
 
ABSTRACT 
The intranuclear positioning of chromatin has been suggested to have an 
important role in gene regulation.  In higher eukaryotic cell nuclei, the nuclear 
periphery is enriched in heterochromatin.  Recent studies have demonstrated that 
attachment of genes to the nuclear periphery can repress their transcription.  
However, the mechanisms underlying the nuclear peripheral localization of 
endogenous genes have not yet been elucidated.  Here we report our initial work 
aimed at identifying cis elements required for the peripheral localization of the human 
beta-globin locus.  Previously, we had demonstrated that in mouse ES cells a BAC 
carrying a 200 kb human genomic fragment containing the beta-globin locus targets to 
the nuclear periphery independent of the chromosome integration site.  We now 
show this autonomous targeting of the beta-globin BAC to the nuclear periphery is 
also observed in mouse fibroblasts.  Using BAC recombineering, we have 
demonstrated that globin related sequences are not required for the nuclear peripheral 
localization of the beta-globin BAC transgene arrays.  Additional work identified 
two genomic regions sufficient to target the BAC transgenes to nuclear periphery.  
Moreover, we demonstrated the association of the BAC transgenes with centromeric 
heterochromatin is also sequence-dependent and is regulated by mechanisms different 
to nuclear peripheral localization.  Finally, we showed that targeting the 
transcriptional activator VP16 to beta-globin BAC arrays resulted in a relocation of 
the arrays to the nuclear interior, suggesting that transcriptional activators can reverse 
58 
 
this peripheral localization.  Ongoing experiments are in progress to further dissect 
this region to identify specific sequences required for peripheral localization as a first 
step towards elucidation of the molecular mechanism for the nuclear peripheral 
localization of genes in mammalian cells. 
 
INTRODUCTION 
The spatial organization of eukaryotic genome in 3D space of nucleus is not 
random. In several normal and tumor human cell lines, gene-rich chromosomes were 
shown to locate towards the nuclear interior while the gene-poor chromosomes 
adopted a more peripheral nuclear localization (Cremer et al., 2003; Croft et al., 1999).  
Multiple lines of evidence also have suggested a general correlation between nuclear 
radial positioning and gene activity, with active genes preferentially located in the 
nuclear interior and silent genes located at the nuclear periphery(Takizawa et al., 
2008a; Zink et al., 2004). 
The localization of genes at the nuclear periphery has been linked with gene 
repression.  Electron micrographs have revealed that transcriptionally inactive, 
highly compacted heterochromatin accumulates adjacent to the nuclear envelope in 
typical mammalian cells (Akhtar and Gasser, 2007).  Consistent with these 
observations, the nuclear periphery has been shown to be relatively depleted of 
markers of active transcription such as histone acetylation (Sadoni et al., 1999), 
histone H3 lysine 4 dimethylation (H3K4me2) and RNA polymerase II (Luco et al., 
2008).  These results suggest that the nuclear periphery is either relatively depleted 
of active genes and/or creates a repressive environment for transcription.  Moreover, 
several developmentally regulated genes have been shown to locate at the nuclear 
periphery in their silent state and reposition to the nuclear interior upon gene 
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activation; examples include the beta-globin genes during murine erythroid 
maturation (Ragoczy et al., 2006), the IgH gene during murine B cell differentiation 
(Kosak et al., 2002) and the Mash1 gene during murine neuronal differentiation 
(Williams et al., 2006).  These results suggest that the nuclear peripheral localization 
of genes may play a role in maintaining the gene repressive state during development. 
The functional consequences of nuclear peripheral localization have been directly 
tested experimentally in yeast (Andrulis et al., 1998) and mammalian cells (Finlan et 
al., 2008; Kumaran and Spector, 2008; Reddy et al., 2008) by artificially tethering 
chromosome sites to the nuclear lamina.  In yeast, tethering to the nuclear periphery 
did not result directly in gene silencing per se but did appear to strengthen silencing 
associated with telomere position effects, restoring gene repression to a defective 
silencer.  In the three mammalian systems tested to date, the actual fusion proteins 
used for tethering, the reporter constructs and genes used to monitor changes in 
expression, and the number of copies of the tethering sequence have all differed 
making it difficult to directly compare results from each study.  However, a general 
conclusion emerging from these studies viewed together is that the degree of gene 
repression associated with tethering to the nuclear periphery is gene and promoter 
specific, and typically quantitative, causing a modulation in transcription, rather than 
qualitative (i.e. turning transcription from on to off). 
To fully understand the physiological significance of the nuclear peripheral 
positioning of genes, the molecular mechanisms underlying such positioning needs to 
be unveiled.  Recent studies using the DamID method (Greil et al., 2006; Vogel et al., 
2007) have mapped the preferred genome-lamina interactions in Drosophila and 
cultured mammalian cells (Guelen et al., 2008; Peric-Hupkes et al., 2010; Pickersgill 
et al., 2006).  In human fibroblasts, more than 1300 sharply defined domains with 
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sizes of 0.1- 10 megabases were shown to preferentially interact with the nuclear 
lamina.  These lamina-associated domains (LADs) are enriched in genes with low 
expression-levels and repressive chromatin marks such as H3K27me3 and H3K9me2, 
while depleted of the active chromatin mark H3K4me2.   
The discovery of LADs revealed important features of the spatial organization of 
mammalian genome.  However, our understanding on how specific genomic regions 
are located to nuclear periphery is rudimentary.  Whether there is a causal 
relationship between the direct molecular interaction with nuclear lamina components 
and the peripheral localization of genomic regions at the microscopic level remains 
unknown.  It is also unclear whether specific sequences within the LADs serve as the 
“anchor points” for nuclear periphery targeting or whether targeting to the nuclear 
periphery is a general property for all the sequences within the LADs.  To date, a 
functional assay to directly test the ability of specific sequences to target to the 
nuclear periphery is lacking. 
Here we describe a BAC transgene system for identifying sequence determinants 
of nuclear peripheral localization of specific genomic regions.  BACs are large DNA 
constructs, typically carrying 100-300 kb mammalian genomic DNA fragment 
(Shizuya et al., 1992).  Previous studies in our lab have suggested that transgene 
arrays consisting OF tandem repeats of the BACs recapitulate several important 
features of endogenous genes, including similar expression levels to the 
corresponding endogenous genes, chromatin decondensation after gene activation, 
and localization of the BAC transgenes to the same specific nuclear compartments as 
the endogenous gene locus (Bian and Belmont, 2010; Hu et al., 2009a; Sinclair et al., 
2010).  Using a BAC recombineering system (Warming et al., 2005) to delete 
specific sequences from the BAC, in theory we should be able to identify specific 
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genomic regions within the BAC sequence required for gene targeting to specific 
nuclear compartments.  
In this study, we dissected a ~200kb human genomic region containing the 
beta-globin locus.  Beta-globin genes are specifically expressed in erythroid cells.  
It has been well documented that the beta-globin locus is preferentially associated 
with the nuclear periphery in cell types where it is inactive, such as ES cells 
(Hepperger et al., 2008; Ragoczy et al., 2006).  Previously we have shown that a 
BAC containing a 200kb human genomic region including the beta-globin locus 
autonomously targeted to nuclear periphery in murine ES cells (Sinclair et al., 2010).  
Here we demonstrated the same BAC also targeted to nuclear periphery in murine 
fibroblasts.  By systematically deleting sequences from the 200kb BAC, we showed 
the beta-globin gene cluster itself and its regulatory elements, including the locus 
control region (LCR), the upstream Hispanic region (UHR) and 3’ DNase I 
hypersensitive site (3’ HS1) are not required for the peripheral localization of the 
genomic region.  We identified two genomic regions, 32 and 48 kb in size, which 
independently are sufficient to target the BAC transgenes to nuclear periphery.  We 
also observed the association of these beta-globin BAC transgenes with mouse 
chromocenter, another heterochromatic compartment, changed upon sequence 
alterations.  Finally, we showed that these beta-globin BAC transgene arrays 
relocated from the nuclear periphery to the interior upon tethering of the acidic 
transcriptional activator VP16.  Further sequence dissection is in progress to define 
the minimal sequence elements for determining the nuclear peripheral localization of 
this locus.  Further analysis of these cis-elements should eventually lead to the 
elucidation of at least one molecular mechanism for nuclear peripheral localization of 
genes in mammalian cells.  
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RESULTS 
A BAC containing the human beta-globin locus autonomously targets to the 
nuclear periphery in mouse fibroblasts. 
Previous studies in our lab had shown that the transgene arrays consisting of 
multi-copies of a 207kb BAC containing the human beta-globin locus targeted to the 
nuclear periphery in mouse ES cells independent of the chromosomal insertion sites 
(Sinclair et al., 2010).  In three randomly selected stable clones carrying the 
beta-globin BAC, BAC transgene arrays partially overlapped with the nuclear pore 
staining signals in 50%-80% cells.  This extreme peripheral localization is specific to 
the beta-globin BAC, as DHFR and alpha-globin BAC with similar size to beta-globin 
BAC did not show obvious nuclear periphery targeting.  These results suggested that 
the 207kb human beta-globin genomic fragment may contain functional DNA 
elements responsible for autonomous targeting of this locus to the nuclear periphery. 
As a strategy to identify the cis requirements for this peripheral targeting of the 
beta-globin locus, we decided to test systematically the ability of different BACs with 
specific deletions within the beta-globin genomic insert for their ability to target 
autonomously to the nuclear periphery.  Our approach was to use BAC 
recombineering techniques to remove specific sequences from the BAC and then 
introduce this modified BAC DNA into cells using stable transfection to establish 
independent cell lines with the BAC DNA integrated at different chromosome 
locations.  Use of a parental cell line already stably expressing GFP-LacI would 
facilitate visualization of the location of these beta-globin BAC transgenes relative to 
the nuclear periphery (Fig. 3.1). 
Due to the technical difficulty of obtaining stable ES cell lines stably expressing 
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GFP-LacI, and the resulting difficulty of screening of ES clones carrying BAC 
transgene arrays, we decided to perform this sequence interrogation study in mouse 
NIH/3T3 fibroblasts.  We first determined whether the beta-globin BAC would 
autonomously target to the nuclear periphery in these 3T3 mouse fibroblasts as 
previously observed in mouse ES cells.  The beta-globin BAC containing a 256mer 
lac operator repeat was transfected into a NIH/3T3 cell line which expressed 
GFP-LacI at a suitably low level allowing sensitive detection of BAC transgenes.  
Stable clones carrying BAC transgenes were isolated and clones containing only one 
BAC transgene insertion site were selected for further analysis.    
In 4 out of 5 randomly selected NIH/3T3 cell clones, the beta-globin BAC 
transgenes were located within 0.5μm from the nuclear periphery (defined by 4', 6- 
diamidino-2-phenylindole (DAPI) staining) in 30-64% of the cells (Fig. 3.2 a,d).  
Association with the nuclear periphery was measured in two dimensions from single 
optical sections.  The percentages of peripheral localization of BAC transgenes in all 
5 clones are significantly higher than the 14.8% predicted for an average-sized 2D 
nucleus with diameters of 16 and 11μm (Fig. 3.2 d).  Similar patterns of nuclear 
peripheral localization were also observed using Lamin A or nuclear pore 
immunostaining to define the nuclear periphery (Fig. 3.2 b,c).  In contrast, three 
previously established NIH/3T3 clones carrying DHFR BAC transgene arrays showed 
5-16% of peripheral localization (Fig. 3.2 d).  Therefore, we concluded that the 
human beta-globin BAC confers BAC-specific, autonomous nuclear peripheral 
localization in mouse NIH/3T3 fibroblasts. 
The peripheral localization pattern of the beta-globin BAC transgenes  
recapitulates the behavior of the endogenous human beta-globin locus in human 
fibroblasts.  Fluorescent in situ hybridization (FISH) using the human beta-globin 
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BAC as a probe following immunostaining against Lamin A was performed in human 
fibroblasts BJ-hTERT cells.  Measurements of the distance of the endogenous human 
beta-globin locus from the nuclear periphery in BJ-hTERT cells were compared to 
measurements of the distance of the human beta-globin BAC transgenes from the 
nuclear periphery, also defined by Lamin A immunostaining, in NIH/3T3 cell clone 
HBB C3.  The BAC beta-globin transgene in the HBB C3 clone showed a pattern of 
localization relative to the nuclear periphery strikingly similar to the endogenous 
beta-globin, with more than 50% of spots localizing within 0.5 um to the nuclear 
periphery as measured in 2D optical sections (Fig. 3.2 e,f).  In contrast, no 
significant nuclear peripheral localization was observed for the human alpha-globin 
locus in BJ-hTERT cells (Fig. 3.2 d). 
 
Beta-globin genes, locus control region (LCR), upstream Hispanic region (UHR) 
and 3’ HS1 are not required for the nuclear peripheral localization of the 
beta-globin BAC transgene arrays. 
There has been a long standing theory that the nuclear peripheral localization of 
genes may have a functional impact on gene regulation.  Moreover, the beta-globin 
locus moves from the nuclear periphery to the nuclear interior during erythrocyte 
maturation (Ragoczy et al., 2006).  Therefore we first tested whether known 
regulatory elements of the beta-globin locus were required for the peripheral 
association of the beta-globin locus in non-erythroid cells. 
The human beta-globin gene cluster consists of five globin genes (HBE1, HBG1, 
HBG2, HBD and HBB).  A 39.5 kb deletion upstream of the beta-globin gene cluster, 
named the Hispanic deletion, causes profound alteration of beta-globin gene 
expression.  The most important regulatory region within the Hispanic deletion is the 
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LCR (locus control region) containing six DNase I hypersensitive sites (HSs).  The 
LCR is located 6-22 kb upstream of the HBE1 gene and is required for the high 
expression level of all beta-globin genes.  The 27.5kb region upstream of the LCR 
which was also removed by Hispanic deletion is called the UHR (upstream Hispanic 
region) and may also contain functional elements for beta-globin gene regulation.  
Two erythroid-specific DNase I hypersensitive sites (HS), the 3’HS1 located at the 3’ 
side of beta-globin gene cluster between the HBB and olfactory receptor OR51V1 
genes and HS-110 located 110kb upstream of HBE1 between olfactory receptor genes 
OR51B6 and OR51M1, also have been demonstrated as important for beta-globin 
regulation.  
We used a λ-red based BAC recombineering system and a GalK based dual 
selection system to remove specific sequences from the beta-globin BAC (Warming et 
al., 2005).  The use of GalK as a selectable marker for both positive and negative 
selection allowed us to remove the GalK after one deletion and use it again in the 
selection for a subsequent deletion.  A single deletion (D5) removed a ~116kb region 
between olfactory receptor genes OR51V1 and OR51B2, deleting the entire 
beta-globin gene cluster as well as the LCR, UHR and 3’HS1 sequences (Fig. 3.3 a).  
The HS-110 site, which is equivalent to the HS-62.5 site in mouse, could not be 
removed in the same deletion due to the insertion of the LacO repeat between 
OR51B2 and OR51B5 in previous BAC engineering.   
We transfected the deleted BAC (HBBD5) into NIH/3T3 cells and analyzed the 
nuclear localization of the BAC transgenes in stable clones.  All 5 randomly picked 
clones showed at least 30% peripheral localization of BAC transgenes, with 4 out of 5 
clones showing more than 50% peripheral localization (Fig. 3.3 b,f).  Therefore, 
HBBD5 BAC transgenes still conferred the autonomously localization to nuclear 
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periphery and we concluded that the beta-globin genes themselves, LCR, UHR and 
3’HS1 were not required for the nuclear peripheral targeting of the human beta-globin 
locus. 
 
Each of two genomic regions located upstream of beta-globin genes is sufficient 
for nuclear peripheral localization of human beta-globin locus. 
To examine whether there are functional sequence elements outside of the D5 
region responsible for the nuclear peripheral localization of the human beta-globin 
BAC, we made a second deletion starting with the HBBD5 BAC to remove the ~80kb 
region between the LacO repeat and BAC vector backbone (Fig. 3.3 a).  As the result, 
this double deletion HBBD5D7 BAC contains only the BAC vector backbone, the 
LacO repeat, and an ~5kb human genomic fragment which includes the olfactory 
receptor genes OR51V1 and OR51B2. None of 5 randomly selected clones carrying 
the HBBD5D7 BAC transgene showed more than 20% peripheral localization (Fig. 
3.3 c,f), demonstrating that specific sequences on the HBB BAC located within the 
D7 deletion region are required for peripheral targeting.  
To further confirm the existence of elements for peripheral localization in the D7 
region, we made the D4 deletion removing a 56kb sub-region of D7 from the 
full-length beta-globin BAC (Fig. 3.3 a).  The D4 region contains olfactory genes 
OR51B5, OR51B6 and OR51M1 and the HS-110 site. Only 1 out of 5 randomly 
selected clones carrying this HBBD4 BAC showed greater than 20% peripheral 
localization (Fig. 3.3 c,f), demonstrating the existence of functional DNA sequences 
located in the olfactory receptor region upstream of the beta-globin genes which are 
responsible for the nuclear peripheral localization of the human beta-globin BAC.  
We further dissected this region to narrow down the possible region containing 
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peripheral targeting elements.  Previous studies in human lung fibroblasts using the 
DamID technique have mapped the position of lamin-associated domains (LADs) 
which are large genomic domains preferentially interacting with nuclear lamina.  
The high-resolution LAD map indicates a 32kb LAD region at the 3' end of the 
beta-globin BAC used in this study (Fig. 3.3 a).  LADs are often demarcated by 
CTCF binding sites (Guelen et al., 2008) .  CTCF is a protein binding to insulator 
sequences which has been implicated to have an important role in organizing global 
chromatin architecture.  Available ChIP-on-chip data indicates the presence of 
multiple CTCF binding sites, some of which coincide with the HS-110 site, in an 
~10kb region 5' to the LAD (Fig. 3.3 a).  To investigate whether the LAD and/or 
CTCF enriched boundary region are the determinants for the nuclear peripheral 
localization of the beta-globin BAC, we deleted either the 32kb LAD region (deletion 
D8) or the 43kb region including both the LAD and the LAD boundary region 
(deletion D9) (Fig. 3.3 a).   
Both the HBBD8 and HBBD9 BAC transgenes still showed a high percentage of 
nuclear peripheral localization, suggesting either that the LAD region does not contain 
a peripheral targeting sequence or that the LAD region contains a peripheral targeting 
sequence but that at least one additional peripheral targeting sequence is present 
outside of the LAD region within the D4 deletion (Fig. 3.3 d,f). 
 To test whether there was a redundant peripheral targeting sequence located 
outside of the LAD region plus a targeting sequence inside of the LAD region, we 
then made a new deletion D10 which removed the ~48kb region outside of the LAD 
region in the D7 deleted region (Fig. 3.3 a).  Similar to deletion D8, D10 also did not 
change the ability of the BAC transgenes to target to nuclear periphery (Fig. 3.3 e,f).  
Therefore, our results suggested there aretwo functionally redundant regions within 
68 
 
the BAC responsible for the nuclear peripheral localization. 
To determine whether these two genomic regions are sufficient by themselves to 
confer the nuclear peripheral localization of the locus or instead need to function 
together with other regulatory elements of the beta-globin locus, we deleted the D8 or 
D10 regions from the HBBD5 BAC (Fig. 3.3 a).  There were no significant 
differences in nuclear peripheral localization between the double deletions HBBD5D8 
or HBBD5D10 BACs versus the full-length beta-globin BAC (Fig. 3.3 e,f), 
suggesting that both the 32kb D8 region and 48kb D10 region contain functional 
sequence elements sufficient to confer nuclear peripheral localization. 
 
Co-transfection of beta-globin and DHFR BAC results in nuclear interior 
localization of BAC transgenes. 
Our data have demonstrated that the beta-globin BAC transgenes, when randomly 
integrated into the genome, exhibited significant nuclear peripheral localization in 
most of the examined cell clones.  However, it is still unclear whether the peripheral 
localization signals present in the beta-globin locus have a dominant effect over 
nearby transcriptionally active genomic loci, which are usually found in the interior of 
the nucleus. 
To directly test this, we co-transfected the beta-globin BAC and a BAC containing 
the mouse housekeeping gene DHFR locus into NIH/3T3 cells.  The 175kb DHFR 
BAC contains the full-length DHFR gene and most of the Msh3 gene (Fig. 3.4 a).  
Both the DHFR and Msh3 genes are expressed in proliferating cells and are 
transcribed from the same divergent promoter (Schilling and Farnham, 1995).  
Previously we have shown the DHFR BAC transgenes were preferentially positioned 
to the nuclear interior in mouse ES and NIH/3T3 cells (Sinclair et al., 2010).  The 
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multi-copy DHFR BAC transgenes support copy-number dependent and position 
independent expression of the DHFR gene as well as mini-gene reporters embedded 
in the BAC (Bian and Belmont, 2010). 
The DHFR BAC was tagged with a 256mer lac operator repeat and a zeocin 
selectable marker using the Tn5 transposon system as described previously (Bian and 
Belmont, 2010).  The linearized DHFR and beta-globin BACs were mixed together 
and transfected into NIH/3T3 cells. Stable transformants containing both BACs were 
selected with the combination of G418 and zeocin.  Stable clones containing a single, 
visible insertion, suggesting that the DHFR and beta-globin BACs were integrated 
into the same chromosome site, were selected for further analysis.  None of the five 
examined clones showed substantial peripheral localization, with the highest 
peripheral localization percentage being 16% and the lowest being 0% (Fig. 3.4 b).  
This is significantly different from BAC transgenes arrays containing only the 
beta-globin BAC (p-value=0.006).  Therefore, when present within the same 
multi-copy BAC transgene array, the housekeeping DHFR locus prevented the 
sequence elements in the beta-globin BAC from targeting the BAC transgenes to 
nuclear periphery. 
 
The interior localization of beta-globin BAC transgenes upon sequence 
modifications is accompanied by elevated chromocenter association. 
In addition to the nuclear periphery, another important nuclear compartment 
related to gene silencing is centromeric heterochromatin.  The association of inactive 
genes with the mouse centromeric heterochromatin has been observed in a number of 
cell types (Brown et al., 1999; Brown et al., 1997; Francastel et al., 2001).  A 
previous study has suggested that the inactive beta-globin locus preferentially 
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localized to both the centromeres and the nuclear periphery in murine 
erythroleukemia (MEL) cells(Francastel et al., 2001).  However, the mechanisms 
underlying the differential distribution of inactive genes between different 
heterochromatin compartments are unknown. 
During our dissection of the human beta-globin locus, we also examined effects of 
different sequence deletions on the association of the BAC transgenes with the 
chromocenters.  The full-length beta-globin BAC transgenes did not exhibit 
significant association with the chromocenters, with only one out of five clones 
showing association in more than 30% of the nuclei (Fig. 3.5 a).  Interestingly, a 
general anti-correlation between chromocenter association and the peripheral 
localization of the BAC transgenes was observed, with clones showing a higher 
degree of nuclear peripheral localization also showing lower degree of chromocenter 
association (Fig. 3.5 c).  A similar pattern was also observed in clones containing 
HBBD5 BAC transgenes, which were also preferentially localized at nuclear 
periphery (Fig. 3.5 a). 
Previously we have shown that the HBBD4 BAC, in which a region upstream of 
the beta-globin gene cluster was deleted, lost the ability to autonomously target to 
nuclear periphery.  Surprisingly, we found that these HBBD4 BAC transgenes 
showed an accompanying increase in chromocenter association compared with the 
full-length beta-globin BAC (p-value= 0.01) (Fig. 3.5 a,b).  The anti-correlation 
between chromocenter association and nuclear peripheral localization was also 
observed in these clones (Fig. 3.5 c).  Therefore, our data indicated that the 
association of genomic regions with centromeric heterochromatin is governed by 
signals different to the ones targeting genes to the nuclear periphery.  Moreover, 
changes of sequence composition at the beta-globin locus can alter its distribution 
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between these two heterochromatin compartments. 
We also examined the clones carrying the HBBD5D7 BAC transgenes, in which 
the beta-globin genes and most of the olfactory receptor genes were removed.  The 
HBBD5D7 BAC transgenes retained the ability to target to chromocenters to some 
degree, with two out of five clones showing higher than 40% chromocenter 
association (Fig. 3.5 a).  In fact, we found that a plasmid containing the 256 mer lac 
operator repeat alone could give rise to about 30% chromocenter association in mixed 
populations of stably transfected cells (data not shown), suggesting that the lac 
operator direct repeat, and/or vector backbone sequence we used as the tag for 
microscopic visualization, may partially contribute to the chromocenter association of 
the BAC transgenes.  Notably, we observed no obvious correlation between 
chromocenter association and nuclear periphery localization in the HBBD5D7 clones, 
with three out of five clones showing lower than 30% association with both 
heterochromatic compartments (Fig. 3.5 c).  In this way the chromatin regions 
consisting of the HBBD5D7 BAC behaved differently from the other BAC 
transgenes. 
We have shown that co-transfection with the transcriptionally active DHFR locus 
abolished the nuclear periphery targeting of beta-globin locus.  Does this also change 
the nuclear localization pattern of the BAC transgenes in terms of chromocenter 
association?  To our surprise, the clones carrying both the DHFR and beta-globin 
BAC transgenes exhibited a high degree of chromocenter association, similar to that 
observed in HBBD4 clones and significantly higher than the full-length beta-globin 
BAC clones (p-value=0.006) (Fig. 3.5 d,e).  This suggests that the ability of 
truncated  beta-globin BAC transgenes to target to centromeric heterochromatin is 
insensitive to the signals from surrounding active genes, which were sufficient to 
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change the radial positioning pattern of the transgenes.  
It is noteworthy that in the clones analyzed in this study, the total percentage of 
the BAC transgenes associated with nuclear periphery or chromocenter was usually 
60-90% but never 100%.  This may be partially attributed to the dynamic nature of 
the chromatin in interphase nucleus.  On the other hand, we have evidence showing 
that most of the BAC transgene arrays co-localized to heterochromatin foci 
highlighted by H3K9me3 immunostaining (Fig. 3.6).  In some cases, the BAC 
transgenes showing no association with the nuclear periphery and chromocenters 
co-localized with small foci of H3K9me3 staining in the nuclear interior (Fig. 3.6 c), 
suggesting that the inactive loci may find alternative heterochromatin compartments 
other than the predominant nuclear periphery and centromeres.  
 
Tethering of the acidic transcriptional activator VP16 relocates the beta-globin 
BAC transgenes from the nuclear periphery to the nuclear interior  
A number of developmental regulated genomic loci, including beta-globin locus, 
have been shown to reposition from nuclear periphery to interior upon gene activation 
during development.  This suggests that the nuclear peripheral localization of genes 
can be reversed and this reversion may be related to transcription activity.  
Previously in our lab, we have described an inducible movement of an engineered 
chromosome site from the nuclear periphery to interior upon targeting the 
transcription activator VP16 to a peripherally located plasmid gene array (Chuang et 
al., 2006; Tumbar and Belmont, 2001).  We therefore set out to test whether this 
repositioning can be recapitulated at peripherally located beta-globin BAC transgene 
arrays. 
A fusion protein consisting of mRFP, Lac repressor and the acidic activation 
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domain of VP16 was constructed and transfected into several NIH/3T3 clones 
carrying full length HBB or HBBD5 BAC transgenes.  Two days after transient 
transfection, the intranuclear positioning of the BAC transgenes in RFP expressing 
cells was examined.  Due to the competition of the overexpressed mRFP-LacI-VP16, 
the LacI-GFP spots appeared dimmer and became invisible in some clones.  
Nevertheless, a more interior localization of the BAC transgenes was observed in 
multiple clones.  For example, in clone HBBD5 C43, the percentage of BAC 
transgenes at nuclear periphery decreased from 52% to 14% after VP16 tethering (Fig. 
3.7 b,d).   
We note that the Lac operator repeat, which is the tethering site for VP16, is more 
than 3kb away from the nearest olfactory receptor promoter.  Therefore, it is unclear 
whether transcription is required for such a redistribution of the BAC transgenes.   
Previously we have shown a synthetic acidic peptide (DELQPASIDP), which did not 
activate transcription, could also induce the repositioning of a periphery located 
plasmid transgene array (Chuang et al., 2006; Tumbar and Belmont, 2001).  We then 
tested whether this peptide caused the redistribution of beta-globin BAC transgenes.  
Indeed, the transfection of a mCherry-LacI- DELQPASIDP construct into clone 
HBBD5C43 resulted in a redistribution of BAC transgenes toward nuclear interior 
similarly to VP16 (Fig. 3.7 c,d).  Our data thus suggests the recruitment of certain 
transcription activator is sufficient to change the nuclear peripheral localization of 
genes.  We reason the beta-globin BAC transgene arrays provide a valuable system 
for studying the intranuclear movement of genomic loci in mammalian cells.   
 
DISCUSSION 
The three-dimensional organization of eukaryotic genome within the nucleus has 
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been implied to have an important regulatory role on transcription by a large 
collection of studies.  However, the molecular mechanisms controlling the spatial 
organization of genome are largely unknown.  Also whether the intranuclear 
positioning of genomic loci is coded by specific sequences has not been directly 
tested.  In this study, we demonstrate we can recapitulate the nuclear peripheral 
localization of human beta-globin locus using engineered chromosome regions 
consisting of multi-copy BAC transgenes.  By combining this BAC transgene 
system with BAC recombineering techniques we identify specific genomic regions 
responsible for the nuclear peripheral targeting of the beta-globin locus.  This likely 
opens the door for future mechanistic studies on nuclear peripheral localization. 
 
An effective system for dissecting the intranuclear positioning of specific 
chromosome regions 
Previously, we have shown that the multi-copy BAC transgene arrays recapitulate 
several features of endogenous chromosomes, including intranuclear localization (Hu 
et al., 2009a; Sinclair et al., 2010).  Here we demonstrate we can further employ this 
system to dissect the sequence elements responsible for nuclear positioning to the 
nuclear periphery. 
This BAC transgene array system possesses some unique advantages over the 
traditional, plasmid transgene based system for identifying sequence determinants for 
intranuclear positioning of genomic loci.  It has been well documented that plasmid 
transgenes are susceptible to chromosome position effect and repeat-induced 
transgene silencing.  Previous electron microscopic studies in our lab revealed that 
multi-copy plasmid transgene arrays often appeared as chromatin structures more 
compacted than surrounding endogenous chromatin (Kireev et al., 2008).  Such a 
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tendency of heterochromatinization of plasmid arrays may impair their ability to 
recapitulate the intranuclear positioning patterns of endogenous genomic loci.  In 
contrast, in previous studies and this study, we have shown several different BAC 
transgenes localized to the same nuclear compartment as their endogenous 
counterparts, such as the Hsp70 BACs to the nuclear speckles after heat shock and the 
beta-globin BACs to the nuclear periphery (Hu et al., 2009a; Sinclair et al., 2010).  
The large sequence capacity of BACs provides another apparent advantage for 
sequence dissection, as the intranuclear positioning of genomic loci may be 
determined by large sequence elements or synergistic activities of multiple sequence 
motifs.  The sizes of these elements may exceed the capacity of typical plasmid 
constructs, therefore limiting the effectiveness of the plasmid transgene system in 
dissection of functional sequences determining intranuclear positioning.   
We note an alternative approach for dissecting the sequence determinants for 
intranuclear positioning is to remove specific sequences from endogenous genomic 
loci and examine the effects.  However, this approach requires significantly more 
work for generating proper cell lines for the analysis.  More importantly, we reason 
the BAC transgene arrays, as a reductionist system, reduces the complexity for the 
sequence dissection.  The interphase chromatin is highly compacted, with several 
hundred kilobases of DNA detected by FISH usually appearing as a spot under the 
diffraction limit of light microscopy (Lawrence et al., 1990; Yokota et al., 1995).  
The large-scale chromatin structure is also organized to accommodate a large number 
of interactions between distal sequences, which are poorly characterized.  Therefore, 
the intranuclear localization of an endogenous genomic locus could be influenced or 
constrained by the features of other sequences in its spatial proximity.  Given that 
there may be redundancy of signals for determining nuclear positioning, the 
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likelihood of seeing a phenotype after removing several or tens of kilobases of 
specific sequences from an endogenous locus may be low, and the interpretation of 
phenotypes will be difficult.  By using the multiple-copy BAC transgene tandem 
arrays, which form engineered chromosome regions with size from several hundred 
kilobases to several megabases, the influence of neighboring genomic regions and 
other long-range chromatin interactions is diluted.  Moreover, the intranuclear 
localization of these BAC transgene arrays is more likely determined by the 
sequences contained within the BAC.  As a result, the chances of identifying smaller 
sequence determinants for intranuclear positioning by extensive sequence dissection 
will be significantly enhanced. 
 
The nuclear peripheral localization of human beta-globin locus is determined by 
its genomic neighborhood. 
The relationship between the transcription activation of beta-globin locus and its 
intranuclear positioning pattern has been extensively investigated.  However, little is 
known about the mechanisms underlying the remarkable nuclear peripheral 
localization of inactive beta-globin locus.  In this study, by dissecting a ~200kb BAC 
containing the beta-globin locus, we demonstrated that the inactive beta-globin genes 
themselves, as well as the known regulatory elements for beta-globin expression, are 
not required for the nuclear peripheral localization of this locus in fibroblasts.  
Further dissection leads to the identification of two genomic regions responsible for 
localization of the multi-copy BAC transgenes to nuclear periphery.  Both of these 
regions reside in the olfactory receptor gene clusters flanking the beta-globin locus.  
Therefore, our data suggests the preferential nuclear peripheral localization of the 
beta-globin locus is dictated by its genomic neighborhood. 
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Although we have not yet narrowed down the signals for nuclear periphery 
targeting to the olfactory receptor genes, it is noteworthy that the genomic structure of 
the beta-globin region, with the beta-globin genes and LCR embedded in the middle 
of a large cluster of olfactory receptor genes, is highly conserved in mammals.  
Olfactory receptor genes were also found in the neighborhood of beta-globin genes in 
chicken, but not in lower vertebrates.  It is possible that this particular genomic 
arrangement reflects an evolutionary mechanism to establish the nuclear peripheral 
localization of inactive beta-globin locus, therefore reinforce its correct expression 
pattern. 
 
Competition between nuclear peripheral and nuclear interior positioning signals 
Active and inactive genomic loci usually display different intranuclear positioning 
pattern, with active loci preferentially located in the interior and inactive loci located 
at the periphery of the nucleus.  However, whether the interior or the peripheral 
localization has a dominant effect over the other is poorly understood, due to the lack 
of the knowledge for their respective molecular mechanisms.  A recent study in 
C.elegans examined the positioning of small transgene arrays containing two 
differentially expressed tissue specific promoters (Meister et al., 2010).  The results 
suggested the active promoter dictated the intranuclear positioning over the inactive 
promoter, resulting in internalization of the transgene arrays in specific tissues.  Here 
we reported that the DHFR housekeeping gene loci has a similar effect on the 
positioning of inactive loci in mammalian cells. 
In our initial studies, we observed that the transgene arrays containing tandem 
repeats of the beta-globin BAC targeted to nuclear periphery independent of their 
chromosomal integration sites, at least in the clones examined.  However, when we 
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co-transfected the beta-globin BAC with a BAC containing housekeeping gene DHFR 
locus, the transgene arrays containing both BACs were predominantly positioned in 
the interior of the nucleus.  Although not directly mapped, we assume the two types 
of BACs were arranged in an interleaved fashion within each engineered chromosome 
region.  This suggests the 200kb genomic locus carried by the BAC was not 
sufficient to establish the nuclear peripheral positioning when flanked by highly 
transcribed housekeeping locus. 
The internal positioning of the transgenes may be due to a mechanism actively 
targeting the housekeeping gene loci to nuclear subcompartments in the interior.  
Alternatively, the surrounding housekeeping gene loci may change the properties of 
the periphery targeting elements within the inactive loci and block their functions.  It 
is also possible that the localization of a locus is determined by the integration of 
different positioning signals over a large chromatin domain.  Nonetheless, our data 
suggest the nuclear peripheral localization of inactive loci can be profoundly 
influenced by adjacent active loci.  This is also compatible with the observation that 
most of the identified LADs are large genomic domains with a size larger than 1Mb 
and depleted of highly transcribed genes. 
 
Localization of beta-globin BAC transgenes to the nuclear periphery or 
chromocenter is determined by different mechanisms 
In addition to the nuclear periphery, centromeres exist as another important 
docking site for heterochromatin.  Multiple studies have reported the association of 
inactive genomic loci with centromeric heterochromatin.  However, whether there is 
preferential association of inactive loci with specific heterochromatic nuclear 
compartments has not been investigated in detail.   
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In this study, we showed the 200kb BAC containing beta-globin genes and 
neighboring olfactory receptor genes, when introduced into cells as tandem transgene 
arrays, preferentially targeted to nuclear periphery.  The removal of sequence 
elements required for peripheral targeting resulted in the interior localization of the 
BAC transgenes arrays.  Interestingly, these modified BAC transgenes displayed a 
high degree of association with chromocenters.  Similar preferential association with 
chromocenters was also observed in the transgene arrays containing both the 
beta-globin BAC and DHFR BAC.  Our data therefore suggests the association of 
the inactive beta-globin locus with the nuclear periphery versus chromocenters is 
regulated by different mechanisms.  Our results indicate that the inactive loci may be 
organized to preferentially locate to certain accumulation sites for heterochromatin 
instead of a random distribution.  And the distribution between different 
heterochromatic compartments may be changed by modifying the sequence 
composition.   
We speculate that the association of inactive loci with the nuclear periphery may 
require the functions of some specific sequence elements, while the association with 
chromocenters may be a general feature for heterochromatin.  The 200kb genomic 
region containing beta-globin locus, when flanked by active housekeeping locus, was 
not able to confer the nuclear periphery targeting but may still retained certain 
features of heterochromatin sufficient for the chromocenter targeting.  It is 
conceivable that the association of inactive loci with the nuclear periphery is a more 
“stringent” nuclear organization as the active transcription machinery is largely 
excluded from nuclear periphery.  On the other hand, the interior localized chromatin 
may have the flexibility to associate with both active and inactive nuclear 
subcompartments. 
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Future directions   
In this study, we report a system for identification of sequence determinants for 
the nuclear peripheral localization of genomic loci.  Sequence dissection on a 
~200kb region reveals two redundant regions sufficient to confer the nuclear 
peripheral targeting of human beta-globin locus.  Our future studies will aim to 
further narrow down these genomic regions to identify the minimal motifs controlling 
nuclear peripheral localization of chromatin.  The follow-up functional interrogation 
of those motifs via bioinformatic and biochemical studies will serve as a necessary 
step toward the eventual understanding of the molecular mechanisms underlying the 
spatial organization of genome within nucleus.   Finally, the periphery-targeting 
sequences identified in this study also provide a means to study the functional 
consequences of tethering genes to nuclear periphery in a more natural context. 
 
MATERIALS AND METHODS 
BAC Recombineering 
Human BAC CTD-2643I7 was obtained from Invitrogen. A 256mer lac operator 
direct repeat and kanamycin/neomycin selectable marker was inserted into the BAC 
using a Tn5 transposon as described previously (Bian and Belmont, 2010; Levi et al., 
2005). BAC clone 2643I7-C4, which contains the lac operator repeat between 
olfactory receptor genes OR51B2 and OR51B5 was selected for subsequent 
engineering. 
A λ red-mediated BAC recombineering system and GalK-based dual selection 
scheme was used to delete specific regions from the beta-globin BAC.  The purified 
2643I7-C4 DNA was transformed into an E.coli strain SW102, in which the 
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expression of λ red recombination machinery can be induced by shifting temperature 
from 32˚C to 42˚C.  The DNA fragments for recombination were prepared by PCR 
from plasmid template pGalK using 60bp primer pairs (Table 3.1).  Each primer 
consists of a 43bp homology sequence flanking the region to be deleted from the BAC 
and a 17bp sequence for amplifying the GalK selectable marker 
(5’-cgacggccagtgaattg-3’ for the forward primer and 5’-tgcttccggctcgtatg-3’ for the 
reverse primer).  The recombination was performed according to standard 
protocols(Warming et al., 2005).  Following the recombination, the recombinants 
were selected at 32˚C on minimal medium in which galactose was supplied as the 
only carbon source.  Following the galactose selection, the recombinants were 
screened by PCR using 20bp primers outside of the target regions (CHECK-F and –R 
primers, Table 3.1).  
To make subsequent deletions from a previous deletion, the GalK selectable 
markers were removed from the BAC.  The DNA fragments for the removal of GalK 
were generated by PCR using 60bp primers partially complementary to each other 
(GkRm-F and –R, Table 3.1).  Each of the 60bp primers consists of a 52bp 
homology region flanking the GalK marker and an 8 bp sequence complementary to 
the last 8 bp of the other homology region.  The 100bp PCR products were 
introduced into SW102 cells to replace the GalK.  Following recombination, 
negative selection was performed using minimal medium containing 2-deoxy-glactose 
(DOG) and the recombinants were again screened using the CHECK-F and –R 
primers.  After the removal of GalK was confirmed, another round of recombination 
was performed as described above.  
After each recombineering step, the integrity of the BAC constructs and the length 
of lac operator repeats was checked by restriction fingerprinting.  Small amount of 
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BAC DNA was purified using the buffers from Qiagen Large Construct Kit (Qiagen).  
The DNA was then digested with AvaI and HindIII and ran on a 0.5% agarose gel.  
The restriction digestion patterns were compared with the predicted digestion patterns 
generated by program Gene Construction Kit (Textco BioSoftware).  Only BAC 
clones showing correct digestion pattern and also containing full-length 256mer lac 
operator repeats were chosen for further modifications.  
DHFR BAC 057L22 (CITB mouse library) is a gift from Edith Heard (Curie 
Institute). The insertion of lac operator repeat and a CMV-RFP-SV40-Zeocin reporter 
was performed using a Tn5 transposon system as described before(Bian and Belmont, 
2010). 
 
Cell culture and establishment of BAC cell lines 
NIH 3T3 cells (CRL-1658, ATCC) were grown in Dulbecco modified Eagle’s 
medium (Invitrogen) plus 10% Bovine Growth Serum (HyClone) at 37 oC with 5% 
CO2. To create a cell line stably expressing EGFP-dimer lac repressor fusion protein, 
the plasmid p3’SS-d-LacI (Robinett et al., 1996) was linearized by XmnI and 
transfected into 3T3 cells using lipofectamin 2000 (invitrogen) according to 
manufacturer’s directions. 24 hours after transfection, the cells were plated onto 
94mm hybridoma dishes (Greiner Bio-One) and then incubated overnight before 
selection with 200μg/ml Hygromycin B. Two weeks after transfection, the subclones 
were transferred from the dishes to 96 well plates and propagated. A subclone 
3T3_LG_C29 expressing EGFP-dimer lac repressor at desirable level was chosen for 
the subsequent BAC transfection. 
The full-length and modified 2643I7 BACs were purified using the Qiagen 
large-construct kit. Purified BAC DNA was linearized with PI-SceI, 
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ethanol-precipitated and transfected into 3T3_LG_C29 cells. The stable transfectants 
were selected using 800μg/ml G418 and 200μg/ml Hygromycin B for two weeks 
and subclones were picked. To examine the conformation and localization of BAC 
transgenes in individual subclones, the cells were plated on coverslips, fixed with 3 % 
paraformaldehyde (Polysciences) in calcium, magnesium free PBS buffer for 10 min 
and stained with 0.2μg/ml DAPI (Sigma-Aldrich).  Deconvolution wide field light 
microscopy was carried out as described previously. 
For co-transfection of beta-globin BAC and DHFR BAC, the beta-globin BAC 
and DHFR BAC was linearized with PI-SceI and BsiWI, respectively, and transfected 
into 3T3_LG_C29 as described above.  Following transfection, the stable clones 
were selected using 800μg/ml G418, 200μg/ml Hygromycin B and 75μg/ml 
Zeocin. 
BJ-hTERT cells were obtained as a gift from Dr. Peter Adams (Beatson Institute/ 
Glasgow University) and grown in DMEM supplemented with 10% FBS, non 
essential amino acids, vitamins and 0.54μg/ml Puromycin. 
 
Immunofluorescence 
NIH/3T3 cells were fixed with 3% paraformaldehyde in CMF-PBS for 10min at 
room temperature and washed three times with CMF-PBS. Following fixation the 
cells were permeabilized with 0.5% Triton X-100 in CMF-PBS for 5min at room 
temperature and blocked with 5% normal goat serum for 30min. Primary antibody 
was applied for 4 hours at room temperature at the following dilutions in CMF-PBS 
containing 0.1% Triton X-100: mouse monoclonal antibody RL1 against nuclear pore 
O-linked glycoprotein, 1:500 (ABR-Affinity BioReagents); anti–lamin A antibody, 
1:500 (obtained from B. Goldman, Northwestern University, Evanston, IL) and rabbit 
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anti-H3K9 trimethylation (Upstate), 1:1000. Cells were washed with CMF-PBS for 3 
times and stained with secondary goat anti-rabbit or anti-mouse antibody conjugated 
with Texas red (Jackson ImmunoResearch Laboratories) at 1:500 dilution overnight at 
4°C. 
 
Immunostaining followed by DNA FISH 
BJ-hTERT cells were fixed with 3% paraformaldehyde for 10min at room 
temperature and permeabilized with 0.5% Triton X-100 in PBS for 5 min on ice. 5% 
normal goat serum diluted in PBS was used for blocking. Rabbit anti-lamin-A 
antibody (obtained from Bob Goldman, Northwestern University, IL) was used at 
1:1000 dilution and secondary goat anti-rabbit antibody conjugated to Texas-Red 
(Jackson Labs) were used at a 1:500 dilution. Following immunostaining, cells were 
postfixed in 3% paraformaldehyde in PBS for 10 min at room temperature and 
permeabilized in 0.1M HCl / 0.7% Triton X-100 in 2xSSC for 10 min on ice. DNA 
FISH was then performed as described previously (Hu et al., 2009b). The probes for 
detecting α-globin and β-globin loci were prepared from BACs RP11-344L6 and 
CTD-2643I7 using nick translation.  
 
Microscopy and image analysis 
A personal deconvolution microscope system (DeltaVision; Applied Precision) 
was used with a 60× NA 1.4 lens for data collection. XY and Z optical displacement 
between different filter sets was determined experimentally using fluorescent 
microspheres (Tetraspeck; Invitrogen). Deconvolution on the optical sections was 
performed using an enhanced ratio iterative-constrained algorithm(Agard et al., 1989).  
The distances between LacI-GFP spots and nuclear edge defined by DAPI staining 
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were measured using ImageJ (National Institutes of Health) open-source software.  
For defining nucleus edge, the optical section of DAPI staining in which the 
LacI-GFP is in focus was selected.  Segmentation of nucleus was then performed 
using the OtsuThresholding 16Bit and k-mean clustering plugins with the following 
parameters: number=2, cluster=0.00010000 and randomization=48. For BAC 
transgenes consisting of multiple LacI-GFP spots, measurements were taken from the 
EGFP-LacI signal closest to the nuclear edge. 
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FIGURES AND TABLE 
 
 
Fig. 3.1 Experimental system for dissecting sequence elements required for 
nuclear peripheral localization.  BAC recombineering is used to remove specific 
regions from a BAC containing lac operator repeat.  Modified BACs are introduced 
to mouse fibroblast NIH/3T3 cells stably expressing LacI-GFP and the intranuclear 
positioning of the BAC transgenes can be assessed. 
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Fig. 3.2 The ~200kb human beta-globin BAC autonomously targets to nuclear 
periphery in mouse fibroblasts.  (a-c) Representative examples from NIH/3T3 
clone HBB_C3 showing that the BAC transgenes, appearing as LacI-GFP spots 
(green), target to nuclear periphery defined by DAPI counterstaining (a, blue), Lamin 
A staining (b, red) or nuclear pore staining (c, red).  (d) The beta-globin BAC 
transgenes in five independent NIH/3T3 clones show significantly higher nuclear 
peripheral localization compared with either the DHFR BAC transgenes in NIH/3T3 
clones or the endogenous alpha-globin locus in human fibroblast BJ_hTERT cells.  
A transgene is defined as “peripheral” when the distance between the transgene and 
nuclear edge defined by DAPI staining is shorter than 0.5μm.  At least 50 cells from 
each NIH/3T3 clone and at least 45 BJ_hTERT cells were analyzed.  (e,f) Detailed 
analysis suggests the beta-globin BAC transgenes in clone HBB_C3 recapitulate the 
radial nuclear localization pattern of endogenous human beta-globin locus in 
BJ_hTERT cells.  The distance between the BAC transgene in HBB_C3 highlighted 
by LacIGFP binding (e, green) or the endogenous beta-globin locus labeled by FISH 
signal (f, green) and the Lamin A signal (e and f, red) was measured and summarized 
as histograms.  All scale bars= 2μm. 
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Fig. 3.3 Sequence dissection reveals two redundant regions in the ~200kb 
beta-globin BAC responsible for the nuclear peripheral localization.  (a) Map of 
the 200kb BAC containing beta-globin locus.  Red lines indicate the regions to be 
deleted.  The map of the BAC is aligned with the Lamin B1 DamID map in human 
Fig. 3.3 (con’t) 
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fibroblast Tig3 cells, the DNaseI hypersensitivity map in normal human lung 
fibroblasts (NHLF) and the CTCF binding map in NHLF, all available in UCSC 
Genome Browser.  (b) The beta-globin genes, LCR, UHR and 3’HS1 are not 
required for the peripheral localization of the locus.  Histogram shows the 
percentages of BAC transgenes at nuclear periphery in five NIH/3T3 clones carrying 
full-length beta-globin BAC (HBB) and five clones carrying HBBD5 BAC.  (c) 
There are functional elements required for the nuclear peripheral localization of the 
200kb region, as HBBD5D7 and HBBD4 BAC lose the ability to target to nuclear 
periphery.  (d) Previously defined LAD /LAD Boundary is not the only region 
responsible for peripheral targeting, as HBBD8 and HBBD9 BACs show nuclear 
periphery targeting similarly to HBB BAC.  P-value is from two-tailed, two sample 
unequal variance t-test.  (e) Each of two redundant regions sufficient to target the 
BAC transgenes to nuclear periphery, as HBBD8, HBBD10, HBBD5D8 and 
HBBD5D10 BACs all display similar level of nuclear peripheral localization.  (f) 
Summary of the sequence dissection.  The median level of peripheral targeting of the 
five cell clones for each BAC is shown.  For each NIH/3T3 cell clone, the distance 
between BAC transgenes and nuclear periphery was measured in at least 50 cells.  
  
 
 
 
Fig. 3.4 Nuclear interior localization of BAC transgenes consisting of both 
beta-globin and DHFR BACs.  (a) Map of the ~180kb DHFR BAC containing a 
256mer lac operator repeat and a Zeocin selectable marker.  (b) Transgenes 
consisting of both DHFR and beta-globin BACs in five independent NIH/3T3 clones 
show significantly lower percentage of nuclear peripheral localization compared with 
the beta-globin BAC alone. 
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Fig. 3.5 Association of beta-globin BAC transgenes with chromocenters.  (a) 
HBBD4 and HBBD5D7 BAC transgenes exhibit significantly higher level of 
chromocenter association compared with HBB and HBBD5 BAC transgenes.  (b) 
Representative cells from three independent clones showing the association of 
HBBD4 transgenes (green) with chromocenters.  (c) The percentages of  
Fig. 3.5 (con’t) 
chromocenter association are plotted against the percentages of nuclear peripheral 
localization.  Linear fitting of the HBB clones (black triangles), HBBD4 clones (blue 
triangles) and HBBD5 clones (green triangles) shows remarkable correlation as 
indicated by R2 value while the HBBD5D7 clones (red squares) shows no obvious 
linear correlation.  (e) Transgenes consisting of both DHFR and HBB BACs (green) 
show remarkable chromocenter association regardless of the size of transgenes.  (f) 
The percentages of chromocenter association for DHFR_HBB transgenes are 
significantly higher than HBB transgenes.  P-values are calculated from two-tailed, 
two sample unequal variance t-test.  DNA is stained with DAPI (blue) in all images. 
All scale bars= 2μm. 
 
 
Fig. 3.6 The association of beta-globin BAC transgenes with heterochromatin 
compartments enriched in H3K9me3.  Examples from clone HBB_C3 showing 
the association of the BAC transgenes (green) with H3K9me3 stained foci (red) 
regardless the intranuclear positioning of the BAC transgenes. (a) BAC transgene at 
nuclear periphery.  (b) BAC transgene adjacent to a chromocenter.  (c) BAC 
transgene is located in interior of nucleus and not associated with chromocenter.  
DNA is stained with DAPI and scale bars=2μm. 
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Fig. 3.7 Peripheral localization of BAC transgene arrays can be reversed by 
recruitment of transcriptional activator.  (a) A representative cell of clone 
3T3_HBBD5_C43. The BAC transgene (green) shows nuclear peripheral localization.  
After transient transfection with mRFP-LacI-VP16 (b) or 
mCherry-LacI-DELQPASIDP (c), the transcriptional activator VP16 or the short 
peptide (red) is targeted to the BAC transgene. This resulted in the relocation of the  
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Fig. 3.7 (con’t) 
BAC transgenes to nuclear interior. DNA is stained with DAPI (blue). Scale bar = 
2μm. The distances between BAC transgenes and nuclear periphery defined by DAPI 
staining are measured in at least 50 cells before or after transfection. The result is 
summarized in (d). 
 
 
Table 3.1 Primers for BAC recombineering 
Primer Name Primer Sequence 
HBBD4-F 
HBBD4-R 
HBBD5-F 
HBBD5-R 
HBBD7-F 
HBBD7-R 
HBBD8-F 
HBBD8-R 
HBBD9-F 
HBBD9-R 
HBBD10-F 
HBBD10-R 
 
D4-Check-F 
D4-Check-R 
D5-Check-F 
D5-Check-R 
D7-Check-F 
D7-Check-R 
D8-Check-F 
D8-Check-R 
D9-Check-F 
D9-Check-R 
D10-Check-F 
D10-Check-R 
 
D5-GkRm-F 
D5-GkRm-R 
D8-GkRm-F 
D8-GkRm-R 
5’-gaaatgtcttcttcagaaaatttgtatacggcaaagatagagacgacggccagtgaattg-3’ 
5’-gtttgtgtgtttcttttgtaaatatgtctaagttcctcatagatgcttccggctcgtatg-3’ 
5’-ccctgatcccagaaatttatttgatgtgtctctcatagcacaccgacggccagtgaattg-3’ 
5’-ttcttcagactgactacaaaggcttcagactagctacaaagcttgcttccggctcgtatg-3’ 
5’-aattcaagaatgaagccgaggaccctcaaggtgattgttacagcgacggccagtgaattg-3' 
5’-gcagtcttatttaacgagaaattcagaatcctggaggcaagtctgcttccggctcgtatg-3’ 
Same as HBBD7-F 
5’-acacatagaccaaattgaacagaataaagagcccagaaataaatgcttccggctcgtatg-3’ 
Same as HBBD7-F 
5’-agcctagtatccatcagaaaatgtatgcaaatccttataaacctgcttccggctcgtatg-3’ 
5’-tttatttctgggctctttattctgttcaatttggtctatgtgtcgacggccagtgaattg-3’ 
Same as HBBD7-R 
 
5’-aaacgagtggtcctgtttgg-3’ 
5’-tgcaaccttgctagcatctg-3’ 
5’-tcttgccccattaccaatgt-3’ 
5’-agctcaggagttggagacca-3’ 
5’-gttttcccagtcacgacgtt-3’  
5’-gttttcttggttgccacgat-3’  
Same as D7 check F 
5’-gcagcacacgttctgatttc-3’ 
Same as D7 check F 
5’-tttgacatgaggcacaatgc-3’ 
5’-caggaaagggaactccatga-3’  
D10 CHECK R: same as D7 check R 
 
5’-atttcttctggaaaatgttccctgatcccagaaatttatttgatgtgtctcttctcccaa-3’ 
5’-ataattagctgggcatggcagtgtgctcctgtaatcccagttacttgggagaagagacac-3’ 
5’-tatagggcgaattcaagaatgaagccgaggaccctcaaggtgattgttacagccggaagc-3’ 
5’-acacatagaccaaattgaacagaataaagagcccagaaataaatgcttccggctgtaaca-3’  
 
94 
 
REFERENCES 
 
Agard, D.A., Y. Hiraoka, P. Shaw, and J.W. Sedat. 1989. Fluorescence microscopy in 
three dimensions. Methods Cell Biol. 30:353-377. 
Akhtar, A., and S.M. Gasser. 2007. The nuclear envelope and transcriptional control. 
Nat Rev Genet. 8:507-517. 
Andersen, D.C., and L. Krummen. 2002. Recombinant protein expression for 
therapeutic applications. Curr Opin Biotechnol. 13:117-123. 
Andrulis, E.D., A.M. Neiman, D.C. Zappulla, and R. Sternglanz. 1998. Perinuclear 
localization of chromatin facilitates transcriptional silencing. Nature. 
394:592-595. 
Antoch, M.P., E.J. Song, A.M. Chang, M.H. Vitaterna, Y. Zhao, L.D. Wilsbacher, A.M. 
Sangoram, D.P. King, L.H. Pinto, and J.S. Takahashi. 1997. Functional 
identification of the mouse circadian Clock gene by transgenic BAC rescue. 
Cell. 89:655-667. 
Antoniou, M., L. Harland, T. Mustoe, S. Williams, J. Holdstock, E. Yague, T. Mulcahy, 
M. Griffiths, S. Edwards, P.A. Ioannou, A. Mountain, and R. Crombie. 2003. 
Transgenes encompassing dual-promoter CpG islands from the human TBP 
and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. 
Genomics. 82:269-279. 
Bednar, J., R.A. Horowitz, S.A. Grigoryev, L.M. Carruthers, J.C. Hansen, A.J. Koster, 
and C.L. Woodcock. 1998. Nucleosomes, linker DNA, and linker histone form 
a unique structural motif that directs the higher-order folding and compaction 
of chromatin. Proc Natl Acad Sci U S A. 95:14173-14178. 
Belmont, A.S., and K. Bruce. 1994. Visualization of G1 chromosomes: a folded, 
twisted, supercoiled chromonema model of interphase chromatid structure. J 
Cell Biol. 127:287-302. 
Belmont, A.S., S. Dietzel, A.C. Nye, Y.G. Strukov, and T. Tumbar. 1999. Large-scale 
chromatin structure and function. Curr Opin Cell Biol. 11:307-311. 
Belmont, A.S., and A.F. Straight. 1998. In vivo visualization of chromosomes using 
lac operator-repressor binding. Trends Cell Biol. 8:121-124. 
Bernardi, R., and P.P. Pandolfi. 2007. Structure, dynamics and functions of 
promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol. 8:1006-1016. 
Bharadwaj, R.R., C.D. Trainor, P. Pasceri, and J. Ellis. 2003. LCR-regulated transgene 
expression levels depend on the Oct-1 site in the AT-rich region of beta -globin 
intron-2. Blood. 101:1603-1610. 
Bian, Q., and A.S. Belmont. 2010. BAC TG-EMBED: one-step method for high-level, 
copy-number-dependent, position-independent transgene expression. Nucleic 
Acids Res. 38:e127. 
Brown, K.E., J. Baxter, D. Graf, M. Merkenschlager, and A.G. Fisher. 1999. Dynamic 
repositioning of genes in the nucleus of lymphocytes preparing for cell 
division. Mol Cell. 3:207-217. 
95 
 
Brown, K.E., S.S. Guest, S.T. Smale, K. Hahm, M. Merkenschlager, and A.G. Fisher. 
1997. Association of transcriptionally silent genes with Ikaros complexes at 
centromeric heterochromatin. Cell. 91:845-854. 
Callan, H.G. 1982. The Croonian Lecture, 1981. Lampbrush chromosomes. Proc R 
Soc Lond B Biol Sci. 214:417-448. 
Carpenter, A.E., and A.S. Belmont. 2004. Direct visualization of transcription 
factor-induced chromatin remodeling and cofactor recruitment in vivo. 
Methods Enzymol. 375:366-381. 
Carpenter, A.E., S. Memedula, M.J. Plutz, and A.S. Belmont. 2005. Common effects 
of acidic activators on large-scale chromatin structure and transcription. Mol 
Cell Biol. 25:958-968. 
Carter, D., L. Chakalova, C.S. Osborne, Y.F. Dai, and P. Fraser. 2002. Long-range 
chromatin regulatory interactions in vivo. Nat Genet. 32:623-626. 
Chambeyron, S., and W.A. Bickmore. 2004. Chromatin decondensation and nuclear 
reorganization of the HoxB locus upon induction of transcription. Genes Dev. 
18:1119-1130. 
Cheutin, T., S.A. Gorski, K.M. May, P.B. Singh, and T. Misteli. 2004. In vivo 
dynamics of Swi6 in yeast: evidence for a stochastic model of heterochromatin. 
Mol Cell Biol. 24:3157-3167. 
Cheutin, T., A.J. McNairn, T. Jenuwein, D.M. Gilbert, P.B. Singh, and T. Misteli. 2003. 
Maintenance of stable heterochromatin domains by dynamic HP1 binding. 
Science. 299:721-725. 
Chuang, C.H., A.E. Carpenter, B. Fuchsova, T. Johnson, P. de Lanerolle, and A.S. 
Belmont. 2006. Long-range directional movement of an interphase 
chromosome site. Curr Biol. 16:825-831. 
Chung, J.H., A.C. Bell, and G. Felsenfeld. 1997. Characterization of the chicken 
beta-globin insulator. Proc Natl Acad Sci U S A. 94:575-580. 
Chung, J.H., M. Whiteley, and G. Felsenfeld. 1993. A 5' element of the chicken 
beta-globin domain serves as an insulator in human erythroid cells and 
protects against position effect in Drosophila. Cell. 74:505-514. 
Cremer, M., K. Kupper, B. Wagler, L. Wizelman, J. von Hase, Y. Weiland, L. Kreja, J. 
Diebold, M.R. Speicher, and T. Cremer. 2003. Inheritance of gene 
density-related higher order chromatin arrangements in normal and tumor cell 
nuclei. J Cell Biol. 162:809-820. 
Croft, J.A., J.M. Bridger, S. Boyle, P. Perry, P. Teague, and W.A. Bickmore. 1999. 
Differences in the localization and morphology of chromosomes in the human 
nucleus. J Cell Biol. 145:1119-1131. 
Dechat, T., K. Pfleghaar, K. Sengupta, T. Shimi, D.K. Shumaker, L. Solimando, and 
R.D. Goldman. 2008. Nuclear lamins: major factors in the structural 
organization and function of the nucleus and chromatin. Genes Dev. 
22:832-853. 
Denoeud, F., P. Kapranov, C. Ucla, A. Frankish, R. Castelo, J. Drenkow, J. Lagarde, T. 
Alioto, C. Manzano, J. Chrast, S. Dike, C. Wyss, C.N. Henrichsen, N. Holroyd, 
M.C. Dickson, R. Taylor, Z. Hance, S. Foissac, R.M. Myers, J. Rogers, T. 
96 
 
Hubbard, J. Harrow, R. Guigo, T.R. Gingeras, S.E. Antonarakis, and A. 
Reymond. 2007. Prominent use of distal 5' transcription start sites and 
discovery of a large number of additional exons in ENCODE regions. Genome 
Res. 17:746-759. 
Dietzel, S., K. Zolghadr, C. Hepperger, and A.S. Belmont. 2004. Differential 
large-scale chromatin compaction and intranuclear positioning of transcribed 
versus non-transcribed transgene arrays containing beta-globin regulatory 
sequences. J Cell Sci. 117:4603-4614. 
Dillon, N., and R. Festenstein. 2002. Unravelling heterochromatin: competition 
between positive and negative factors regulates accessibility. Trends Genet. 
18:252-258. 
Dorer, D.R., and S. Henikoff. 1997. Transgene repeat arrays interact with distant 
heterochromatin and cause silencing in cis and trans. Genetics. 
147:1181-1190. 
Eltsov, M., K.M. Maclellan, K. Maeshima, A.S. Frangakis, and J. Dubochet. 2008. 
Analysis of cryo-electron microscopy images does not support the existence of 
30-nm chromatin fibers in mitotic chromosomes in situ. Proc Natl Acad Sci U 
S A. 105:19732-19737. 
Emery, D.W., E. Yannaki, J. Tubb, and G. Stamatoyannopoulos. 2000. A chromatin 
insulator protects retrovirus vectors from chromosomal position effects. Proc 
Natl Acad Sci U S A. 97:9150-9155. 
Fan, Y., T. Nikitina, J. Zhao, T.J. Fleury, R. Bhattacharyya, E.E. Bouhassira, A. Stein, 
C.L. Woodcock, and A.I. Skoultchi. 2005. Histone H1 depletion in mammals 
alters global chromatin structure but causes specific changes in gene 
regulation. Cell. 123:1199-1212. 
Ferrai, C., I.J. de Castro, L. Lavitas, M. Chotalia, and A. Pombo. 2010. Gene 
positioning. Cold Spring Harb Perspect Biol. 2:a000588. 
Ferreira, J., G. Paolella, C. Ramos, and A.I. Lamond. 1997. Spatial organization of 
large-scale chromatin domains in the nucleus: a magnified view of single 
chromosome territories. J Cell Biol. 139:1597-1610. 
Festenstein, R., S.N. Pagakis, K. Hiragami, D. Lyon, A. Verreault, B. Sekkali, and D. 
Kioussis. 2003. Modulation of heterochromatin protein 1 dynamics in primary 
Mammalian cells. Science. 299:719-721. 
Finlan, L.E., D. Sproul, I. Thomson, S. Boyle, E. Kerr, P. Perry, B. Ylstra, J.R. Chubb, 
and W.A. Bickmore. 2008. Recruitment to the nuclear periphery can alter 
expression of genes in human cells. PLoS Genet. 4:e1000039. 
Francastel, C., W. Magis, and M. Groudine. 2001. Nuclear relocation of a 
transactivator subunit precedes target gene activation. Proc Natl Acad Sci U S 
A. 98:12120-12125. 
Francis, N.J., R.E. Kingston, and C.L. Woodcock. 2004. Chromatin compaction by a 
polycomb group protein complex. Science. 306:1574-1577. 
Fraser, P. 2006. Transcriptional control thrown for a loop. Curr Opin Genet Dev. 
16:490-495. 
Gall, J.G. 2003. The centennial of the Cajal body. Nat Rev Mol Cell Biol. 4:975-980. 
97 
 
Gandor, C., C. Leist, A. Fiechter, and F.A. Asselbergs. 1995. Amplification and 
expression of recombinant genes in serum-independent Chinese hamster ovary 
cells. FEBS Lett. 377:290-294. 
Garrick, D., S. Fiering, D.I. Martin, and E. Whitelaw. 1998. Repeat-induced gene 
silencing in mammals. Nat Genet. 18:56-59. 
Georgel, P.T., R.A. Horowitz-Scherer, N. Adkins, C.L. Woodcock, P.A. Wade, and J.C. 
Hansen. 2003. Chromatin compaction by human MeCP2. Assembly of novel 
secondary chromatin structures in the absence of DNA methylation. J Biol 
Chem. 278:32181-32188. 
Gilbert, N., S. Boyle, H. Fiegler, K. Woodfine, N.P. Carter, and W.A. Bickmore. 2004. 
Chromatin architecture of the human genome: gene-rich domains are enriched 
in open chromatin fibers. Cell. 118:555-566. 
Greil, F., C. Moorman, and B. van Steensel. 2006. DamID: mapping of in vivo 
protein-genome interactions using tethered DNA adenine methyltransferase. 
Methods Enzymol. 410:342-359. 
Grigoryev, S.A., G. Arya, S. Correll, C.L. Woodcock, and T. Schlick. 2009. Evidence 
for heteromorphic chromatin fibers from analysis of nucleosome interactions. 
Proc Natl Acad Sci U S A. 106:13317-13322. 
Grosveld, F., G.B. van Assendelft, D.R. Greaves, and G. Kollias. 1987. 
Position-independent, high-level expression of the human beta-globin gene in 
transgenic mice. Cell. 51:975-985. 
Gruenbaum, Y., A. Margalit, R.D. Goldman, D.K. Shumaker, and K.L. Wilson. 2005. 
The nuclear lamina comes of age. Nat Rev Mol Cell Biol. 6:21-31. 
Guelen, L., L. Pagie, E. Brasset, W. Meuleman, M.B. Faza, W. Talhout, B.H. Eussen, 
A. de Klein, L. Wessels, W. de Laat, and B. van Steensel. 2008. Domain 
organization of human chromosomes revealed by mapping of nuclear lamina 
interactions. Nature. 453:948-951. 
Guy, L.G., R. Kothary, Y. DeRepentigny, N. Delvoye, J. Ellis, and L. Wall. 1996. The 
beta-globin locus control region enhances transcription of but does not confer 
position-independent expression onto the lacZ gene in transgenic mice. Embo 
J. 15:3713-3721. 
Hall, L.L., K.P. Smith, M. Byron, and J.B. Lawrence. 2006. Molecular anatomy of a 
speckle. Anat Rec A Discov Mol Cell Evol Biol. 288:664-675. 
Hansen, J.C. 2002. Conformational dynamics of the chromatin fiber in solution: 
determinants, mechanisms, and functions. Annu Rev Biophys Biomol Struct. 
31:361-392. 
Heintz, N. 2000. Analysis of mammalian central nervous system gene expression and 
function using bacterial artificial chromosome-mediated transgenesis. Hum 
Mol Genet. 9:937-943. 
Hepperger, C., A. Mannes, J. Merz, J. Peters, and S. Dietzel. 2008. Three-dimensional 
positioning of genes in mouse cell nuclei. Chromosoma. 117:535-551. 
Hino, S., J. Fan, S. Taguwa, K. Akasaka, and M. Matsuoka. 2004. Sea urchin insulator 
protects lentiviral vector from silencing by maintaining active chromatin 
structure. Gene Ther. 11:819-828. 
98 
 
Horn, P.J., and C.L. Peterson. 2002. Molecular biology. Chromatin higher order 
folding--wrapping up transcription. Science. 297:1824-1827. 
Horowitz, R.A., D.A. Agard, J.W. Sedat, and C.L. Woodcock. 1994. The 
three-dimensional architecture of chromatin in situ: electron tomography 
reveals fibers composed of a continuously variable zig-zag nucleosomal 
ribbon. J Cell Biol. 125:1-10. 
Hu, Y., I. Kireev, M. Plutz, N. Ashourian, and A.S. Belmont. 2009a. Large-scale 
chromatin structure of inducible genes: transcription on a condensed, linear 
template. J Cell Biol. 185:87-100. 
Hu, Y., I. Kireev, M.J. Plutz, N. Ashourian, and A.S. Belmont. 2009b. Large-scale 
chromatin structure of inducible genes- transcription on a linear template J. 
Cell Biol. 185:87-100. 
Iwanaga, R., H. Komori, and K. Ohtani. 2004. Differential regulation of expression of 
the mammalian DNA repair genes by growth stimulation. Oncogene. 
23:8581-8590. 
Kang, S.H., P.P. Levings, F. Andersen, P.J. Laipis, K.I. Berns, R.T. Zori, and J. 
Bungert. 2004. Locus control region elements HS2 and HS3 in combination 
with chromatin boundaries confer high-level expression of a human 
beta-globin transgene in a centromeric region. Genes Cells. 9:1043-1053. 
Karpen, G.H. 1994. Position-effect variegation and the new biology of 
heterochromatin. Curr Opin Genet Dev. 4:281-291. 
Kaufman, R.M., C.T. Pham, and T.J. Ley. 1999. Transgenic analysis of a 100-kb 
human beta-globin cluster-containing DNA fragment propagated as a bacterial 
artificial chromosome. Blood. 94:3178-3184. 
Kim, J.M., J.S. Kim, D.H. Park, H.S. Kang, J. Yoon, K. Baek, and Y. Yoon. 2004. 
Improved recombinant gene expression in CHO cells using matrix attachment 
regions. J Biotechnol. 107:95-105. 
Kireev, I., M. Lakonishok, W. Liu, V.N. Joshi, R. Powell, and A.S. Belmont. 2008. In 
vivo immunogold labeling confirms large-scale chromatin folding motifs. Nat 
Methods. 5:311-313. 
Kosak, S.T., J.A. Skok, K.L. Medina, R. Riblet, M.M. Le Beau, A.G. Fisher, and H. 
Singh. 2002. Subnuclear compartmentalization of immunoglobulin loci during 
lymphocyte development. Science. 296:158-162. 
Kumaran, R.I., and D.L. Spector. 2008. A genetic locus targeted to the nuclear 
periphery in living cells maintains its transcriptional competence. J Cell Biol. 
180:51-65. 
Kwaks, T.H., P. Barnett, W. Hemrika, T. Siersma, R.G. Sewalt, D.P. Satijn, J.F. Brons, 
R. van Blokland, P. Kwakman, A.L. Kruckeberg, A. Kelder, and A.P. Otte. 
2003. Identification of anti-repressor elements that confer high and stable 
protein production in mammalian cells. Nat Biotechnol. 21:553-558. 
Kwaks, T.H., and A.P. Otte. 2006. Employing epigenetics to augment the expression 
of therapeutic proteins in mammalian cells. Trends Biotechnol. 24:137-142. 
Lawrence, J.B., R.H. Singer, and J.A. McNeil. 1990. Interphase and metaphase 
resolution of different distances within the human dystrophin gene. Science. 
99 
 
249:928-932. 
Levi, V., Q. Ruan, M. Plutz, A.S. Belmont, and E. Gratton. 2005. Chromatin dynamics 
in interphase cells revealed by tracking in a two-photon excitation microscope. 
Biophys J. 89:4275-4285. 
Li, G., G. Sudlow, and A.S. Belmont. 1998. Interphase cell cycle dynamics of a 
late-replicating, heterochromatic homogeneously staining region: precise 
choreography of condensation/decondensation and nuclear positioning. J Cell 
Biol. 140:975-989. 
Li, Q., K.R. Peterson, X. Fang, and G. Stamatoyannopoulos. 2002. Locus control 
regions. Blood. 100:3077-3086. 
Linton, J.P., J.Y. Yen, E. Selby, Z. Chen, J.M. Chinsky, K. Liu, R.E. Kellems, and G.F. 
Crouse. 1989. Dual bidirectional promoters at the mouse dhfr locus: cloning 
and characterization of two mRNA classes of the divergently transcribed 
Rep-1 gene. Mol Cell Biol. 9:3058-3072. 
Luco, R.F., M.A. Maestro, N. Sadoni, D. Zink, and J. Ferrer. 2008. Targeted 
deficiency of the transcriptional activator Hnf1alpha alters subnuclear 
positioning of its genomic targets. PLoS Genet. 4:e1000079. 
Luger, K., A.W. Mader, R.K. Richmond, D.F. Sargent, and T.J. Richmond. 1997. 
Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 
389:251-260. 
Maeshima, K., S. Hihara, and M. Eltsov. 2010. Chromatin structure: does the 30-nm 
fibre exist in vivo? Curr Opin Cell Biol. 22:291-297. 
Mahy, N.L., P.E. Perry, and W.A. Bickmore. 2002. Gene density and transcription 
influence the localization of chromatin outside of chromosome territories 
detectable by FISH. J Cell Biol. 159:753-763. 
Manuelidis, L. 1990. A view of interphase chromosomes. Science. 250:1533-1540. 
McKenzie, S.L., S. Henikoff, and M. Meselson. 1975. Localization of RNA from 
heat-induced polysomes at puff sites in Drosophila melanogaster. Proc Natl 
Acad Sci U S A. 72:1117-1121. 
Meister, P., B.D. Towbin, B.L. Pike, A. Ponti, and S.M. Gasser. 2010. The spatial 
dynamics of tissue-specific promoters during C. elegans development. Genes 
Dev. 24:766-782. 
Misteli, T. 2007. Beyond the sequence: cellular organization of genome function. Cell. 
128:787-800. 
Muller, W.G., D. Rieder, G. Kreth, C. Cremer, Z. Trajanoski, and J.G. McNally. 2004. 
Generic features of tertiary chromatin structure as detected in natural 
chromosomes. Mol Cell Biol. 24:9359-9370. 
Muller, W.G., D. Walker, G.L. Hager, and J.G. McNally. 2001. Large-scale chromatin 
decondensation and recondensation regulated by transcription from a natural 
promoter. J Cell Biol. 154:33-48. 
Munkel, C., R. Eils, S. Dietzel, D. Zink, C. Mehring, G. Wedemann, T. Cremer, and J. 
Langowski. 1999. Compartmentalization of interphase chromosomes observed 
in simulation and experiment. J Mol Biol. 285:1053-1065. 
Mutskov, V.J., C.M. Farrell, P.A. Wade, A.P. Wolffe, and G. Felsenfeld. 2002. The 
100 
 
barrier function of an insulator couples high histone acetylation levels with 
specific protection of promoter DNA from methylation. Genes Dev. 
16:1540-1554. 
Osborne, C.S., L. Chakalova, J.A. Mitchell, A. Horton, A.L. Wood, D.J. Bolland, A.E. 
Corcoran, and P. Fraser. 2007. Myc dynamically and preferentially relocates to 
a transcription factory occupied by Igh. PLoS Biol. 5:e192. 
Parseghian, M.H., R.L. Newcomb, and B.A. Hamkalo. 2001. Distribution of somatic 
H1 subtypes is non-random on active vs. inactive chromatin II: distribution in 
human adult fibroblasts. J Cell Biochem. 83:643-659. 
Peric-Hupkes, D., W. Meuleman, L. Pagie, S.W. Bruggeman, I. Solovei, W. Brugman, 
S. Graf, P. Flicek, R.M. Kerkhoven, M. van Lohuizen, M. Reinders, L. 
Wessels, and B. van Steensel. 2010. Molecular maps of the reorganization of 
genome-nuclear lamina interactions during differentiation. Mol Cell. 
38:603-613. 
Peterson, K.R., P.A. Navas, Q. Li, and G. Stamatoyannopoulos. 1998. LCR-dependent 
gene expression in beta-globin YAC transgenics: detailed structural studies 
validate functional analysis even in the presence of fragmented YACs. Hum 
Mol Genet. 7:2079-2088. 
Pickersgill, H., B. Kalverda, E. de Wit, W. Talhout, M. Fornerod, and B. van Steensel. 
2006. Characterization of the Drosophila melanogaster genome at the nuclear 
lamina. Nat Genet. 38:1005-1014. 
Pikaart, M.J., F. Recillas-Targa, and G. Felsenfeld. 1998. Loss of transcriptional 
activity of a transgene is accompanied by DNA methylation and histone 
deacetylation and is prevented by insulators. Genes Dev. 12:2852-2862. 
Ragoczy, T., M.A. Bender, A. Telling, R. Byron, and M. Groudine. 2006. The locus 
control region is required for association of the murine beta-globin locus with 
engaged transcription factories during erythroid maturation. Genes Dev. 
20:1447-1457. 
Ragoczy, T., A. Telling, T. Sawado, M. Groudine, and S.T. Kosak. 2003. A genetic 
analysis of chromosome territory looping: diverse roles for distal regulatory 
elements. Chromosome Res. 11:513-525. 
Recillas-Targa, F., M.J. Pikaart, B. Burgess-Beusse, A.C. Bell, M.D. Litt, A.G. West, 
M. Gaszner, and G. Felsenfeld. 2002. Position-effect protection and enhancer 
blocking by the chicken beta-globin insulator are separable activities. Proc 
Natl Acad Sci U S A. 99:6883-6888. 
Reddy, K.L., J.M. Zullo, E. Bertolino, and H. Singh. 2008. Transcriptional repression 
mediated by repositioning of genes to the nuclear lamina. Nature. 
452:243-247. 
Robinett, C.C., A. Straight, G. Li, C. Willhelm, G. Sudlow, A. Murray, and A.S. 
Belmont. 1996. In vivo localization of DNA sequences and visualization of 
large-scale chromatin organization using lac operator/repressor recognition. J 
Cell Biol. 135:1685-1700. 
Rubin, J.E., P. Pasceri, X. Wu, P. Leboulch, and J. Ellis. 2000. Locus control region 
activity by 5'HS3 requires a functional interaction with beta-globin gene 
101 
 
regulatory elements: expression of novel beta/gamma-globin hybrid 
transgenes. Blood. 95:3242-3249. 
Sadoni, N., S. Langer, C. Fauth, G. Bernardi, T. Cremer, B.M. Turner, and D. Zink. 
1999. Nuclear organization of mammalian genomes. Polar chromosome 
territories build up functionally distinct higher order compartments. J Cell Biol. 
146:1211-1226. 
Schilling, L.J., and P.J. Farnham. 1995. The bidirectionally transcribed dihydrofolate 
reductase and rep-3a promoters are growth regulated by distinct mechanisms. 
Cell Growth Differ. 6:541-548. 
Schmidt, E.E., and G.F. Merrill. 1989a. Maintenance of dihydrofolate reductase 
enzyme after disappearance of DHFR mRNA during muscle cell 
differentiation. In Vitro Cell Dev Biol. 25:697-704. 
Schmidt, E.E., and G.F. Merrill. 1989b. Transcriptional repression of the mouse 
dihydrofolate reductase gene during muscle cell commitment. J Biol Chem. 
264:21247-21256. 
Schoenfelder, S., T. Sexton, L. Chakalova, N.F. Cope, A. Horton, S. Andrews, S. 
Kurukuti, J.A. Mitchell, D. Umlauf, D.S. Dimitrova, C.H. Eskiw, Y. Luo, C.L. 
Wei, Y. Ruan, J.J. Bieker, and P. Fraser. 2010. Preferential associations 
between co-regulated genes reveal a transcriptional interactome in erythroid 
cells. Nat Genet. 42:53-61. 
Schuettengruber, B., D. Chourrout, M. Vervoort, B. Leblanc, and G. Cavalli. 2007. 
Genome regulation by polycomb and trithorax proteins. Cell. 128:735-745. 
Sekkali, B., H.T. Tran, E. Crabbe, C. De Beule, F. Van Roy, and K. Vleminckx. 2008. 
Chicken beta-globin insulator overcomes variegation of transgenes in Xenopus 
embryos. Faseb J. 22:2534-2540. 
Shizuya, H., B. Birren, U.J. Kim, V. Mancino, T. Slepak, Y. Tachiiri, and M. Simon. 
1992. Cloning and stable maintenance of 300-kilobase-pair fragments of 
human DNA in Escherichia coli using an F-factor-based vector. Proc Natl 
Acad Sci U S A. 89:8794-8797. 
Simpson, R.T., F. Thoma, and J.M. Brubaker. 1985. Chromatin reconstituted from 
tandemly repeated cloned DNA fragments and core histones: a model system 
for study of higher order structure. Cell. 42:799-808. 
Sinclair, P., Q. Bian, M. Plutz, E. Heard, and A.S. Belmont. 2010. Dynamic plasticity 
of large-scale chromatin structure revealed by self-assembly of engineered 
chromosome regions. J Cell Biol. 190:761-776. 
Slansky, J.E., and P.J. Farnham. 1996. Transcriptional regulation of the dihydrofolate 
reductase gene. Bioessays. 18:55-62. 
Smith, K.P., P.T. Moen, K.L. Wydner, J.R. Coleman, and J.B. Lawrence. 1999. 
Processing of endogenous pre-mRNAs in association with SC-35 domains is 
gene specific. J Cell Biol. 144:617-629. 
Solovei, I., A. Cavallo, L. Schermelleh, F. Jaunin, C. Scasselati, D. Cmarko, C. 
Cremer, S. Fakan, and T. Cremer. 2002. Spatial preservation of nuclear 
chromatin architecture during three-dimensional fluorescence in situ 
hybridization (3D-FISH). Exp Cell Res. 276:10-23. 
102 
 
Springhetti, E.M., N.E. Istomina, J.C. Whisstock, T. Nikitina, C.L. Woodcock, and 
S.A. Grigoryev. 2003. Role of the M-loop and reactive center loop domains in 
the folding and bridging of nucleosome arrays by MENT. J Biol Chem. 
278:43384-43393. 
Stamatoyannopoulos, J.A., C.H. Clegg, and Q. Li. 1997. Sheltering of gamma-globin 
expression from position effects requires both an upstream locus control 
region and a regulatory element 3' to the A gamma-globin gene. Mol Cell Biol. 
17:240-247. 
Takizawa, T., P.R. Gudla, L. Guo, S. Lockett, and T. Misteli. 2008a. Allele-specific 
nuclear positioning of the monoallelically expressed astrocyte marker GFAP. 
Genes Dev. 22:489-498. 
Takizawa, T., K.J. Meaburn, and T. Misteli. 2008b. The meaning of gene positioning. 
Cell. 135:9-13. 
Tolhuis, B., R.J. Palstra, E. Splinter, F. Grosveld, and W. de Laat. 2002. Looping and 
interaction between hypersensitive sites in the active beta-globin locus. Mol 
Cell. 10:1453-1465. 
Truffinet, V., L. Guglielmi, M. Cogne, and Y. Denizot. 2005. The chicken beta-globin 
HS4 insulator is not a silver bullet to obtain copy-number dependent 
expression of transgenes in stable B cell transfectants. Immunol Lett. 
96:303-304. 
Tumbar, T., and A.S. Belmont. 2001. Interphase movements of a DNA chromosome 
region modulated by VP16 transcriptional activator. Nat Cell Biol. 3:134-139. 
Tumbar, T., G. Sudlow, and A.S. Belmont. 1999. Large-scale chromatin unfolding and 
remodeling induced by VP16 acidic activation domain. J Cell Biol. 
145:1341-1354. 
Verschure, P.J., I. van der Kraan, E.M. Manders, D. Hoogstraten, A.B. Houtsmuller, 
and R. van Driel. 2003. Condensed chromatin domains in the mammalian 
nucleus are accessible to large macromolecules. EMBO Rep. 4:861-866. 
Vogel, M.J., D. Peric-Hupkes, and B. van Steensel. 2007. Detection of in vivo 
protein-DNA interactions using DamID in mammalian cells. Nat Protoc. 
2:1467-1478. 
Volpi, E.V., E. Chevret, T. Jones, R. Vatcheva, J. Williamson, S. Beck, R.D. Campbell, 
M. Goldsworthy, S.H. Powis, J. Ragoussis, J. Trowsdale, and D. Sheer. 2000. 
Large-scale chromatin organization of the major histocompatibility complex 
and other regions of human chromosome 6 and its response to interferon in 
interphase nuclei. J Cell Sci. 113 ( Pt 9):1565-1576. 
Wansink, D.G., W. Schul, I. van der Kraan, B. van Steensel, R. van Driel, and L. de 
Jong. 1993. Fluorescent labeling of nascent RNA reveals transcription by RNA 
polymerase II in domains scattered throughout the nucleus. J Cell Biol. 
122:283-293. 
Warming, S., N. Costantino, D.L. Court, N.A. Jenkins, and N.G. Copeland. 2005. 
Simple and highly efficient BAC recombineering using galK selection. 
Nucleic Acids Res. 33:e36. 
Wijgerde, M., F. Grosveld, and P. Fraser. 1995. Transcription complex stability and 
103 
 
chromatin dynamics in vivo. Nature. 377:209-213. 
Williams, R.R., V. Azuara, P. Perry, S. Sauer, M. Dvorkina, H. Jorgensen, J. Roix, P. 
McQueen, T. Misteli, M. Merkenschlager, and A.G. Fisher. 2006. Neural 
induction promotes large-scale chromatin reorganisation of the Mash1 locus. J 
Cell Sci. 119:132-140. 
Williams, S., T. Mustoe, T. Mulcahy, M. Griffiths, D. Simpson, M. Antoniou, A. 
Irvine, A. Mountain, and R. Crombie. 2005. CpG-island fragments from the 
HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene 
expression from the hCMV promoter/enhancer in mammalian cells. BMC 
Biotechnol. 5:17. 
Woodcock, C.L. 2006. Chromatin architecture. Curr Opin Struct Biol. 16:213-220. 
Woodcock, C.L., and R.P. Ghosh. 2010. Chromatin higher-order structure and 
dynamics. Cold Spring Harb Perspect Biol. 2:a000596. 
Woodcock, C.L., and R.A. Horowitz. 1995. Chromatin organization re-viewed. Trends 
Cell Biol. 5:272-277. 
Woodcock, C.L., A.I. Skoultchi, and Y. Fan. 2006. Role of linker histone in chromatin 
structure and function: H1 stoichiometry and nucleosome repeat length. 
Chromosome Res. 14:17-25. 
Wuebbles, R.D., M.L. Hanel, and P.L. Jones. 2009. FSHD region gene 1 (FRG1) is 
crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular 
dystrophy-associated vasculopathy. Dis Model Mech. 2:267-274. 
Wurm, F.M. 2004. Production of recombinant protein therapeutics in cultivated 
mammalian cells. Nat Biotechnol. 22:1393-1398. 
Xing, Y., C.V. Johnson, P.T. Moen, Jr., J.A. McNeil, and J. Lawrence. 1995. 
Nonrandom gene organization: structural arrangements of specific pre-mRNA 
transcription and splicing with SC-35 domains. J Cell Biol. 131:1635-1647. 
Yang, X.W., P. Model, and N. Heintz. 1997. Homologous recombination based 
modification in Escherichia coli and germline transmission in transgenic mice 
of a bacterial artificial chromosome. Nat Biotechnol. 15:859-865. 
Yokota, H., G. van den Engh, J.E. Hearst, R.K. Sachs, and B.J. Trask. 1995. Evidence 
for the organization of chromatin in megabase pair-sized loops arranged along 
a random walk path in the human G0/G1 interphase nucleus. J Cell Biol. 
130:1239-1249. 
Zahn-Zabal, M., M. Kobr, P.A. Girod, M. Imhof, P. Chatellard, M. de Jesus, F. Wurm, 
and N. Mermod. 2001. Development of stable cell lines for production or 
regulated expression using matrix attachment regions. J Biotechnol. 87:29-42. 
Zhou, V.W., A. Goren, and B.E. Bernstein. 2011. Charting histone modifications and 
the functional organization of mammalian genomes. Nat Rev Genet. 12:7-18. 
Zink, D., M.D. Amaral, A. Englmann, S. Lang, L.A. Clarke, C. Rudolph, F. Alt, K. 
Luther, C. Braz, N. Sadoni, J. Rosenecker, and D. Schindelhauer. 2004. 
Transcription-dependent spatial arrangements of CFTR and adjacent genes in 
human cell nuclei. J Cell Biol. 166:815-825. 
104 
 
APPENDIX 
BAC RECOMBINEERING PROTOCOLS 
Bacterial artificial chromosomes (BACs) are a class of DNA constructs carrying 
100-300 kb of eukaryotic genomic fragments and have been used extensively in a 
variety of genomic sequencing projects. BACs have also been proven to be valuable 
tools for study gene functions and regulations and confer several remarkable 
advantages over typical plasmid constructs. First, because the BAC can carry a much 
larger size of insertion, it can be used to study the function of large genes. 
Furthermore, the BACs can contain not only the coding regions of genes but also their 
distal regulatory elements, which may be hundreds of kb away from the genes. It has 
been shown in transgenic animals and cell lines the genes contained in the big BAC 
insertions can be expressed at similar levels to their endogenous counterparts. A 
recent study has also suggested BACs can be used as tools to survey the expression 
patterns and functions of genes in a high-throughput way by inserting sequences 
coding for fluorescent tags to the UTRs of genes contained in the BACs. In addition, 
by making specific deletions within the BACs, the functions of regulatory elements 
important for gene expression can be investigated. 
Most of the applications of BACs require addition, deletion or introducing point 
mutations into the BAC sequences. However, due to its large size, it is usually 
difficult to find appropriate restriction sites to perform the sequence manipulation 
using standard recombinant DNA technology. Instead, recent technical advances have 
made it possible to use recombination to engineer BAC DNA sequences. Our lab has 
been using the BAC recombineering (recombination-mediated genetic engineering) 
technique to effectively make serial insertions and deletions in BACs. Here I will 
briefly review the BAC recombineering schemes and introduce the technical 
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modifications we made on the common recombineering strategies. 
 
BAC recombineering using λ-red encoded genes 
An early version of recombineering scheme was designed based on the activity of 
E.coli RecA gene, which mediates homologous recombination between circular DNA 
constructs. However, this method has a severe limitation for BAC recombineering as 
the RecA has been known to cause instability of BAC constructs. BACs carry large 
eukaryotic genomic inserts and usually contain repetitive sequences and RecA may 
induce unwanted recombination between repeats and generate rearranged BACs. The 
screening for correctly recombined BACs may be laborious. 
It has later been discovered bacteriophage λ also contains a homologous 
recombination system which is termed red. λ- red system is more powerful than 
bacterial recombination system and requires much shorter homology arms to perform 
recombination at high fidelity. Another advantage of the λ-red system is that it can 
perform recombination with linear DNA fragment, therefore make it possible to use a 
PCR fragment for recombineering. The first generation of λ-red system was 
developed by transforming a RecA negative E.coli strain with a plasmid encoding 
three proteins: Exo, Bet and Gam. Exo possesses 5' to 3' exonuclease activity and 
generate 3' end overhangs at the ends of the linear fragment. Bet then binds to the 
overhangs and mediate recombination between the linear fragment and the target 
construct. The expression of Gam inhibit the activity of RecBCD proteins from the 
host bacteria strain, which have linear double strand DNA exonuclease activity, 
therefore protect the linear fragment from being degraded. The λ-red system is so far 
the most standard and efficient recombineering system. 
The expression of phage recombination machinery may still cause unwanted 
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rearrangement of BAC constructs. To improve the stability of the λ-red system, the 
three phage genes are expressed from a λ phage which is integrated into E.coli 
genome. The expression of the three genes is under tight control of temperature 
sensitive λ-cI857 repressor. This engineered bacteria strain was normally cultured at 
32˚C and the expression of the λ-red recombination machinery is suppressed by the 
active λ-cI857 repressor. When the temperature is shifted to 42˚C for 15 minutes, the 
repressor is inactivated and the recombination machinery is expressed to a high level. 
The amount of the recombinant machinery will ensure high frequency of 
recombination. 
 
GalK for efficient positive and negative selection 
The selection for correct recombinants after induced recombineering is used 
achieved by using drug resistant selectable markers. However, for many applications, 
the removal of the selectable marker after the first round of recombineering is 
necessary. For instance, if a point mutation or a deletion is to be made in a gene 
contained in a BAC, the selectable marker needs to be removed to avoid disruption of 
the coding region. In addition, the selectable markers used for selection in bacterial 
recombination are usually prokaryotic genes and driven by prokaryotic promoter. The 
introduction of these exogenous prokaryotic sequences into eukaryotic genomic 
regions may cause unwanted chromatin effects such as accumulation of DNA 
methylation, thus give rise to artifacts. Furthermore, in some applications multiple 
rounds of addition or deletion of sequences need to be made in the same BAC. 
Although different selectable markers can be used in each round of recombination, 
this will limit the flexibility of the BAC recombineering. Therefore, selectable 
markers which can be used in both positive and negative selection need to be 
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developed for "seamless" sequence manipulations in BACs. 
The sacB-neo is one of the most widely used positive/negative selectable marker. 
Neomycin resistance is used for the positive selection. And glucose toxicity in the 
presence of SacB protein can be used in negative selection to specifically select the 
clones in which the sacB-neo is removed. The drawback of this selection strategy is 
that the sacB is prone to point mutations in E.coli, which results in high background 
in negative selection. 
More recently, galK has been developed as a new selectable marker for both 
positive and negative selection. E.coli galK gene encodes protein galactokinase, 
which is essential for utilizing the galactose as the carbon source. On the other hand, 
galK gene can catalyze the phosphorylation of a galactose isoform 2-deoxy-galactose 
(DOG), and eventually generate the 2-deoxy-galactose-1-phosphate which is toxic to 
the cells. To employ galK gene as the selectable marker, the endogenous galK gene 
was removed from the bacterial genome to generate a specialized strain. The BAC to 
be modified needs to be introduced to this strain. A linear DNA fragment containing 
galK gene can then be integrated to the BAC by homologous recombination. The 
recombinants are selected on minimal medium in which the galactose is supplied as 
the only carbon source. Only the bacteria cells containing the exogenous galK can 
grow. The galK can then be removed from the correct recombinants by another round 
of recombination. And the negative selection is performed with minimal medium 
containing DOG. Only the recombinants in which the galK is removed can survive, 
therefore resulting in efficient negative selection. Although spontaneous mutations 
within galK can still give rise to background clones in negative selection, the ratio of 
correctly recombined clones to background clones is relatively high, making the 
screening very feasible. 
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Revised recombination scheme for seamless insertion into BAC 
Using the GalK selection system, efficient point mutations and deletions within 
BACs have been achieved. The established scheme for making point mutation in 
genes within BACs contains two steps. In the first step, a galK fragment flanked by 
about 50bp of homology arms is generated by PCR. The fragment is transformed into 
the E.coli strain carrying the target BAC. After recombination, E.coli clones carrying 
the BAC which contains the galK insertion at the target location are selected on plates 
containg galactose as the only carbon source. In the second step, a PCR product 
containing the appropriate homology arms and the point mutation was introduced to 
replace the galK. The negative selection is performed on minimal plates which 
contain glycerol as the carbon source and also DOG to select for the loss of galK. Up 
to 67% of clones surviving the negative selection are correct recombinants. 
We initially adopted this system to insert a DNA fragment about 4-5kb into DHFR 
BAC. However, after we did the recombination to replace the galK with the insert at 
the site of interest, we failed to get any correct recombinants from screening a total of 
40 colonies after the negative selection with DOG. All the background clones we 
checked are due to gross deletions within the BAC or the loss of GalK activity 
without removing it from the BAC. We reasoned that the big size of our DNA 
fragment may result in low rate of replacement of galK, and the correct recombinants 
may be overwhelmed in the background clones. 
To obtain the ratio of correct recombinants to background clones, we replaced the 
galK insertion in the BAC with a 1.7 kb Kan/Neo fragment, and selected the clones 
either on DOG plates or on DOG plates containing 20ug/ml Kanamycin. The colonies 
growing on the latter represent the recombinants in which the Kan/Neo selectable 
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marker replaced the galK. We observed that the number of colonies on DOG/Kan 
plates is only ~2% of the number of colonies on DOG plate. We suspect this 
percentage may even decrease when using a bigger fragment to replace galK. This 
will make the screening of clones very difficult. 
To solve this problem, we revised the scheme of the two-step recombination to 
achieve the "seamless" insertion of bigger DNA sequences into BACs (Fig). A 
targeting fragment containing three homology arms A, B and C, each with the size of 
45-50bp, is generated. The galK selectable marker is then inserted between homology 
boxes Band C. And the DNA sequence to be added in to the BAC, X, is cloned into 
the sites between A and B. An alternative method to generate the master targeting 
fragment is by doing recombinant PCR. This fragment is then introduced to bacteria 
carrying the target BAC and recombination will occur between homology boxes A 
and C, resulting the simultaneous insertion of both galK and X. The recombinants can 
be efficiently selected for the presence of galK. To remove galK, a DNA fragment 
containing homology boxes B and C is generated by PCR using the BAC DNA as 
template, and is used to replace galK. Because of the small size of the fragment, the 
recombination is usually very efficient. As a result, 20%-50% of total colonies after 
DOG selection are correct recombinants, which can be screened relatively easily. 
 
Summary of the applications of BAC recombineering in Belmont lab 
In Belmont lab, we are most interested in using the engineered BAC to create 
transgene arrays to study the behavior of chromatin. By adding fluorescent tag or 
MS2 repeats, the mRNA and/or the protein product from genes contained in the BACs 
can be visualized, making live cell imaging feasible. In addition, by introducing 
mini-gene reporters to the BAC, we are able to study the influence of large-scale 
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chromatin folding on gene expression. 
The DNA sequences can be conveniently inserted to specific locations within the 
BAC using the recombineering approaches. The selectable marker for the additon of 
sequences may or may not need to be removed. If the marker do not need to be 
removed, any common drug resistance gene can be used as selectable marker. For 
instance, a DNA fragment containing a GFP reporter driven by a CMV promter and 
the Kan/Neo resistant gene driven by SV40 promoter was introduced into a BAC 
containing mouse DHFR locus and the recombinants were selected on LB plates 
containing Kanamycin. If the marker need to be removed to ensure the flexibility for 
further manipulation or to minimize effects of prokaryotic sequences, the galK should 
be the choice of selectable marker. As an example, four minigenes were inserted into 
different locations within DHFR BAC sequentially. The galK was used as selectable 
marker for both positive and negative selection for the insertion of each of the four 
genes. 
We are also exploiting BACs to identy cis DNA elements regulating the behavior 
of chromatin. For instance, by dissecting specific genomic loci we want to identify 
DNA elements required for the specific nuclear localization of the genes or the 
chromatin decondensation accompanying transcriptional activation. 
We have been able to efficiently delete genomic regions up to 75kb from a 200kb 
BAC containg human beta-globin locus. Similar to adding sequences to BAC, one can 
use different selectable markers depending on whether they need to be removed. If 
galK is used as the selectable marker, it can be removed to facilitate the next round of 
manipulation in the same BAC. 
Details about the recombineering procedures are summarized in the protocols 
attached. 
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Protocol 1. 
Transform BAC into E.coli SW102 strain for recombineering 
E.coli SW102 strain was obtained from Neal Copeland lab (NCI) and is derived 
from DY380 strain. This strain is specifically engineered for the λ-red mediated DNA 
recombination and GalK selection. To suppress the expression of recombination 
machinery, the strain should be culture at 32˚C. Culturing at elevated temperature may 
cause genomic instability of the strain. 
To modify a BAC with recombination, the first step is to introduce the BAC DNA 
into the SW102 strain. In this protocol, SW102 E.coli cells are made electrocompetent 
and the BAC DNA is transformed into the cells by electroporation. 
 
1. Before transformation, the BAC DNA should be purified by mini-prep or 
maxi-prep. The quality and the integrity of the BAC DNA should be checked 
by restriction digestion pattern generated by appropriate enzymes. 
2. Autoclave one 250ml flask and four 30ml centrifuge tubes the day before 
transformation. 
3. The day before transformation, inoculate a 2ml LB culture with the frozen 
glycerol stock of the SW102 cell. Grow the culture overnight in a 32˚C 
shaking waterbath. 
4. Inoculate a 100ml LB culture in a flask with 1ml of the overnight culture and 
grow the culture at 32˚C. It will take approximately 3 hours for the culture to 
reach the OD600 value of 0.55-0.6. Start monitoring the OD600 of the culture 
from the 2hr45min mark to ensure the culture is not overgrown. 
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5. Prepare an ice-water bath before the culture is ready. Cool down ddH2O and 
the centrifuge tubes on ice.  
6. When the culture is ready, briefly cool it down on ice. Then aliquot 25ml 
culture to each centrifuge tube.  
7. Centrifuge the culture at 5,000 rpm for 5min at 4˚C withe the Sorvall SS34 
rotor. Pour off the supernatant. Put the tubes back to the ice-water bath. Then 
add 1ml of ice-cold water to each tube. Swirl the tube in the ice-water slurry 
until the pellet is completely resuspended. This may take 1-2 minutes for each 
tube. Add 9ml more ice-cold water to the tube to bring the total volume to 
10ml, then swirl briefly.  
8. Repeat step 7. The pellet will become much looser after this centrifugation. 
The supernatant should be removed with a 10ml serological pipette with great 
caution instead of poured off. Remove as much supernatant as you can without 
disturbing the pellet. Because the pellet is loose, it should be easily 
resuspended. 
9. Centrifuge again. After this centrifugation, remove as much supernatant as 
you can, this usually leaves 0.5-1 ml of supernatant in the tube. Resuspend the 
pellet with a pipetteman, then transfer the suspension in each centrifuge tube 
to a clean 1.5ml microcentrifuge tube. Keep the cell suspension on ice. 
10. Centrifuge the suspension using a benchtop centrifuge machine in 4˚C cold 
room at 1,000 g for 5min. Remove supernatant to reduce the volume to about 
200μl per tube. This will give you 200ul electrocompetent SW102 cells per 25 
ml of culture or 800μl competent cells per 100 ml culture. Combine the cells 
in all 4 tubes and aliquot them to 500ul microcentrifuge tubes at 50ul per tube. 
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Unused SW102 competent cells can be flash frozen with liquid nitrogen or 
ethanol/ dry ice and stored at -80˚C. 
11. Mix the BAC DNA to be transformed with 50ul SW102 competent cells. Use 
10-50ng of maxi-prepped or 1ul of mini-prepped BAC for each transformation. 
Mix DNA with competent cells thoroughly by pipetting.  
12. Perform electroporation following standard protocol. Using 0.2 cm 
electroporation cuvette and the Bio-Rad electroporator with the following 
settings: Resistance=200 Ω, Capacitance= 25 μF and Voltage= 2.5kV. 
13. Recover the cells by adding 950ul of SOC medium. Shake in 32˚C waterbath 
for 1hr. 
14. Plate 100ul (1/10 of the total cells) on a LB plate containing 12.5ug/ml 
chloramphenicol. Incubate the plate at a 32˚C incubator. The colonies should 
be evident after ~24 hours incubation. Depending on the quality of DNA there 
should be tens to hundreds of colonies on the plate. 
15. Inoculate 5ml LB cultures containing chloramphenicol with several colonies. 
Use 4ml of the overnight culture for mini-prep. Check the restriction digestion 
patterns of the DNA to make sure there are no unwanted rearrangements with 
in the BAC. Freeze down the clones with correct digestion patterns.  
 
 
 
Protocol 2. 
Insertion of DNA sequences into BACs using drug resistant selectable marker 
This protocol describes the most straightforward recombineering, which is to 
insert a fragment containing a prokaryotic selectable marker. The correct 
recombinants will be selected using antibiotics, which is usually very efficient. 
However, the drawback of this protocol is the selectable marker can not be removed 
subsequently. We have successfully inserted fragments up to 4.5 kb containing a GFP 
or RFP reporter together with a Kan/Neo or Zeocin selectable marker into the BAC of 
interest using this protocol.  
This protocol consists of three parts: the generation of DNA fragment for 
recombination, the recombination and the screening of recombinants. 
 
 
Protocol 2.1 Generation of DNA fragment containing drug resistant selectable 
marker for recombination 
A DNA fragment containing the selectable marker and the homology boxes is 
usually generated by PCR. First, the target location in the BAC for the insertion needs 
to be determined. The DNA sequences flanking the targeting site will be the 
homology boxes for the recombination. The PCR primers should be designed to 
contain a 43-47 bp homology box (43 bp is the minimal length for efficient 
recombination) and a 13-17 bp sequence complementary to the ends of the sequence 
114 
 
115 
 
to be inserted. The total length of the primers should be 60bp (this is the most 
economical length for oligo synthesis). 
 
1. Amplify the sequence to be inserted from a plasmid template using standard 
PCR protocol. The PCR program should consist of two parts. For the first 5 
cycles, the annealing temperature should be set at about 3 degrees lower the 
melting temperatures of the 13-17 bp DNA stretch within the primers. This is 
followed by 35 more cycles with the primer annealing temperature set at 
about 3 degrees lower than the melting temperature of the full length primers. 
2. After the PCR amplification, run 2ul of the samples from a 50ul PCR reaction 
on a mini-gel. If the PCR works, add 2ul of DpnI directly to the PCR reaction 
and incubate at 37˚C for 2-4 hours. The DpnI enzyme is a frequent cutter 
which digests the plasmid template but not the PCR product.  
3. After the digestion, gel-purify the PCR product. The gel should be run slowly. 
I usually set the voltage at ~100V to get better separation of the bands. 
4. Run the recovered PCR product on a mini-gel to check the purity of the PCR 
product and estimate the concentration. The concentration of the DNA 
fragment should be at least 20ng/μl and usually the higher the better. The 
purified PCR product can be stored at -20˚C. 
 
Protocol 2.2 Insertion of DNA sequences of interest into BAC by homologous 
recombination 
In this protocol, the SW102 E.coli cells already carrying the BAC will be induced 
by heat-shock to express the recombination machinery, then made electrocompetent. 
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DNA fragment generated in protocol 2.1 will then be transformed into these cells by 
electroporation. The recombinants will be selected by antibiotics. As the negative 
control for the recombination, the same amount of the DNA fragment needs to be 
transformed into uninduced SW102 cells and selected with the same antibiotics. The 
colonies grown on the control plates indicate the background from the carry-over of 
the undigested plasmid template used in previous PCR. 
 
1. The day before recombination, inoculate a 5ml LB culture containing 
12.5ug/ml chloramphenicol with the SW102 bacteria clone carrying the BAC 
to be modified. Grow the culture overnight in a 32˚C shaking waterbath. 
2. Inoculate a 50ml LB culture with 1ml of the overnight culture and shake at 
32˚C. Grow the culture to the OD600 of about 0.55-0.6. Monitor the OD600 
value as described before. 
3. After the culture reaches the optimal density, split the culture into halves. 
Transfer 25ml of the culture into a 30ml centrifuge tube and leave it on ice. 
This will be used as the uninduced control for recombination. Heat-shock the 
other half of the culture at 42˚C for 15min in a shaking waterbath. After 
heat-shock, briefly cool down the culture on ice, then transfer it to a 30ml 
centrifuge tube. 
4. Follow steps 7-10 in protocol 1. Wash the bacteria with ice-water to make 
both the induced and uninduced SW102 cells electrocompetent. Reduce the 
volume of each 25ml culture to 150-200ul, this will be enough for 3-4 
electroporation reactions. 
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5. Transform 5ul of the DNA fragment prepared in protocol 2.1 into 50ul of 
induced or uninduced SW102 competent cells following standard procedures. 
Recover the cells with 950ul of SOC medium and shake in 32˚C waterbath for 
1hr. The recombination reaction will occur in the bacteria during this period. 
6. After recovery, plate the induced and uninduced samples on LB plates 
containing chloramphenicol and the appropriate antibiotics for selection. The 
recombination efficiency may vary depending on the homology arms and the 
size of the DNA fragment. I usually plate 1/10 and the rest (9/10) of the 
culture of both induced and uninduced samples on plates. 
7. Incubate the plates at a 32˚C incubator. The colonies should become obvious 
after 24hrs, which is much faster than the selection using GalK and minimal 
medium. Compare the numbers of colonies on the plates of induced and 
uninduced samples. There are usually at least 5 times more colonies on the 
plate of induced sample versus uninduced sample. 
 
Protocol 2.3 Screening for clones carrying correctly recombined BACs 
After drug selection, PCR will be used to confirm whether the DNA sequence of 
interest is inserted into the correct site within the BAC. The PCR primers bind to 
regions flanking the homology boxes can be used to amplify the regions between 
them in the engineered BAC. The size of the product will indicate whether there is 
insertion in the desired location. However, when the insertion is big (>4kb), this PCR 
may not work efficiently and likely give rise to high background. To efficiently screen 
for correct recombinants, we usually use two primer pairs to check the ends of the 
insertion. Each of the primer pair consists of one primer binding to a region outside of 
the homology box within the BAC and one primer binding to a region within the 
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insertion. The primers should be designed in a way that the product size will be 
100-500 bp. The specific PCR product from either pair of the primers will only be 
obtained when the insertion occurs at the correct location. 
After the verification of the recombinants by PCR method, the routine restriction 
digestion should be performed to check whether there are unwanted rearrangements 
of the BACs and, in case of the presence of lac operator repeats, the shortening of 
repetitive sequences. 
 
1. Draw grids on the bottom of a LB-Chloramphenicol plate and number the 
grids. Pick a colony from the experimental plate with a pipette tip and dab 
onto the gridded plate. Transfer 20-30 colonies for each experiment. Incubate 
the gridded plate at 32˚C overnight. 
2. After the colonies grow up on the gridded plate, scrape some bacteria from 
each colony with a pipette and transfer the bacteria into a 500ul eppendorf 
tube containing 25ul ddH2O. Resuspend the bacteria thoroughly by pipetting 
or vortexing. 
3. Lyse the bacteria by heating at 99˚C for 15min on a thermocycler. Briefly 
cool down the tubes on ice then spin the cells down at top speed for 2min with 
a benchtop centrifuge. Transfer 20ul of the supernatant to a clean tube for each 
clone. This will be used as the template for PCR. 
4. Perform PCR following standard protocols. Use 1ul of the colony prep as 
template for each 25ul PCR reaction. Also set up a control reaction using 
unmodified BAC DNA as PCR template. Run agarose gel to check the size of 
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the PCR products. The percentage of correct recombinants may vary from 
10-100%. 
5. For the clones showing correct PCR products, inoculate 5ml LB+ 
Chloramphenicol cultures with colonies on the gridded plate. Grow the 
cultures overnight at 32˚C. Mini-prep the BAC DNA and check the restriction 
digestion pattern with appropriate enzymes. 
6. Freeze down the clones carrying the correctly modified BACs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protocol 3. Seamless insertion of DNA sequences into BAC using galK as the dual 
selectable marker 
As discussed before, the use of common drug resistant selectable marker usually 
does not allow the removal of marker afterwards. To achieve seamless insertion of the 
sequence of interest, we use galK as the selectable marker for both positive and 
negative selection. The galK will be inserted along with the sequence of interest into 
the target BAC. The recombinants are selected with minimal medium containing 
galactose. A second recombination will then be performed to remove the galK and the 
recombinants are selected with minimal medium containing DOG. This scheme is 
particularly useful for sequential insertion of multiple DNA sequences into different 
locations in the same BAC. 
 
 
Protocol 3.1 Generation of a DNA fragment containing homology regions, galK 
selection cassette and the sequence to be inserted 
As described before, a DNA fragment consisting of five segments: homology 
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regions A, B and C, the galK selection cassette and the sequence X of interest needs to 
be generated. The homologous regions should be at least 43bp in length for efficient 
recombination. The sequence X is placed between homology regions A and B. The 
galK selection cassette is placed between homology regions B and C and will 
eventually be removed. 
This five-element fragment can be generated by routine molecular cloning. To 
speed up the cloning procedure, an oligo containing homology regions A, B and C and 
appropriate restriction sites can be synthesized. Then the galK and sequence X can be 
inserted at the restriction sites sequentially. Theoretically, this fragment can also be 
generated by a PCR based method called recombinant PCR. However, we haven't 
been able to test this method because all the DNA sequences we have inserted with 
the galK strategy are relatively large (ranging from 4.5-6kb) and the PCR 
amplification of them is relatively inefficient. 
 
1. Design the oligo containing homology regions A, B and C. First decide the 
site of insertion in the BAC. The 50bp regions flanking the targeting site can 
then be picked as homology regions A and B. And the 50bp region 
downstream of B can then be picked as homology region C. Check the 
restriction sites with in the regions A, B and C and make sure they do not 
contain the sites will be used later for cloning. Then add the sequences of the 
restriction sites between the homology regions (I usually use site EcoRI to 
insert galK cassette between B and C). Also add a rare restriction site to either 
end of the oligo (I usually add blunt-end restriction sites PmeI to both ends).  
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2. A pair of primers which match the ends of homology region B and C should 
also be designed, this will be used to generate a DNA fragment consisting B 
and C for the removal of galK.  
3. Transform the commercially synthesized oligo, which is already been inserted 
in a vector of choice, to an appropriate E.coli strain. Purify the plasmid DNA. 
Insert the galK selection cassette, which can be digested from plasmid pGalK, 
into the site between homology regions B and C. Screen for correct clones 
4. Insert the sequence X into the site(s) between homology regions A and B. 
Screen for correct clones. 
5. Purify the plasmid DNA. Digest the plasmid with the restriction enzymes 
which cut at the ends of the oligo to release the five-element fragment. 
 
Protocol 3.2 Insertion of the sequence of interest to the BAC followed by Gal 
selection 
The experiment procedure for the insertion of the sequence of interest to the target 
BAC is almost identical to protocol 2.2. The only difference is that the SW102 
bacteria need to be washed with minimal medium for multiple times before plating to 
remove the traces of rich medium. The selection of recombinants on minimal plates is 
slower than common drug selection, which takes 3-4 days. 
Recipes for the M9 medium and the M63 minimal plates (GAL or DOG) can be 
found at: 
http://web.ncifcrf.gov/research/brb/protocol/Protocol3_SW102_galK_v2.pdf 
 
1-5. Same as Protocol 2.2 
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6. After recovery, transfer the 1ml cultures to autoclaved eppendorf tubes. Spin 
the cells down with a benchtop centrifuge at top speed for 1min.  
7. Carefully remove the supernatant with pipettes as some of the pellets may be 
loose. Resuspend the pellet thoroughly with 1ml of M9 minimal medium. 
Then centrifuge again. 
8. Repeat step 7. 
9. Remove the supernatant and resuspend the pellet with 1ml M9 minimal 
medium. Plate 1/10 and 9/10 of the induced and uninduced samples on 
M63-Gal minimal plates. 
10. Incubate the plates in a 32˚C incubator. The plates should be placed into 
humid containers as they may dry out. The colonies should become obvious by 
day 3 of selection and reach desirable size at day 3 or day 4. 
 
Protocol 3.3 Screening for clones carrying correctly recombined BACs 
The clones will be screened by PCR to check whether the insertion occurs at the 
correct location. The strategy and experimental procedures are the same as protocol 
2.3. 
 
Protocol 3.4 Generation of DNA fragment for removing galK 
The DNA sequence of interest, X, and the galK selection cassette have been 
inserted into the BAC. And galK can be removed by a second round of recombination 
followed by negative selection. Because galK is inserted between homology regions B 
and C, a DNA fragment consisting only homology regions B and C can be generated 
by PCR and used to remove galK. 
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1. Perform standard PCR using the primers designed in Protocol 3.1 and the 
unmodified BAC DNA as template. 
2. Purify the PCR product using Qiagen PCR purification kit. Gel purification is 
not necessary. The concentration of purified fragment should be at least 
20ng/μl. 
 
Protocol 3.5 Removal of galK followed by negative selection with DOG 
The galK selection cassette will be removed and the recombinants are selected 
with DOG, which is toxic to the bacteria in the presence of GalK enzyme. However, 
the loss-of-function mutations of the galK gene or the loss of the galK by unwanted 
deletions of the BAC can also give rise to clones surviving the DOG selection. As a 
result, the number of background colonies after negative selection is significantly 
higher than positive selection. As the control for the galK removal, instead of 
transfecting DNA fragment into uninduced SW102 bacteria, the same volume of 
ddH2O or EB buffer is transfected into heat-shocked sample to evaluate the level of 
spontaneous loss of galK. 
Another possible source of background could be the carry-over of the SW102 
cells containing unmodified BAC. In the positive selection using galactose as the only 
carbon source, cells not expressing GalK stop growing, instead of being killed. 
Therefore, when colonies are picked from the GAL plate, there may be small numbers 
of "hitchhikers" also being picked, which can recover later in normal media and 
survive the DOG selection following the galK removal. To eliminate the 
contamination of the "hitchhikers", the galK-positive clone should be streaked onto a 
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special indicator plate (MacConkey indicator plates). And only bright red colonies 
should be picked for subsequent removal of galK. 
Recipe for MacConkey indicator plates: Add 20g Difco MacConkey Agar Base 
(BD, catalog# 281810) and 5g galactose to 500ml water, autoclave to sterilize. Let 
cool down to about 50˚C. Add 500ul of 12.5 mg/ml Chloramphenicol. Pour plates, 
20ml per plate. 
 
3. Streak the glycerol stock galK-positive clone onto a MacConkey plate to 
obtain single colonies. Incubate the plate at 32˚C. Bright red colonies should 
become obvious after 24 hours. 
4. Pick one bright red colony from the MacConkey plate and inoculate a 5ml 
culture containing Chloramphenicol. Shake overnight at 32˚C. 
5. Inoculate a 25 ml culture with 0.5 ml overnight culture. Grow the culture to 
the OD600 of 0.55-0.6. 
6. Heat shock the culture at 42˚C for 15min. 
7. Make the cells electrocompetent as described before. 
8. Electroporate 50ul of the electrocompetent cells with 5μl of the DNA 
fragment prepared in Protocol 3.4. As control, electroporate another 50μl of 
cells with 5μl of EB buffer. Recover the cells in 10ml LB for 4.5 hours at 
32˚C. 
9. As in protocol 3.2, pellet 1ml of the recovered culture and wash twice with 
1xM9 salts. Then make two serial dilutions with 1xM9 salts. Plate 100ul of the 
resuspended pellet (1/100 of the total cells), 100μl of 1:10 dilution (1/1000 of 
the total cells) and 100μl of 1:100 dilutions (1/10000 of the total cells) on 
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DOG plates. Incubate at 32˚C for 3 days. The number of colonies on the 
recombination plates may not be significantly different to the control plates 
(could vary from 1:1 to 100:1, according to literature). Screen 20-30 colonies 
from the recombination plate.  
 
Protocol 3.6 Screening for clones carrying correctly recombined BACs 
Following galK removal, the recombinants should again be screened using PCR. I 
usually use primers outside of the galK sequence, with one primer upstream of 
homology box B and in the insertion X and the other primer downstream of homology 
box C, for the screening. The correct product size will not only indicate the galK has 
been removed but not confirm the sequence X is still at the correct location. The 
experiment procedures for PCR screening are similar to protocol 2.3. 
Following the PCR screening the restriction fingerprinting should be performed to 
confirm the correct arrangement of the BAC sequences. By choosing proper enzyme 
the loss of the ~1.5 kb galK fragment should be obvious. 
 
 
 
 
 
 
 
 
 
Protocol 4. Deletion of specific BAC sequences using galK as the dual selectable 
marker 
BAC recombineering provides a convenient system for deleting specific 
sequences from the BAC. Using this method I have deleted regions ranging from 
2.8kb (the promoter region in DHFR BAC) to 116kb (the beta-globin genes in HBB 
BAC). The use of galK as selectable marker again allows the removal of galK and 
making subsequent deletions from one deletion. 
 
 
Protocol 4.1 Generation of a DNA fragment containing homology regions and galK 
using PCR 
The recombination fragment for making deletions can be conveniently generated 
using PCR. The sequences flanking the region to be deleted are chosen as the 
homology boxes. And a plasmid containing galK-pGalK (from Neal Copeland lab) is 
used as the PCR template. The PCR primers should consist of two parts, the 17bp 
sequence homology to the template pGalK and the 43 bp homology box, similar to the 
primes described in protocol 2.1. 
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The 17bp universal sequences I have been using to PCR pGalK are: 
Forward primer: 5’-cgacggccagtgaattg-3’  
Reverse primer: 5’-tgcttccggctcgtatg-3’  
As described in protocol 2.1, it is critical to completely remove the pGalK 
template from the PCR product by doing DpnI digestion and gel extraction as this will 
contribute to most of the background for the positive selection.  
 
Protocol 4.2 Deletion of sequences followed by Gal selection 
The experimental procedure is exactly the same as protocol 3.2. The uninduced 
control should give nearly zero colonies while the one tenth of the induced sample 
should give dozens to hundreds of colonies after the selection.  
 
Protocol 4.3 Screening for clones carrying correctly recombined BACs 
PCR will be used to screen the recombinants. The PCR primers flanking the 
deleted region should be used. And the BAC before the deletions should be used as 
the negative control. Due to the usually big size of the deleted regions, the control 
BAC should not give rise to any PCR product. And the correct recombinants should 
produce a PCR product containing the galK, which should have the size between 
1.5-2.5kb, depending on the primers used. 
Following the PCR screening, the restriction fingerprinting should be performed. 
If the desirable recombinants are obtained, the BAC can be stored as glycerol 
stock at -80˚C or streaked on a MAC plate for subsequent removal of galK and further 
deletions. 
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Protocol 4.4 Generation of DNA fragment for removing galK 
The DNA fragments for the removal of GalK were generated by PCR using 60bp 
primers partially complementary to each other (GkRm-F and –R). Each of the 60bp 
primers consists of a 52bp homology region flanking the galK marker and a 8bp 
sequence complementary to the last 8 bp of the other homology region. This will give 
rise to a 16bp complementary region between the two primers. For PCR, no extra 
template is needed. The PCR program should consist of 5 cycles with annealing 
temperature lower than the melting temperature of the 16bp stretch and 35 cycles with 
annealing temperature lower than the melting temperature of the full length primers, 
as described in protocol 2.1. 
 
Protocol 4.5 Removal of galK followed by negative selection with DOG 
The experimental procedures are exactly the same as protocol 3.5. 
 
Protocol 4.6 Screening for clones carrying correctly recombined BACs 
The same pair of primers designed for screening in protocol 4.3 can be used to 
screen for the loss of galK. The PCR products should have the sizes of several 
hundred bp after the removal of galK.  
 
